CCV | Cataract, congenital, Volkmann type (2)
ENO1, PPH, MPB1 | Enolase deficiency (1)
HMGCL | HMG-CoA lyase deficiency, 246450 (3)
AGRN | Myasthenia, limb-girdle, familial, 254300 (3)
SDC3, SYND3, SDCN | {Obesity, association with}, 601665 (3)
PEX10, NALD | Zellweger syndrome, 214100 (3); Adrenoleukodystrophy, neonatal,
DYT13 | Dystonia 13, torsion (2)
KONDS | Kondoh syndrome (2)
DFNB96 | Deafness, autosomal recessive 96 (2)
GABRD, GEFSP5, EIG10, EJM7 | {Generalized epilepsy with febrile seizures plus, type 5,
MTHFR | Homocystinuria due to MTHFR deficiency, 236250 (3); {Schizophrenia,
UBIAD1, TERE1, SCCD | Corneal dystrophy, crystalline, of Schnyder, 121800 (3)
MASP2 | MASP2 deficiency, 613791 (3)
PLOD, PLOD1 | Ehlers-Danlos syndrome, type VI, 225400 (3); Nevo syndrome, 601451
ESPN | Deafness, autosomal recessive 36, 609006 (3); Deafness, neurosensory,
C1QA | C1q deficiency, 613652 (3)
C1QB | C1q deficiency, 613652 (3)
C1QC, C1QG | C1q deficiency, 613652 (3)
CTRC, CLCR | {Pancreatitis, chronic, susceptibility to}, 167800 (3)
GDB2 | Gallbladder disease 2 (2)
KIF1B, CMT2A, CMT2A1, NBLST1 | Charcot-Marie-Tooth disease, type 2A1, 118210 (3); Pheochromocytoma,
MFN2, KIAA0214, CMT2A2 | Charcot-Marie-Tooth disease, type 2A2, 609260 (3); Hereditary motor
NPPA, PND, ANP, ATFB6 | Atrial fibrillation, familial, 6, 612201 (3)
PEX14 | Zellweger syndrome, 214100 (3)
SCZD12 | {Schizophrenia 12}, 181500 (2)
TARDBP, TDP43, ALS10 | Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3);
PAX7, RMS2 | Rhabdomyosarcoma 2, alveolar, 268220 (3)
GLC3B | Glaucoma 3, primary infantile, B (2)
EPB41, EL1 | Elliptocytosis-1, 611804 (3)
RHCE | [Blood group, Rhesus] (3); Rh-null disease, amorph type (3)
RHD | [Rh-negative blood type] (3)
PADI4, PADI5, PAD | {Rheumatoid arthritis, susceptibility to}, 180300 (3)
ANIB3 | Aneurysm, intracranial berry, 3 (2)
B6QTL1 | {Vitamin B6 plasma level QTL 1} (2)
BFIS4, BFIC4 | Seizures, benign familial infantile, 4 (2)
DHDDS, HDS, RP59 | Retinitis pigmentosa 59, 613861 (3)
FCN3, HAKA1 | Immunodeficiency due to ficolin 3 deficiency, 613860 (3)
PIGV | Mabry syndrome, 239300 (3)
ECE1 | Hirschsprung disease, cardiac defects, and autonomic dysfunction,
EPHA2, ECK, ARCC2, CTPP1, CTPA, ARCC2 | Cataract, posterior polar, 1, 116600 (3); Cataract, age-related
HSPG2, PLC, SJS, SJA, SJS1 | Schwartz-Jampel syndrome, type 1, 255800 (3); Dyssegmental dysplasia,
NR0B2, SHP | Obesity, mild, early-onset, 601665 (3)
EPHB2, EPHT3, DRT, ERK, PCBC, CAPB | Prostate cancer, progression and metastasis of, 603688 (3)
RPL11, DBA7 | Diamond-Blackfan anemia 7, 612562 (3)
SDHB, SDH2, SDHIP, PGL4 | Paragangliomas 4, 115310 (3); Pheochromocytoma, 171300 (3);
ALPL, HOPS, TNSALP | Hypophosphatasia, infantile, 241500 (3); Hypophosphatasia, childhood,
ALDH4A1, ALDH4, P5CDH | Hyperprolinemia, type II, 239510 (3)
ALPQTL2 | {Alkaline phosphatase, plasma level of, QTL 2} (2)
ATP13A2, PARK9, KRPPD | Parkinson disease 9, 606693 (3)
BCC1 | {Basal cell carcinoma, susceptibility to, 1} (2)
BMND3 | [Bone mineral density QTL 3] (2)
CLCNKA | Bartter syndrome, type 4b, digenic, 613090 (3)
CLCNKB | Bartter syndrome, type 3, 607364 (3); Bartter syndrome, type 4,
CMM, MLM, DNS | {Melanoma, cutaneous malignant, 1} (2)
DEL1p36, C1DELp36 | Chromosome 1p36 deletion syndrome (4)
DJ1, PARK7 | Parkinson disease 7, autosomal recessive early-onset, 606324 (3);
H6PD, GDH, G6PDH | Cortisone reductase deficiency, 604931 (3)
IBD7 | {Inflammatory bowel disease 7} (2)
LCA9 | Leber congenital amaurosis 9 (2)
MS4 | {Multiple sclerosis, susceptibility to, 4} (2)
MYP14 | Myopia 14 (2)
NPHP4, SLSN4 | Nephronophthisis 4, 606966 (3); Senior-Loken syndrome 4, 606996 (3)
PINK1, PARK6 | Parkinson disease 6, early onset, 605909 (3)
PLEKHG5, KIAA0720, DSMA4 | Spinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3)
SCAR4, SCASI | Spinocerebellar ataxia, autosomal recessive 4 (2)
TP73 | ?Neuroblastoma (1)
GALE | Galactose epimerase deficiency, 230350 (3)
LDLRAP1, ARH, FHCB2, FHCB1 | Hypercholesterolemia, familial, autosomal recessive, 603813 (3)
SEPN1, SELN, RSMD1, CFTD | Muscular dystrophy, rigid spine, 1, 602771 (3); Myopathy, congenital,
DYX8 | {Dyslexia, susceptibility to, 8} (2)
PLA2G5, FRFB | Fleck retina, familial benign, 228980 (3)
CCDC28B, MGC1203 | {Bardet-Biedl syndrome, modifier of}, 209900 (3)
GJB3, CX31, DFNA2B | Erythrokeratodermia variabilis et progressiva, 133200 (3); Deafness,
GJB4, CX30.3 | Erythrokeratodermia variabilis with erythema gyratum repens,
PLA2G2A, PLA2B, PLA2L, MOM1 | {Colorectal cancer}, 114500 (3)
WNT4, SERKAL | SERKAL syndrome, 611812 (3); Mullerian aplasia and hyperandrogenism,
YARS, CMTDIC, TYRRS, YTS, YRS | Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3)
CSF3R, GCSFR | Neutrophilia, hereditary, 162830 (3)
LCK | SCID due to LCK deficiency (1)
FAAH | {Drug addiction, susceptibility to} (3)
SLC2A1, GLUT1, DYT18, PED, ,GLUT1DS | GLUT1 deficiency syndrome 1, 606777 (3); GLUT1 deficiency syndrome
GDB2 | Gallbladder disease 3 (2)
RSPO1, FLJ40906 | Palmoplantar hyperkeratosis with squamous cell carcinoma of skin
COL8A2, FECD1, PPCD2 | Corneal dystrophy, Fuchs endothelial, 1, 136800 (3); Corneal
CATC3 | Cataract, autosomal recessive congenital 3 (2)
MUTYH, MYH | Adenomas, multiple colorectal, 608456 (3); Gastric cancer, somatic,
CLDN19, HOMG5 | Hypomagnesemia 5, renal, with ocular involvement, 248190 (3)
WDR65, VWS2 | van der Woude syndrome 2, 606713 (3)
EIF2B3 | Leukoencephalopathy with vanishing white matter, 603896 (3)
MMACHC | Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3)
ST3GAL3, SIAT6, ST3GALII, MRT12 | Mental retardation, autosomal recessive 12, 611090 (3)
PTOS1 | Ptosis, hereditary congenital, 1 (2)
AK2 | Reticular dysgenesis, 267500 (3)
ELAVL4, HUD, PNEM | Neuropathy, paraneoplastic sensory (1)
ERMAP, SC, RD | [Blood group, Scianna system], 111750 (3); [Blood group, Radin],
FUCA1 | Fucosidosis, 230000 (3)
KCNQ4, DFNA2A | Deafness, autosomal dominant 2A, 600101 (3)
LEPRE1, P3H1, GROS1, OI8 | Osteogenesis imperfecta, type VIII, 610915 (3)
LRP8, APOER2, MCI1 | {Myocardial infarction, susceptibility to}, 608446 (3)
MPL, TPOR, MPLV | Thrombocytopenia, congenital amegakaryocytic, 604498 (3);
UROD | Porphyria cutanea tarda, 176100 (3); Porphyria, hepatoerythropoietic,
ZMPSTE24, FACE1, STE24, MADB | Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3);
POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye
MACST | Macrostomia (2)
OFC13 | Orofacial cleft 13 (2)
BMND14 | [Bone mineral density QTL 14] (2)
COL9A2, EDM2, STL5 | Epiphyseal dysplasia, multiple, 2, 600204 (3); {Intervertebral
RHDNS1 | Renal hypodysplasia, nonsyndromic, 1 (2)
DHCR24, KIAA0018 | Desmosterolosis, 602398 (3)
FWS | Forsythe-Wakeling syndrome (2)
C8A | C8 deficiency, type I, 613790 (3)
C8B | C8 deficiency, type II, 613789 (3)
CPT2, IIAE4 | Myopathy due to CPT II deficiency, 255110 (3); CPT deficiency,
FOXE3, FKHL12, ASMD | Anterior segment mesenchymal dysgenesis, 107250 (3); Aphakia,
ORC1, ORC1L | Meier-Gorlin syndrome 1, 224690 (3)
PARK10, AAOPD | Parkinson disease 10 (2)
PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1 | Hypercholesterolemia, familial, 3, 603776 (3); {Low density
PPT1, CLN1 | Ceroid lipofuscinosis, neuronal, 1, 256730 (3)
PTCH2 | Medulloblastoma, 155255 (3); Basal cell carcinoma, somatic, 605462
RAD54L, HR54, HRAD54 | {Breast cancer, invasive ductal}, 114480 (3); Lymphoma, non-Hodgkin,
SCP2 | Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3)
STIL, SIL, MCPH7 | Microcephaly, primary autosomal recessive, 7, 612703 (3)
STQTL23 | {Stature QTL 23} (2)
TACSTD2, TROP2, M1S1 | Corneal dystrophy, gelatinous drop-like, 204870 (3)
TAL1, TCL5, SCL | Leukemia-1, T-cell acute lymphocytic (3)
DEL1p32p31, C1DELp32p31 | Chromosome 1p32-p31 deletion syndrome (4)
NEXN, NELIN, CMD1CC, CMH20 | Cardiomyopathy, dilated, 1CC, 613122 (3); Cardiomyopathy, familial
SLC35D1, UGTREL7, KIAA0260 | Schneckenbecken dysplasia, 269250 (3)
IL23R, IBD17 | {Inflammatory bowel disease 17, protection against}, 612261 (3);
DSAP3 | Porokeratosis, disseminated superficial actinic, 3 (2)
PBC3 | {Biliary cirrhosis, primary, 3} (2)
CTH | Cystathioninuria, 219500 (3); Homocysteine, total plasma, elevated
SPG29 | Spastic paraplegia-29 (2)
ACADM, MCAD | Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3)
AIR | Acute insulin response (2)
FOXD3, AIS1, VAMAS2 | {Autoimmune disease, susceptibility to, 1}, 607836 (3)
ANGPTL3, ANGPT5, FHBL2 | Hypobetalipoproteinemia, familial, 2, 605019 (3)
ARHI | Ovarian cancer (1)
ASRT4 | {Asthma-related traits, susceptibility to, 4} (2)
BSND | Bartter syndrome, type 4a, 602522 (3); Sensorineural deafness with
DBT, BCATE2 | Maple syrup urine disease, type II, 248600 (3)
LEPR, OBR | Obesity, morbid, with hypogonadism (3)
PAOD1 | Peripheral arterial occlusive disease 1 (2)
PGM1, GSD14 | Glycogen storage disease XIV, 612934 (3)
RPE65, RP20, LCA2 | Leber congenital amaurosis 2, 204100 (3); Retinitis pigmentosa 20,
AVSD1, AVCD | {Atrioventricular septal defect, susceptibility to, 1} (2)
ALG6, CDG1C | Congenital disorder of glycosylation, type Ic, 603147 (3)
ZNF644, MYP21 | Myopia 21, autosomal dominant, 614167 (3)
ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2 | Stargardt disease 1, 248200 (3); Retinitis pigmentosa 19, 601718 (3);
GCLM, GLCLR | {Myocardial infarction, susceptibility to}, 608446 (3)
RPL5, DBA6 | Diamond-Blackfan anemia 6, 612561 (3)
BCL10 | Lymphoma, MALT, somatic, 137245 (3); {Lymphoma, follicular, somatic},
CMM4 | {Melanoma, cutaneous malignant, 4} (2)
DPYD, DPD | Dihydropyrimidine dehydrogenase deficiency, 274270 (3);
GFI1, ZNF163, SCN2 | Neutropenia, severe congenital 2, autosomal dominant, 613107 (3);
UOX | [Urate oxidase deficiency] (1)
ABCD3, PXMP1, PMP70 | Zellweger syndrome-2 (3)
GLML, GVM, VMGLOM | Glomuvenous malformations, 138000 (3)
RP32 | Retinitis pigmentosa 32 (2)
ARCODS | Ariculocondylar syndrome (2)
MRT4 | Mental retardation, autosomal recessive, 4 (2)
MUHH2 | Hypotrichosis, hereditary, Marie Unna type, 2 (2)
AGL, GDE | Glycogen storage disease IIIa, 232400 (3); Glycogen storage disease
COL11A1, STL2 | Stickler syndrome, type II, 604841 (3); Marshall syndrome, 154780
STQTL7 | {Stature QTL 7} (2)
WS2B | Waardenburg syndrome, type 2B (2)
ALX3, FND1 | Frontonasal dysplasia 1, 136760 (3)
AMPD1 | Myoadenylate deaminase deficiency (3)
SCA19 | Spinocerebellar ataxia 19 (2)
SORT1, NT3, LDLCQ6 | [Low density lipoprotein cholesterol level QTL6], 613589 (3)
CASQ2 | Ventricular tachycardia, catecholaminergic polymorphic, 2, 611938 (3)
AP4B1, CPSQ5 | Cerebral palsy, spastic quadriplegic, 5, 614066 (3)
NRAS, ALPS4, NS6 | Colorectal cancer, 114500 (3); Thyroid carcinoma, follicular,
SLC16A1, MCT1, HHF7 | Erythrocyte lactate transporter defect, 245340 (3); Hyperinsulinemic
GPSM2, LGN, PINS, DFNB82 | Deafness, autosomal recessive 82, 613557 (3)
HSD3B2 | 3-beta-hydroxysteroid dehydrogenase, type II, deficiency, 201810 (3)
NGFB, HSAN5 | Neuropathy, hereditary sensory and autonomic, type V, 608654 (3)
GNAT2, ACHM4 | Achromatopsia-4, 613856 (3)
PTPN22, PEP, PTPN8, LYP | {Diabetes, type 1, susceptibility to}, 222100 (3); {Rheumatoid
RBM15, SPEN, OTT | Megakaryoblastic leukemia, acute (2)
TBX15 | Cousin syndrome, 260660 (3)
TRIM33, TIF1G, RFG7, PTC7 | Thyroid carcinoma, papillary, 188550 (3)
TSHB, CHNG4 | Hypothryoidism, congenital, nongoitrous 4, 275100 (3)
VANGL1, STBM2 | Caudal regression syndrome, 600145 (3); Neural tube defects, 182940
VUR | Vesicoureteral reflux (2)
HMGCS2 | HMG-CoA synthase-2 deficiency, 605911 (3)
NOTCH2, AGS2, HJCYS | Alagille syndrome 2, 610205 (3); Hajdu-Cheney syndrome, 102500 (3)
MNRI | Meningioma, radiation-induced (2)
ANON | {Anorexia nervosa, susceptibility to} (2)
CSE, DYT9 | Choreoathetosis/spasticity, episodic (2)
PSORS7 | {Psoriasis susceptibility 7} (2)
PHGDH | Phosphoglycerate dehydrogenase deficiency, 601815 (3)
DPM3, CDG1O | Congenital disorder of glycosylation, type Io, 612937 (3)
CORD8 | Cone-rod dystrophy 8 (2)
DDR2, NTRKR3, TKT | Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3)
AD13 | {Alzheimer disease-13} (2)
ADAMTSL4, TSRC1 | Ectopia lentis, isolated, autosomal recessive, 225100 (3)
ARNT | Leukemia, acute myeloblastic (3)
CHRNB2, EFNL3 | Epilepsy, nocturnal frontal lobe, 3, 605375 (3)
CTSK | Pycnodysostosis, 265800 (3)
ECM1 | Lipoid proteinosis, 247100 (3)
FLG, ATOD2 | Ichthyosis vulgaris, 146700 (3); {Dermatitis, atopic, susceptibility
GBA | Gaucher disease, type I, 230800(3); Gaucher disease, type II, 230900
HJV, HFE2A | Hemochromatosis, type 2A, 602390 (3)
LOR | Vohwinkel syndrome with ichthyosis, 604117 (3)
MCKD1 | Medullary cystic kidney disease 1 (2)
MLLT11, AF1Q | Leukemia, acute myelomonocytic (3)
PKLR, PK1 | Pyruvate kinase deficiency, 266200 (3); Adenosine triphosphate,
PRCC, RCCP1 | Renal cell carcinoma, papillary, 605074 (3)
PSORS4 | {Psoriasis susceptibility 4} (2)
PTCPRN, PRN1 | Thyroid carcinoma, papillary, with papillary renal neoplasia (2)
RFH1, AORF | Nephropathy-hypertension (2)
SDHC, PGL3 | Paragangliomas 3, 605373 (3); Paraganglioma
SPTA1, EL2, SPH3, HS3, HPP | Elliptocytosis-2, 130600 (3); Pyropoikilocytosis, 266140 (3);
ASPG3 | {Asperger syndrome susceptibility 3} (2)
NTRK1, TRKA, MTC | Insensitivity to pain, congenital, with anhidrosis, 256800 (3);
APCS, SAP | {?Amyloidosis, secondary, susceptibility to} (1)
APOA2 | Apolipoprotein A-II deficiency (3); {Hypercholesterolemia, familial,
ATP1A2, FHM2, MHP2 | Migraine, familial hemiplegic, 2, 602481 (3); Alternating
BMND2 | [Bone mineral density QTL 2] (2)
DFNA7 | Deafness, autosomal dominant 7 (2)
DFNA49 | Deafness, autosomal dominant 49 (2)
FCGR2A, IGFR2, CD32 | {Lupus nephritis, susceptibility to} (3)
SLEB14 | {Systemic lupus erythematosus, susceptibility to, 14} (2)
DEL1q21, C1DELq21 | Chromosome 1q21.1 deletion syndrome (4)
DUP1q21, C1DUPq21 | Chromosome 1q21.1 duplication syndrome (4)
GJA8, CX50, CAE1 | Cataract, zonular pulverulent-1, 116200 (3); Cataract, nuclear
NBLST6 | {Neuroblastoma, susceptibility to, 6} (2)
TAR | Thrombocytopenia-absent radius syndrome (2)
RFX5 | Bare lymphocyte syndrome, type II, complementation group C, 209920
GJA5, CX40, ATFB11 | Atrial fibrillation, familial, 11, 614049 (3)
HPRP3, RP18 | Retinitis pigmentosa 18, 601414 (3)
LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS, LGMD1B | Emery-Dreifuss muscular dystrophy 2, AD, 181350 (3); Cardiomyopathy, dilated, 1A, 115200 (3); Lipodystrophy, familial partial, 2, 151660 (3);
FCGR1A, IGFR1, CD64 | [IgG receptor I, phagocytic, familial deficiency of] (3)
ADAR, DRADA, DSH, DSRAD, IFI4, G1P1 | Dyschromatosis symmetrica hereditaria, 127400 (3)
HAX1, SCN3 | Neutropenia, severe congenital 3, autosomal recessive, 610738 (3)
HRM2 | Hair, curly (2)
CD244, NAIL, NKR2B4, SLAMF4 | {Rheumatoid arthritis, susceptibility to}, 180300 (3)
FCGR2B, CD32 | {Systemic lupus erythematosus, susceptibility to}, 152700 (3);
MAPBPIP, p14 | Immunodeficiency due to defect in MAPBP-interacting protein, 610798
MPZ, CMT1B, CMTDI3, CHM, DSS | Charcot-Marie-Tooth disease, type 1B, 118200 (3); Dejerine-Sottas
PPOX | Porphyria variegata, 176200 (3)
PEX19, PXF, HK33, D1S2223E | Zellweger syndrome, 214100 (3)
SEMA4A, SEMB, RP35, CORD10 | Retinitis pigmentosa 35, 610282 (3); Cone-rod dystrophy 10, 610283
CD247, CD3Z, TCRZ | Immunodeficiency due to defect in CD3-zeta, 610163 (3)
NCSTN | Acne inversa, familial, 1, 142690 (3)
TPM3, NEM1, CFTD | Nemaline myopathy 1, autosomal dominant, 609284 (3); Myopathy,
USF1, HYPLIP1 | {Hyperlipidemia, familial combined, susceptibility to}, 602491 (3)
ATP1B1 | [Blood pressure regulation QTL], 145500 (2)
BDET | Bleeding disorder, east Texas type (2)
F5, THPH2 | Factor V deficiency, 227400 (3); {Thrombophilia, susceptibility to,
FCGR2C, CD32C | Thrombocytopenic purpura, autoimmune, 188030 (1)
FCGR3A, CD16, IGFR3 | Neutropenia, alloimmune neonatal (3); {Viral infections, recurrent}
LFS3 | Li-Fraumeni syndrome 3 (2)
RGS5 | [Blood pressure regulation QTL], 145500 (2)
NDUFS2 | Mitochondrial complex I deficiency, 252010 (3)
PBX1 | Leukemia, acute pre-B-cell (2)
TNFSF6, APT1LG1, FASL | {Systemic lupus erythematosus, susceptibility}, 152700 (3)
TBX19 | Adrenocorticotropic hormone deficiency, 201400 (3)
FMO3, TMAU | Trimethylaminuria, 602079 (3)
SELE, ELAM1 | [Blood pressure regulation QTL], 145500 (2)
SELP, GRMP | Platelet alpha/delta storage pool deficiency (1); {Atopy,
SERPINC1, AT3, AT3D, THPH7 | Thrombophilia due to antithrombin III deficiency, 613118 (3)
DARC, FY, GPD, WBCQ1 | [Blood group, Duffy system], 110700 (3); {Malaria, vivax, protection
KCNJ10, SESAME | SESAME syndrome, 612780 (3); Enlarged vestibular aqueduct, digenic,
PIGM | Glycosylphosphatidylinositol deficiency, 610293 (3)
PVRL4, PRR4, EDSS1 | Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3)
QTV | [QT interval, variation in] (2)
SLC19A2, THTR1, TRMA, THMD1 | Thiamine-responsive megaloblastic anemia syndrome, 249270 (3)
DFNM1 | {Deafness, nonsyndromic, modifier 1} (2)
PRRX1, PMX1, PHOX1, AGOTC | Agnathia-otocephaly complex, 202650 (3)
SAC, HCA2 | {Hypercalciuria, absorptive, susceptibility to}, 143870 (3)
ABL2, ABLL, ARG | Leukemia, acute myeloid, with eosinophilia (1)
HMCN1, FBLN6, FIBL6, ARMD1 | {Macular degeneration, age-related, 1}, 603075 (3)
PRG4, CACP, MSF, SZP, HAPO | Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3)
TMCO1, CFSMR | Craniofacial dysmorphism, skeletal anomalies, and mental retardation
GORAB, SCYL1BP1, NTKLBP1, GO | Geroderma osteodysplasticum, 231070 (3)
MYOC, TIGR, GLC1A, JOAG, GPOA | Glaucoma 1A, primary open angle, juvenile-onset, 137750 (3);
AD14 | {Alzheimer disease-14} (2)
LHX4, CPHD4 | Pituitary hormone deficiency, combined, 4, 262700 (3)
NCF2 | Chronic granulomatous disease due to deficiency of NCF-2, 233710 (3)
PDON2 | Periodontitis, aggressive, 2 (2)
PLA2G4A, PLA2G4 | Phospholipase A2, group IV A, deficiency of (3)
RNASEL, RNS4, PRCA1, HPC1 | Prostate cancer 1, 176807, 601518 (3)
TNFSF4, GP34, OX4OL | {Myocardial infarction, susceptibility to}, 608446 (3)
HRPT2, C1orf28 | Hyperparathyroidism-jaw tumor syndrome, 145001 (3);
LAMC2, LAMNB2, LAMB2T | Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);
PDCN, NPHS2, SRN1 | Nephrotic syndrome, type 2, 600995 (3)
DARS2, ASPRS. LBSL | Leukoencephalopathy with brain stem and spinal cord involvement and
ASPM, MCPH5 | Microcephaly, primary autosomal recessive, 5, 608716 (3)
BOS2 | Branchiootic syndrome 2 (2)
CELIAC7 | {Celiac disease, susceptibility to, 7} (2)
GLUL, GLNS | Glutamine deficiency, congenital, 610015 (3)
MGR6, FHM3 | Migraine, familial hemiplegic (2); Migraine with or without aura,
PVOP1 | {Pelvic organ prolapse, susceptibility to, 1} (2)
CHIT, CHITD | [Chitotriosidase deficiency], 614122 (3)
IL10, CSIF, GVHDS | {HIV-1, susceptibility to}, 609423 (3); {Graft-versus-host disease,
PTPRC, CD45, LCA | {Hepatitic C virus, susceptibility to}, 609532 (3); Severe combined
CFHR1, FHR1, HFL1, CFHL1 | {Macular degeneration, age-related, reduced risk of}, 603075 (3);
CFHR3, FHR3, HLF4, CFHL3 | {Macular degeneration, age-related, reduced risk of}, 603075 (3);
CRB1, RP12, LCA8 | Retinitis pigmentosa-12, autosomal recessive, 600105 (3);
F13B | Factor XIIIB deficiency, 613235 (3)
PHA2A, PHA2 | Pseudohypoaldosteronism, type IIA (2)
PSEN2, AD4, STM2, CMD1V | Alzheimer disease-4, 606889 (3); Cardiomyopathy, dilated, 1V, 613697
PSNP2 | Supranuclear palsy, progressive, 2 (2)
FLVCR1, AXPC1, PCARP | Ataxia, posterior column, with retinitis pigmentosa, 609033 (3)
CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1 | Hypokalemic periodic paralysis, type 1, 170400 (3); {Malignant
CD55, DAF, CROM | [Blood group Cromer], 613793 (3)
CR1, C3BR | CR1 deficiency (1); {?SLE susceptibility} (1); [Blood group, Knops
CR2, C3DR, SLEB9 | {Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3)
GFND1 | Glomerulopathy with fibronectin deposits 1 (2)
HF1, CFH, HUS, ARMD4, AHUS1 | {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400
KISS1 | Hypogonadotropic hypogonadism, 146110 (3)
LAMB3 | Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);
MCP, CD46, AHUS2 | {Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922
PARK16 | {Parkinson disease-16} (2)
PKP1 | Ectodermal dysplasia/skin fragility syndrome, 604536 (3)
PTPN14, PEZ | Choanal atresia and lymphedema, 613611 (3)
REN, HNFJ2 | [Hyperproreninemia] (3); Renal tubular dysgenesis, 267430 (3);
TNNT2, CMH2, CMD1D, RCM3, LVNC6 | Cardiomyopathy, familial hypertrophic, 2, 115195 (3); Cardiomyopathy,
HSD11B1, HSD11, HSD11L | Cortisone reductase deficiency, 604931 (3)
IRF6, VWS, LPS, PIT, PPS, OFC6 | van der Woude syndrome, 119300 (3); Popliteal pterygium syndrome,
CHI3L1, GP39, YKL40, ASRT7 | {Schizophrenia, susceptibility to}, 181500 (3); {Asthma-related
IBD23 | {Inflammatory bowel disease 23} (2)
SYT14, SCAR11 | Spinocerebellar ataxia, autosomal recessive 11, 614229 (3)
RD3, LCA12, C1orf36 | Leber congenital amaurosis 12, 610612 (3)
RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2 | Martsolf syndrome, 212720 (3); Warburg micro syndrome 2, 614225 (3)
RMD1 | Rippling muscle disease-1, 606072 (2)
USH2A, RP39 | Usher syndrome, type 2A, 276901 (3); Retinitis pigmentosa 39, 613809
AUTS11 | {Autism susceptibility 11} (2)
GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPH1C | Leukodystrophy, hypomyelinating, 2, 608804 (3); Spastic
TLR5, TIL3, SLEB1 | {Legionaire disease, susceptibility to}, 608556 (3); {Systemic
CHRM3, EGBRS | Eagle-Barrett syndrome, 100100 (3)
DEL1q41q42, C1DELq41q42 | Chromosome 1q41-q42 deletion syndrome (4)
BCC2 | {Basal cell carcinoma, susceptibility to, 2} (2)
EA3 | Episodic ataxia, type 3 (2)
GNPAT, DHAPAT | Chondrodysplasia punctata, rhizomelic, type 2, 222765 (3)
MDC1B | Muscular dystrophy, congenital, 1B (2)
PARP1, ADPRT, PPOL, PARP | ?Xeroderma pigmentosum (1)
ACTN2, CMD1AA | Cardiomyopathy, dilated, 1AA, 612158 (3)
AGT, SERPINA8 | {Hypertension, essential, susceptibility to}, 145500 (3);
EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3 | Erythrocytosis, familial, 3, 609820 (3)
TBCE, KCS, KCS1, HRD | Kenny-Caffey syndrome-1, 244460 (3);
DEL1q42q44, C1DELq42q44 | Chromosome 1q42-q44 deletion syndrome (4)
ACTA1, ASMA, NEM3, NEM1, CFTD1 | Myopathy, nemaline, 3, 161800 (3); Myopathy, actin, congenital,
DISC1, SCZD9 | {Schizophrenia, susceptibility to}, 604906 (3); {Schizoaffective
DISC2 | Schizophrenia, 181500 (2)
EBAF, TGFB4, LEFTY2, LEFTA, LEFTYA | Left-right axis malformations (3)
EPHX1 | ?Fetal hydantoin syndrome (1); Diphenylhydantoin toxicity (1);
FH, HLRCC, MCUL1 | Fumarase deficiency, 606812 (3);
LBR, PHA | Pelger-Huet anomaly, 169400 (3); HEM skeletal dysplasia, 215140 (3);
CHS1, LYST | Chediak-Higashi syndrome, 214500 (3)
RYR2, VTSIP, ARVD2, ARVC2 | Ventricular tachycardia, catecholaminergic polymorphic, 1, 604772
CABC1, COQ8, ADCK3, SCAR9, ARCA2 | Coenzyme Q10 deficiency, 607426 (3); Spinocerebellar ataxia,
EDARADD, ED3, EDA3 | Ectodermal dysplasia, anhidrotic, autosomal recessive, 224900 (3);
PCAP | {Prostate cancer, susceptibility to}, 176807 (2)
SHFL1, SHFLD | Split-hand/foot malformation with long bone deficiency 1 (2)
MTR | Methylcobalamin deficiency, cblG type, 250940 (3); {Neural tube
DFNB45 | Deafness, autosomal recessive 45 (2)
NLRP3, CIAS1, FCU, FCAS, NALP3, PYPAF1 | Cold-induced autoinflammatory syndrome, familial, 120100 (3);
SPGF2, ASG | Spermatogenic failure 2 (2)
DFNB47 | Deafness, neurosensory, autosomal recessive 47 (2)
ADAM17, TACE, NISBD | Inflammatory skin and bowel disease, neonatal, 614328 (3)
KLF11, TIEG2, FKLF1, FKLF, MODY7 | Maturity-onset diabetes of the young, type VII, 610508 (3)
ODC1 | {Colonic adenoma recurrence, reduced risk of}, 114500 (3)
PEE2 | Preeclampsia/eclampsia 2 (2)
RPS7, DBA8 | Diamond-Blackfan anemia 8, 612563 (3)
TPO, TPX, TDH2A | Thyroid dyshormonogenesis 2A, 274500 (3)
ETM2, ETM | Tremor, hereditary essential, 2 (2)
HYT3 | {Hypertension, essential, susceptibility to, 3}, 145500 (2)
PPKP3 | ?Keratoderma, palmoplantar, punctate type 3 (2)
MYCN, NMYC, ODED, MODED | Feingold syndrome, 164280 (3)
WDR35, NAOFEN, KIAA1336, CED2 | Cranioectodermal dysplasia 2, 613610 (3); Short rib-polydactyly
ZNF513, RP58 | Retinitis pigmentosa 58, 613617 (3)
C2orf71 | Retinitis pigmentosa 54, 613428 (3)
APOB, FLDB, LDLCQ4 | Hypobetalipoproteinemia (3); Hypobetalipoproteinemia,
CLQTL2 | [Cholesterol level QTL 2] (2)
GEFSP4 | Epilepsy, generalized, with febrile seizures plus, type 4 (2)
KTCN4 | Keratoconus 4 (2)
MATN3, EDM5, HOA, OS2 | Epiphyseal dysplasia, multiple, 5, 607078 (3); {Osteoarthritis
EIF2B4 | Leukoencephaly with vanishing white matter, 603896 (3);
POMC | Obesity, adrenal insufficiency, and red hair due to POMC deficiency,
GCKR, GKRP, FGQTL5 | [Fasting plasma glucose level QTL 5], 613463 (3)
KHK | [Fructosuria], 229800 (3)
GINGF3, HGF3, GGF3 | Fibromatosis, gingival, 3 (2)
ALK, NBLST3 | {Neuroblastoma, susceptibility to, 3}, 613014 (3)
HADHA, MTPA | LCHAD deficiency, 609016 (3); Trifunctional protein deficiency,
HADHB | Trifunctional protein deficiency, 609015 (3)
SRD5A2 | Pseudovaginal perineoscrotal hypospadias, 264600 (3)
OTOF, DFNB9, NSRD9, AUNB1 | Deafness, autosomal recessive 9, 601071 (3); Auditory neuropathy,
XDH | Xanthinuria, type I, 278300 (3)
MPV17, MTDPS6 | Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810
CANDF1, CMCT | Candidiasis, familial, 1, autosomal dominant (2)
HNFJ3 | Hyperuricemic nephropathy, familial juvenile, 3 (2)
CYP1B1, GLC3A | Glaucoma 3A, primary congenital, 231300 (3); Peters anomaly, 604229
MSH2, COCA1, FCC1, HNPCC1 | Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3);
SOS1, GINGF, GF1, HGF, NS4 | Fibromatosis, gingival, 135300 (3); Noonan syndrome 4, 610733 (3)
SPAST, SPG4 | Spastic paraplegia-4, 182601 (3)
ABCG5 | Sitosterolemia, 210250 (3)
ABCG8, GBD4 | Sitosterolemia, 210250 (3); Gallbladder disease 4, 611465 (3)
DEL2p21, C2DELp21 | Hypotonia-cystinuria syndrome (4)
EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8 | Diarrhea 5, with tufting enteropathy, congenital, 613217 (3);
LEPQTL1, LSL | [Leptin serum levels QTL1] (2)
LHCGR, LHR, LCGR | Precocious puberty, male, 176410 (3); Leydig cell hypoplasia with
LPIN1 | Myoglobinuria, acute recurrent, autosomal recessive, 268200 (3)
SIX3, HPE2 | Holoprosencephaly-2, 157170 (3); Schizensephaly, 269160 (3)
MCFD2, F5F8D2 | Factor V and factor VIII, combined deficiency of, 613625 (3)
EPAS1, MOP2, HIF2A, ECYT4 | Erythrocytosis, familial, 4, 611783 (3)
FSHR, ODG1 | Ovarian dysgenesis 1, 233300 (3); Ovarian response to FSH
LRPPRC, LRP130, LSFC | Leigh syndrome, French-Canadian type, 220111 (3)
SCA25 | Spinocerebellar ataxia 25 (2)
NRXN1, PTHSL2, SCZD17 | Pitt-Hopkins-like syndrome 2, 614325 (3); {Schizophrenia,
SLC3A1, ATR1, D2H, NBAT | Cystinuria, 220100 (3)
PHF9, FANCL | Fanconi anemia, complementation group L, 614083 (3)
DEL2p16.1-p15, C2DELp161-p15 | Chromosome 2p16.1-p15 deletion syndrome (4)
ASRT3 | {Asthma-related traits, susceptibility to, 3} (2)
CNC2 | Carney complex, type II (2)
EFEMP1, FBNL, DHRD | Doyne honeycomb degeneration of retina, 126600 (3)
MSH6, GTBP, HNPCC5 | Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3);
STQTL24 | {Stature QTL 24} (2)
DYX3 | {Dyslexia, susceptibility to, 3} (2)
GLC1H | Glaucoma 1, open angle, H (2)
C2orf86, BBS15 | Bardet-Biedl syndrome 15, 209900 (3)
EHBP1, KIAA0903, HPC12 | {Prostate cancer, hereditary, 12}, 611868 (3)
FAM161A, RP28 | Retinitis pigmentosa 28, 606068 (3)
PEX13, ZWS, NALD | Zellweger syndrome, 214100 (3); Adrenoleukodystrophy, neonatal,
NFU1, HIRIP, MMDS1 | Multiple mitochondrial dysfunctions syndrome 1, 605711 (3)
ANIB5 | Aneurysm, intracranial berry, 5 (2)
HRPT3 | Hyperparathyroidism 3 (2)
RLS7 | {Restless legs syndrome 7} (2)
SPR | Dystonia, dopa-responsive, due to sepiapterin reductase deficiency,
MCEE | Methylmalonyl-CoA epimerase deficiency, 251120 (3)
DYSF, LGMD2B, MMD1 | Muscular dystrophy, limb-girdle, type 2B, 253601 (3);
ANTXR1, TEM8, ATR | {Hemangioma, capillary infantile, susceptibility to}, 602089 (3)
BOLA3, MMDS2 | Multiple mitochondrial dysfunctions syndrome 2, 614299 (3)
ALMS1, ALSS, KIAA0328 | Alstrom syndrome, 203800 (3)
CD207, LANGERIN, CLEC4K | [Birbeck granule deficiency], 613393 (3)
DCTN1, HMN7B | Neuropathy, distal hereditary motor, type VIIB, 607641 (3);
DGUOK, DGK, MTDPS3 | Mitochondrial DNA depletion syndrome 3 (hepatocerebral type),
OFC2 | Orofacial cleft-2 (2)
PEE1, PREG1 | Preeclampsia/eclampsia 1 (2)
PARK3 | Parkinson disease 3 (2)
WDM | Welander distal myopathy (2)
GCS1, CDG2B | Congenital disorder of glycosylation, type IIb, 606056 (3)
CCNP | Cataract, nuclear progressive (2)
CD8A | CD8 deficiency, familial, 608957 (3)
DFNA43 | Deafness, autosomal dominant 43 (2)
EIF2AK3, PEK, PERK, WRS | Wolcott-Rallison syndrome, 226980 (3)
FIGLA, POF6 | Premature ovarian failure 6, 612310 (3)
GGCX | Vitamin K-dependent coagulation defect, 277450 (3);
IGKC, IGKCD | [Kappa light chain deficiency], 614102 (3)
HTRA2, OMI, PARK13, PRSS25 | Parkinson disease 13, 610297 (3)
DEL2p12p11.2, C2DELp12p11.2 | Chromosome 2p12-p11.2 deletion syndrome (4)
SFTPB, SFTB3, SMDP1 | Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3)
HSR | [Handedness] (2)
REEP1, C2ORF23, SPG31 | Spastic paraplegia 31, 610250 (3)
RPIA, RPI | Ribose 5-phosphate isomerase deficiency, 608611 (3)
SIAT9, ST3GALV | Amish infantile epilepsy syndrome, 609056 (3)
SUCLG1, SUCLA1, MTDPS9 | Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type
FAME2, BAFME2, ADCME | Epilepsy, myoclonic, adult familial, 2 (2)
ATP6B1, VPP3 | Renal tubular acidosis with deafness, 267300 (3)
GLC1B | Glaucoma 1B, primary open angle, adult onset, 137760 (2)
AUTS5 | {Autism susceptibility 5} (2)
COPD | Pulmonary disease, chronic obstructive, severe early-onset (2)
CNGA3, CNG3, ACHM2 | Achromatopsia-2, 216900 (3)
TMEM127 | {Pheochromocytoma, susceptibility to}, 171300 (3)
CELIAC8 | {Celiac disease, susceptibility to, 8} (2)
EDAR, DL, ED3, EDA3, HRM1 | Ectodermal dysplasia, hypohidrotic, autosomal dominant, 129490 (3);
RANBP2, NUP358, ANE1, IIAE3 | {Encephalopathy, acute, infection-induced, 3, susceptibility to},
NNO3 | Nanophthalmos 3 (2)
C2orf64, PET191 | Mitochondrial complex IV deficiency, 220110 (3)
CNNM4, ACDP4 | Jalili syndrome, 217080 (3)
SNRNP200, ASCC3L1, KIAA0788, RP33 | Retinitis pigmentosa 33, 610359 (3)
ZAP70, SRK, STD | Selective T-cell defect (3)
PAX8 | Hypothyroidism, congenital, due to thyroid dysgenesis or
COMA | Oculomotor apraxia, congenital, Cogan-type (2)
IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP | Psoriasis, generalized pustular, 614204 (3)
NPHP1, NPH1, SLSN1, JBTS4 | Nephronophthisis 1, juvenile, 256100 (3); Senior-Loken syndrome-1,
PROC, PC, THPH3, THPH4 | Thrombophilia due to protein C deficiency, autosomal dominant,
BIN1, AMPHL | Myopathy, centronuclear, autosomal recessive, 255200 (3)
BUB1 | Colorectal cancer with chromosomal instability (3)
HMN7A, DHMNVP | Motor neuronopathy, distal hereditary, with vocal cord paralysis (2)
GLI2, HPE9 | Holoprosencephaly-9, 610829 (3)
IL1B | {Gastric cancer risk after H. pylori infection}, 137215 (3)
GYPC, GE, GPC | {Malaria, resistance to}, 611162 (3); [Blood group, Gerbich] (3)
LCO | ?Hepatocellular carcinoma (1)
CMD1H | Cardiomyopathy, dilated, 1H (2)
BMIQ13 | [Body mass index QTL13] (2)
MERTK, RP38 | Retinitis pigmentosa 38, 613862 (3)
IL1RN, MVCD4, DIRA | {Gastric cancer risk after H. pylori infection}, 137215 (3);
RNU4ATAC, U4ATAC, MOPD1, TALS | Microcephalic osteodysplastic primordial dwarfism, type I, 210710
CXCR4, D2S201E, NPY3R, WHIM | WHIM syndrome, 193670 (3); Myelokathexis, isolated (3)
ERCC3, XPB | Xeroderma pigmentosum, group B, 610651 (3); Trichothiodystrophy,
LCT, LAC, LPH | Lactase deficiency, congenital, 223000 (3)
MCM6 | Lactase persistance/nonpersistance, 223100 (3)
NMTC1 | Thyroid carcinoma, nonmedullary, 1 (2)
ADHD5 | {Attention deficit-hyperactivity disorder, susceptibility to, 5} (2)
CFC1, CRYPTIC, HTX2, DTGA2 | Heterotaxy, visceral, 2, autosomal, 605376 (3); Double-outlet right
CHDS2 | {Coronary heart disease, susceptibility to, 2} (2)
RAB3GAP1, WARBM1, P130 | Warburg micro syndrome 1, 600118 (3)
HNMT | {Asthma, susceptibility to}, 600807 (3)
NEB, NEM2 | Nemaline myopathy 2, autosomal recessive, 256030 (3)
ZEB2, ZFHX1B, SMADIP1, SIP1 | Mowat-Wilson syndrome, 235730 (3)
CACNB4, EJM6, EA5, EIG9 | {Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3);
ORC4, ORC4L | Meier-Gorlin syndrome 2, 613800 (3)
MAFD5 | {Major affective disorder 5} (2)
C2orf37 | Woodhouse-Sakati syndrome, 241080 (3)
ACVR1, ACVRLK2, ALK2, FOP | Fibrodysplasia ossificans progressiva, 135100 (3)
SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS | Seizures, benign familial infantile, 3, 607745 (3); Epileptic
DFNA16 | Deafness, autosomal dominant 16 (2)
DFNB27 | Deafness, autosomal recessive 27 (2)
DEL2q23.1, C2DELq23.1 | Chromosome 2q23.1 deletion syndrome (4)
MBD5, KIAA1461, MRD1 | Mental retardation, autosomal dominant 1, 156200 (3)
C2orf25, MMADHC | Homocystinuria, cblD type, variant 1, 277410 (3); Methylmalonic
ABCB11, BSEP, SPGP, PFIC2, BRIC2 | Cholestasis, progressive familial intrahepatic 2, 601847 (3);
SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3 | Epilepsy, generalized, with febrile seizures plus, type 2, 604403
SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP | Erythermalgia, primary, 133020 (3); Insensitivity to pain,
SLC25A12, ARALAR | Hypomyelination, global cerebral, 612949 (3)
GALNT3, HHS, HFTC | Tumoral calcinosis, hyperphosphatemic, familial, 211900 (3)
LRP2, DBS | Donnai-Barrow syndrome, 222448 (3)
CHRNA1, ACHRD, CMS2A, SCCMS, FCCMS | Myasthenic syndrome, slow-channel congenital, 601462 (3);
FGQTL1 | [Fasting plasma glucose level QTL 1] (2)
MMDK, MDK | Mesomelic dysplasia, Kantaputra type (2)
GPD2 | {Diabetes, type 2, susceptibility to}, 125853 (3)
SYNSTH | Synesthesia (2)
INTLQ2 | {Intelligence QTL3} (2)
IDDM19 | {Diabetes mellitus, insulin-dependent, 19} (2)
TTC21B, THM1, NPHP12, ATD4 | Nephronophthisis 12, 613820 (3); Asphyxiating thoracic dystrophy
AGPS, ADHAPS | Rhizomelic chondrodysplasia punctata, type 3, 600121 (3)
BBS5 | Bardet-Biedl syndrome 5, 209900 (3)
COL3A1 | Ehlers-Danlos syndrome, type IV, 130050 (3); Ehlers-Danlos syndrome,
COL5A2 | Ehlers-Danlos syndrome, type I, 130000 (3)
GAD1, SCP, CPSQ1 | Cerebral palsy, spastic quadriplegic, 1, 603513 (3)
IDDM7 | {Diabetes mellitus, insulin-dependent, 7} (2)
PNKD2 | Paroxysmal nonkinesigenic dyskinesia 2 (2)
SHFM5 | Split-hand/foot malformation 5 (2)
TTN, CMD1G, TMD, LGMD2J, MPRM, HMERF, EOMFC | Cardiomyopathy, familial hypertrophic, 9, 613765 (3); Cardiomyopathy,
HOXD4, HOX4B | {Leukemia, acute lymphoblastic, susceptibility to} (3)
HOXD10, HOX4D | Vertical talus, congenital, 192950 (3); Charcot-Marie-Tooth
HOXD13, HOX4I, SPD, BDSD | Synpolydactyly, type II, 186000 (3); Brachydactyly, type E, 113300
CHN1, CHN, ARHGAP2, RHOGAP2, DURS2 | Duane retraction syndrome 2, 604356 (3)
FRZB, FRZB1, SRFP3, OS1 | {Osteoarthritis susceptibility 1}, 165720 (3)
DUP2q31.1, C2DUPq31.1 | Chromosome 2q31.1 duplication syndrome (4)
ITGA6 | Epidermolysis bullosa, junctional, with pyloric stenosis, 226730
WIPF1, WASPIP, WIP | Wiskott-Aldrich syndrome 2, 614493 (3)
PJVK, DFNB59 | Deafness, autosomal recessive 59, 610220 (3)
PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2 | Pigmented nodular adrenocortical disease, primary, 2, 610475 (3)
DEL2q31 | Chromosome 2q31.2 deletion syndrome (4)
CERKL, RP26 | Retinitis pigmentosa 26, 608380 (3)
NDUFB3 | Mitochondrial complex I deficiency, 252010 (3)
PRKRA, PACT, RAX, DYT16 | Dystonia 16, 612067 (3)
NEUROD1, NIDDM | {Diabetes mellitus, noninsulin-dependent}, 125853 (3);
SLC40A1, SLC11A3, FPN1, IREG1, HFE4 | Hemochromatosis, type 4, 606069 (3)
DEL2q32q33, C2DELq32q33 | Chromosome 2q32-q33 deletion syndrome (4)
SCZD14 | {Schizophrenia, susceptibility to, 14} (2)
ARVD4 | Arrhythmogenic right ventricular dysplasia 4 (2)
GDF8, MSTN, MSLHP | Muscle hypertrophy, 614160 (3)
HIBCH | 3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3)
SUMO1, UBL1, SMT3, OFC10 | Orofacial cleft 10, 613705 (3)
SLEB11 | {Systemic lupus erythematosus, susceptibility to, 11} (2)
STAT1, CANDF7 | Mycobacterial infection, atypical, familial disseminated, 209950 (3);
CREB1 | Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)
ALS2, ALSJ, PLSJ, IAHSP | Amyotrophic lateral sclerosis, juvenile, 205100 (3); Primary
BCS1L, FLNMS, GRACILE, BJS, PTD | Mitochondrial complex III deficiency, 124000 (3); GRACILE syndrome,
BMPR2, PPH1 | Pulmonary hypertension, familial primary, 178600 (3); Pulmonary
CASP8, MCH5, ALPS2B | Immunodeficiency due to CASP8 deficiency, 607271 (3);
CTLA4, IDDM12, CELIAC3, GRD4 | {Graves disease, susceptibility to, 4} (3); {Hypothyroidism,
ICOS, AILIM, CVID1 | Immunodeficiency, common variable, 1, 607594 (3)
RLS4 | {Restless legs syndrome 4} (2)
SATB2, KIAA1034 | Cleft palate and mental retardation, 119540 (3)
CASP10, MCH4, ALPS2 | Autoimmune lymphoproliferative syndrome, type II, 603909 (3);
CHRND, ACHRD, SCCMS, CMS2A, FCCMS | Myasthenic syndrome, slow-channel congenital, 601462 (3);
CHRNG, ACHRG | Myasthenia gravis, neonatal transient (2); Escobar syndrome, 265000
NDUFS1 | Mitochondrial complex I deficiency, 252010 (3)
SPAX3, ARSAL | Ataxia, spastic, 3, autosomal recessive (2)
CRYGC, CRYG3, CCL | Cataract, Coppock-like, 604307 (3); Cataract, variable zonular
CRYGD, CRYG4, CCP | Cataracts, punctate, progressive juvenile-onset (3); Cataract,
IHH, BDA1 | Acrocapitofemoral dysplasia, 607778 (3); Brachydactyly, type A1,
EJM9 | {Epilepsy, juvenile myoclonic, susceptiblity to, 9} (2)
CYP27A1, CYP27, CTX | Cerebrotendinous xanthomatosis, 213700 (3)
ANIB9 | {Aneurysm, intracranial berry, 9} (2)
HSPD1, SPG13, HSP60, HLD4 | Spastic paraplegia-13, 605280 (3); Leukodystrophy, hypomyelinating,
SF3B1, SF3B155, SAP155, MDS | Myelodysplastic syndrome, somatic, 614286 (3)
TMEM237, ALS2CR4, JBTS14 | Joubert syndrome 14, 614424 (3)
FASTKD2, KIAA0971 | Mitochondrial complex IV deficiency, 220110 (3)
OS4, GOA1 | {Osteoarthritis susceptibility 4} (2)
ABCA12, ICR2B, LI2 | Ichthyosis, lamellar 2, 601277 (3); Ichthyosis, harlequin, 242500 (3)
FN1, FN, LETS, FNZ, GFND2 | Glomerulopathy with fibronectin deposits 2, 601894 (3);
IDDM13 | {Diabetes mellitus, insulin-dependent, 13} (2)
TCL4 | Leukemia/lymphoma, T-cell (2)
BARD1 | {Breast cancer, susceptibility to}, 114480 (3)
SLEN2 | {Systemic lupus erythematosus with nephritis, susceptibility to, 2}
SDTY1, SD1 | Syndactyly, type 1 (2)
SMARCAL1, HARP, SIOD | Schimke immunoosseous dysplasia, 242900 (3)
ATIC, PURH, AICAR | AICA-ribosiduria due to ATIC deficiency, 608688 (3)
CPS1 | Carbamoylphosphate synthetase I deficiency, 237300 (3); {Pulmonary
CXCR1, IL8RA | {AIDS, slow progression to}, 609423 (3)
DES, CMD1I | Myopathy, desmin-related, cardioskeletal, 601419 (3);
MR1, TAHCCP2, KIPP1184, BRP17, PNKD, FPD1, PDC, DYT8 | Paroxysmal nonkinesigenic dyskinesia, 118800 (3)
MTBS1 | {Tuberculosis, susceptibility to} (2)
NBLST5 | {Neuroblastoma, susceptibility to, 5} (2)
NHEJ1, XLF | Severe combined immunodeficiency with microcephaly, growth
OBSL1, KIAA0657, 3M2 | 3-M syndrome 2, 612921 (3)
PIKFYVE, PIP5K3 | Corneal fleck dystrophy, 121850 (3)
NRAMP1, NRAMP, SLC11A1 | {Mycobacterium tuberculosis, susceptibility to infection by}, 607948
WNT10A, SSPS, STHAG4, OODD | Odontoonychodermal dysplasia, 257980 (3); Schopf-Schulz-Passarge
PSHK2 | Pseudohyperkalemia, familial, 2, due to red cell leak (2)
VIL1 | Cholestasis, progressive canalicular (1)
ABCB6, MTABC3, MCOPCB7 | Microphthalmia, isolated, with coloboma 7, 614497 (3)
ACRPV | Acropectorovertebral dysplasia (2)
IGAN2 | {IgA nephropathy, susceptibility to, 2} (2)
IRS1 | {Diabetes mellitus, noninsulin-dependent}, 125853 (3); {Coronary
AGXT, SPAT | Hyperoxaluria, primary, type 1, 259900 (3)
COL4A3 | Alport syndrome, autosomal recessive, 203780 (3); Hematuria,
COL4A4 | Alport syndrome, autosomal recessive, 203780 (3); Hematuria,
GCG | [?Hyperproglucagonemia] (1)
PAX3, WS1, HUP2, CDHS, WS3 | Waardenburg syndrome, type 1, 193500 (3); Waardenburg syndrome, type
SPDA3 | {Spondylarthropathy, susceptibility to, 3} (2)
RJBS | Rajab syndrome (2)
CUL3, PHA2E | Pseudohypoaldosteronism, type IIE, 614496 (3)
SLC19A3, THMD2, BBGD | Thiamine metabolism dysfunction syndrome 2 (biotin- or
COL6A3 | Bethlem myopathy, 158810 (3); Ullrich congenital muscular dystrophy,
KCNJ13, SVD, LCA16 | Snowflake vitreoretinal degeneration, 193230 (3); Leber congenital
KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9 | Spastic paraplegia 30, autosomal recessive, 610357 (3); Neuropathy,
MLPH | Griscelli syndrome, type 3, 609227 (3)
UGT1A1, UGT1, GNT1, BILIQTL1 | Crigler-Najjar syndrome, type I, 218800 (3); [Gilbert syndrome],
ATG16L1, APG16L, IBD10 | {Inflammatory bowel disease 10}, 611081 (3)
GIGYF2, KIAA0642, PARK11 | Parkinson disease 11, 607688 (3)
MYP12 | Myopia 12 (2)
PRSS56, MCOP6 | Microphthalmia, isolated 6, 613517 (3)
SP110, IFI41, IFI75, VODI | Hepatic venoocclusive disease with immunodeficiency, 235550 (3);
SAG, RP47 | Oguchi disease-1, 258100 (3); Retinitis pigmentosa 47, 613758 (3)
STQTL21 | {Stature QTL 21} (2)
HPE6 | Holoprosencephaly-6 (2)
HDAC4, HDACA, BDMR, AHO3 | Brachydacytly-mental retardation syndrome, 600430 (3)
CAPN10, NIDDM1 | {Diabetes mellitus, noninsulin-dependent 1}, 601283 (3)
D2HGDH, D2HGD | D-2-hydroxyglutaric aciduria, 600721 (3)
NDUFA10 | Leigh syndrome, 256000 (3)
PDCD1, SLEB2 | {Systemic lupus erythematosus, susceptibility to, 2}, 605218 (3);
PER2, FASPS, KIAA0347 | Advanced sleep phase syndrome, familial, 604348 (3)
DEL3pterp25, C3DELpterp25 | 3p- syndrome (4)
CX3CR1, GPR13, V28 | {Rapid progression to AIDS from HIV1 infection}, 609423 (3);
CRBN, MRT2 | Mental retardation, autosomal recessive 2, 607417 (3)
OGG1 | Renal cell carcinoma, clear cell, somatic, 144700 (3)
ARHI2 | {Age-related hearing impairment 2} (2)
HPC5 | {Prostate cancer, hereditary, 5}, 176807 (2)
IBD9 | {Inflammatory bowel disease 9} (2)
SCA29 | Spinocerebellar ataxia 29 (2)
STQTL5 | {Stature QTL 5} (2)
SUMF1, FGE | Multiple sulfatase deficiency, 272200 (3)
ATP2B2, PMCA2 | {Deafness, autosomal recessive 12, modifier of}, 601386 (3)
GHRL | {Obesity, susceptibility to}, 601665 (3)
ITPR1, SCA15, SCA16 | Spinocerebellar ataxia 15, 606658 (3)
VHL | von Hippel-Lindau syndrome, 193300 (3); Renal cell carcinoma,
MYMY1, MYMY | Moyamoya disease (2)
CRELD1, AVSD2 | {Atrioventricular septal defect, susceptibility to, 2}, 606217 (3);
FANCD2, FANCD, FACD, FAD | Fanconi anemia, complementation group D2, 227646 (3)
MTMR14, C3orf29, HJUMPY | {Centronuclear myopathy, autosomal, modifier of}, 160150 (3)
UBM2 | {Melanoma, uveal, susceptibility to, 2} (2)
BTD | Biotinidase deficiency, 253260 (3)
CAV3, LGMD1C, LQT9 | Muscular dystrophy, limb-girdle, type IC, 607801 (3); Rippling
COLQ, EAD | Endplate acetylcholinesterase deficiency, 603034 (3)
PPARG, PPARG1, PPARG2, CIMT1, GLM1 | Obesity, severe, 601665 (3); [Obesity, resistance to] (3);
RAF1, CRAF, NS5 | Noonan syndrome 5, 611553 (3); LEOPARD syndrome 2, 611554 (3)
ST11, PETS1 | ?Pancreatic endocrine tumors (1)
SYN2 | {Schizophrenia, susceptibility to}, 181500 (3)
TMEM43, ARVD5, ARVC5 | Arrhythmogenic right ventricular dysplasia 5, 604400 (3)
WNT7A | Ulna and fibula, absence of, with sever limb deficiency, 276820 (3);
XPC, XPCC | Xeroderma pigmentosum, group C, 278720 (3)
OVCAS1 | {Ovarian cancer, susceptibility to} (2)
TSEN2, SEN2, PCH2B | Pontocerebellar hypoplasia type 2B, 612389 (3)
LGMD1H | Muscular dystrophy, limb-girdle, type 1H (2)
OS6 | {Osteoarthritis susceptibility 6} (2)
THRB, ERBA2, THR1, PRTH | Thyroid hormone resistance, 188570 (3); Thyroid hormone resistance,
FEB9 | Febrile seizures, familial, 9 (2)
DAZL, DAZH, SPGYLA | {Spermatogenic failure, susceptibility to}  (3)
HSN1B | Neuropathy, hereditary sensory, type IB (2)
ASPG4 | {Asperger syndrome susceptibility 4} (2)
SCLC1 | Small-cell cancer of lung (2)
TDGF1 | Forebrain defects (3)
GPD1L, KIAA0089 | Brugada syndrome 2, 611777 (3)
MHB | Myopathy, hyaline body (2)
ANO10, TMEM16K, SCAR10 | Spinocerebellar ataxia, autosomal recessive 10, 613728 (3)
CTNNB1 | Colorectal cancer (3); Hepatoblastoma (3); Pilomatricoma, 132600 (3);
SLC25A38 | Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive,
NBEAL2, KIAA0540, GPS, BDPLT4 | Gray platelet syndrome, 139090 (3)
CRTAP, CASP, OI7 | Osteogenesis imperfecta, type VII, 610682 (3)
TGFBR2, HNPCC6, AAT3, MFS2, LDS1B, LDS2B | Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3);
ACVR2B, ACTRIIB, HTX4 | Heterotaxy, visceral, 4, autosomal, 613751 (3)
DLEC1, DLC1 | Lung cancer, 211980 (1); Esophageal cancer, 133239 (1)
MYD88, MYD88D | Pyogenic bacterial infections, recurrent, due to MYD88 deficiency,
PLCD1, NDNC3 | Nail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3)
PTHR1, PTHR, PFE | Metaphyseal chondrodysplasia, Murk Jansen type, 156400 (3);
GLB1, MPS4B | GM1-gangliosidosis, type I, 230500 (3); GM1-gangliosidosis, type II,
KLHDC8B | Hodgkin lymphoma, 236000 (3)
NDUFAF3 | Mitochondrial complex I deficiency, 252010 (3)
SLC25A20, CACT, CAC | Carnitine-acylcarnitine translocase deficiency, 212138 (3)
ZD1 | Zygodactyly 1 (2)
BAP1, TPDS | Tumor predisposition syndrome, 614327 (3)
CISH, BACTS2 | {Tuberculosis, susceptibility to}, 607948 (3); {Malaria,
COL7A1 | Epidermolysis bullosa dystrophica, AD, 131750 (3); Epidermolysis
FYCO1, CATC2 | Cataract, autosomal recessive congenital 2, 610019 (3)
GPX1, GPXD | Hemolytic anemia due to glutathione peroxidase deficiency, 614164 (1)
IBD12 | {Inflammatory bowel disease 12} (2)
LAMR1, LAMBR | ?Arrhythmogenic right ventricular dysplasia 5, 604400 (1)
MLH1, COCA2, HNPCC2 | Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3);
RASSF1 | Lung cancer, 211980 (2)
SLC6A20, XT3 | Hyperglycinuria, 138500 (3); Iminoglycinuria, digenic, 242600 (3)
HYAL1 | Mucopolysaccharidosis type IX, 601492 (3)
TREX1, AGS1, CRV, HERNS | Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3);
TNNC1, CMD1Z, CMH13 | Cardiomyopathy, dilated, 1Z, 611879 (3); Cardiomyopathy, familial
IMPDH2, IMPD2 | [IMPDH2 enzyme activity, variation in] (3)
AMT, NKH, GCE | Glycine encephalopathy, 605899 (3)
HESX1, RPX, CPHD5 | Septooptic dysplasia, 182230 (3); Pituitary hormone deficiency,
ITIH4, PK120, ITIHL1 | {Hypercholesterolemia, susceptibility to}, 143890 (3)
ACY1, ACY1D | Aminoacylase 1 deficiency, 609924 (3)
PROK2, PK2, BV8, KAL4 | Kallmann syndrome 4, 610628 (3); Hypogonadism, hypogonadotropic,
RFT1, CDG1N | Congenital disorder of glycosylation, type In, 612015 (3)
DNASE1L3, SLEB16 | Systemic lupus erythematosus 16, 614420 (3)
ABHD5, CGI58, IECN2, NCIE2 | Chanarin-Dorfman syndrome, 275630 (3)
CELIAC9 | {Celiac disease, susceptibility to, 9} (2)
CCR2, CMKBR2 | {HIV infection, susceptibility/resistance to} (3)
CCR5, CMKBR5, CCCKR5, IDDM22 | {HIV infection, susceptibility/resistance to} (3); {West nile virus,
DAG1, DAG, MDDGC7 | Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7,
GLYCTK, GLYCTK1 | D-glyceric aciduria, 220120 (3)
GNAI2, GNAI2B, GIP | Pituitary ACTH-secreting adenoma (3); Ventricular tachycardia,
GNAT1, CSNBAD3 | Night blindness, congenital stationary, autosomal dominant 3,
HSCR6 | {Hirschsprung disease, susceptibility to, 6} (2)
LAMB2, LAMS, NPHS5 | Nephrotic syndrome, type 5, with or without ocular abnormalities,
PSC | Cholangitis, primary sclerosing (2)
SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2 | Long QT syndrome-3, 603830 (3); Brugada syndrome 1, 601144 (3); Heart
TMIE, DFNB6 | Deafness, autosomal recessive 6, 600971 (3)
WNT5A | Robinow syndrome, autosomal dominant, 180700 (3)
MPVQTL2 | [Mean platelet volume QTL2] (2)
FLNB, SCT, AOI, LRS1 | Spondylocarpotarsal synostosis syndrome, 272460 (3); Larsen syndrome,
ZLS | ?Zimmermann-Laband syndrome (2)
ATXN7, SCA7, OPCA3 | Spinocerebellar ataxia 7, 164500 (3)
FOXP1, QRF1 | Mental retardation with language impairment and autistic features,
HYT7 | {Hypertension, essential, susceptibility to, 7} (2)
MITF, WS2A | Waardenburg syndrome, type 2A, 193510 (3); Waardenburg
PRICKLE2, EPM5 | Epilepsy, progressive myoclonic 5, 613832 (3)
KTCN3 | Keratoconus 3 (2)
PDHB, PDHBD | Pyruvate dehydrogenase E1-beta deficiency, 614111 (3)
ROBO2, SAX3, KIAA1568 | Vesicoureteral reflux 2, 610878 (3)
GBE1 | Glycogen storage disease IV, 232500 (3)
ARL6, BBS3, RP55 | Bardet-Biedl syndrome 3, 209900 (3); {Bardet-Biedl syndrome 1,
DYX5 | {Dyslexia, susceptibility to, 5} (2)
SSD | {Speech-sound disorder} (2)
PBC1 | Biliary cirrhosis, primary, 1 (2)
CHMP2B, DMT1, VPS2B | Dementia, familial, nonspecific, 600795 (3); Amyotrophic lateral
POU1F1, PIT1, CPHD1 | Pituitary hormone deficiency, combined, 1, 613038 (3)
CRCL | Creatinine clearance QTL (2)
MYL3, CMH8 | Cardiomyopathy, familial hypertrophic, 8, 608751 (3)
TFG | Chondrosarcoma, extraskeletal myxoid, 612237 (1)
ARL13B, ARL2L1, JBTS8 | Joubert syndrome 8, 612291 (3)
IMPG2, IPM200, RP56 | Retinitis pigmentosa 56, 613581 (3); Maculopathy, IMPG2-related,
PROS1, THPH5, THPH6 | Thrombophilia due to protein S deficiency, autosomal dominant,
CAMPD1 | Camptodactyly 1 (2)
CPOX | Coproporphyria, 121300 (3); Harderoporphyria, 121300 (3)
KALRN, HAPIP, DUO, CHDS5 | {Coronary heart disease, susceptibility to, 5}, 608901 (3)
UMPS, OPRT | Orotic aciduria, 258900 (3)
HMSNO, HMSNP | Neuropathy, hereditary motor and sensory, Okinawa type (2)
MHS4 | {Malignant hyperthermia susceptibility 4} (2)
CD96, TACTILE | C syndrome, 211750 (3)
DRD3, ETM1, FET1 | {Schizophrenia, susceptibility to}, 181500 (3); {Essential tremor,
CASR, HHC1, PCAR1, FIH, EIG8 | Hypocalciuric hypercalcemia, type I, 145980 (3); Hyperparathyroidism,
TRH | Thyrotropin-releasing hormone deficiency, 275120 (1)
ZNF9, CNBP1, DM2, PROMM | Myotonic dystrophy 2, 602668 (3)
ATOD1 | {Dermatitis, atopic, susceptibility to, 1} (2)
CSTA, STFA, STF1, AREI | Exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of
DIRC2, RCC4 | Renal cell carcinoma, 144700 (2)
FGQTL6, BWQTL3, PGQTL1 | [Fasting plasma glucose level QTL 6] (2); [Birth weight QTL 3] (2);
GP9 | Bernard-Soulier syndrome, type C, 231200 (3)
GATA2, DCML, MONOMAC | Dendritic cell, monocyte, B lymphocyte, and natural killer
IFT122, WDR10, CED | Cranioectodermal dysplasia, 218330 (3)
MYLK, MLCK, AAT7 | Aortic aneurysm, familial thoracic 7, 613780 (3)
PSORS5 | {Psoriasis susceptibility 5} (2)
RAB7, CMT2B, PSN | Charcot-Marie-Tooth disease, type 2B, 600882 (3)
SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2 | Hypertrophic osteoarthropathy, primary, autosomal recessive 2,
TF, TFQTL1 | Atransferrinemia, 209300 (3)
HCFP1, MBS2 | Facial paresis, hereditary congenital, 1 (2)
PCCB | Propionicacidemia, 606054 (3)
HGD, AKU | Alkaptonuria, 203500 (3)
ATP2C1, BCPM, HHD | Hailey-Hailey disease, 169600 (3)
GLC1C | Glaucoma 1C, primary open angle (2)
RHO, RP4, OPN2, CSNBAD1 | Retinitis pigmentosa 4, autosomal dominant or recessive, 613731 (3);
AGTR1, AGTR1A, AT2R1 | Hypertension, essential, 145500 (3); Renal tubular dysgenesis,
BFSP2, CP49, CP47 | Cataract, juvenile-onset, 604219 (3); Cataract, congenital, 604219
CLRN1, USH3A, USH3, RP61 | Usher syndrome, type 3A, 276902 (3); Retinitis pigmentosa 61, 614180
MME, CD10, CALLA, NEP | [Neutral endopeptidase deficiency] (1); Membranous
TERC, TRC3, TR, DKCA1 | Dyskeratosis congenita, autosomal dominant 1, 127550 (3); Aplastic
ILDR1, DFNB42 | Deafness, autosomal recessive 42, 609646 (3)
IQCB1, NPHP5, KIAA0036 | Senior-Loken syndrome 5, 609254 (3)
UROC1 | Urocanase deficiency, 276880 (3)
DFNA18 | Deafness, autosomal dominant 18 (2)
NPHP3, NPH3, RHPD, MKS7 | Nephronophthisis 3, 604387 (3); Renal-hepatic-pancreatic dysplasia,
SLSN3 | Senior-Loken syndrome 3 (2)
AD15 | {Alzheimer disease-15} (2)
ATR, FRP1, SCKL | Seckel syndrome 1, 210600 (3)
DWS, C3DELq22q24, DEL3q22q24 | Dandy-Walker syndrome (4)
OTSC5 | Otosclerosis 5 (2)
FOXL2, BPES, BPES1, PFRK, POF3 | Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100
MRPS22, C3orf5, COXPD5 | Combined oxidative phosphorylation deficiency 5, 611719 (3)
STQTL10 | {Stature QTL 10} (2)
CP | [Hypoceruloplasminemia, hereditary], 604290 (3);
PLOD2, LH2, TLH | Bruck syndrome 2, 609220 (3)
GMPS | Leukemia, acute myelogenous, 601626 (3)
HPS3 | Hermansky-Pudlak syndrome 3, 614072 (3)
SLC9A9, AUTS16 | {Autism susceptibility 16}, 613410 (3)
P2RY12, P2Y12, BDPLT8 | Bleeding disorder, platelet-type, 8, 609821 (3)
GYG1, GSD15 | Glycogen storage disease XV, 613507 (3)
HDLCQ5 | [High density lipoprotein cholesterol level QTL 5] (2)
IFT80, KIAA1374, WDR56, ATD2 | Asphyxiating thoracic dystrophy 2, 611263 (3)
UVM1 | {Melanoma, uveal, susceptibility to, 1} (2)
B3GALT3, GLCT3, P | [Blood group, P system], 111400 (3); {Urinary tract infection,
CELIAC10 | {Celiac disease, susceptibility to, 10} (2)
SI | Sucrase-isomaltase deficiency, congenital, 222900 (3)
ASPG1 | {Asperger syndrome susceptibility 1} (2)
AUTS8 | {Autism susceptibility 8} (2)
MCCC1, MCCA | 3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3)
MLF1 | Leukemia, acute myeloid, 601626 (1)
GFM1, EFG1, GFM, COXPD1 | Combined oxidative phosphorylation deficiency 1, 609060 (3)
BWQTL2 | [Birth weight QTL 2] (2)
SLC33A1, ACATN, AT1, SPG42, CCHLND | Spastic paraplegia-42, 612539 (3); Congenital cataracts, hearing
ACAD9 | ACAD9 deficiency, 611126 (3)
AFA1, MPB | Alopecia, androgenetic, 1 (2)
CLCN2, EGMA, ECA2, EGI11, EJM8 | {Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3);
EVI1 | 3q21q26 syndrome (1)
MDS1 | Myelodysplasia syndrome-1 (3)
MYP8 | Myopia 8 (2)
SERPINI1, PI12 | Encephalopathy, familial, with neuroserpin inclusion bodies, 604218
PDCD10, TFAR15, CCM3 | Cerebral cavernous malformations 3, 603285 (3)
BCHE, CHE1 | Apnea, postanesthetic (3)
MNG3 | Goiter, multinodular, 3 (2)
SLC2A2, GLUT2 | {Diabetes mellitus, noninsulin-dependent} (3); Fanconi-Bickel
APMR2 | Alopecia with mental retardation syndrome 2 (2)
FEB10 | Febrile seizures, familial, 10 (2)
CCDC39 | Ciliary dyskinesia, primary, 14, 613807 (3)
DNAJC19, TIM14 | 3-methylglutaconic aciduria, type V, 610198 (3)
GHSR | Short stature, 604271 (3)
PIK3CA | Ovarian cancer, somatic, 167000 (3); Breast cancer, somatic, 114480
SPATA16, SPGF6 | Spermatogenic failure 6, 102530 (3)
SOX2, MCOPS3 | Microphthalmia, syndromic 3, 206900 (3); Optic nerve hypoplasia
THPO, MGDF, MPLLG, TPO | Thrombocythemia, essential, 187950 (3)
APMR1 | Alopecia with mental retardation syndrome 1 (2)
ADIPOQ, APM1, GBP28, ADIPQTL1 | Adiponectin deficiency, 612556 (3)
ALG3, NOT56L, CDGS4, CDG1D | Congenital disorder of glycosylation, type Id, 601110 (3)
AOMS1, SYNX | Abdominal obesity-metabolic syndrome (2)
BCL6 | Lymphoma, B-cell (2)
CLDN16, PCLN1, HOMG3 | Hypomagnesemia 3, renal, 248250 (3)
CRYGS, CRYG8 | Cataract, progressive polymorphic cortical (3)
EIF2B5, LVWM, CACH, CLE | Leukoencephalopathy with vanishing white matter, 603896 (3);
EIF4G1, EIF4G, PARK18 | Parkinson disease 18, 614251 (3)
HRG, THPH11 | Thrombophilia due to HRG deficiency, 613116 (3); Thrombophilia due
KNG1, KNG | [Kininogen deficiency], 228960 (3); [High molecular weight kininogen
TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8 | Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome
LIPH, LAH2, ARWH2 | Hypotrichosis, localized, autosomal recessive 2, 604379 (3);
SPG14 | Spastic paraplegia 14, autosomal recessive (2)
CCDC50, C3orf6, DFNA44 | Deafness, autosomal dominant 44, 607453 (3)
CELIAC11 | {Celiac disease, susceptibility to, 11} (2)
IGF2BP2, IMP2 | {Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853
LNCR5 | {Lung cancer susceptibility 5} (2)
LPP | Lipoma (3); Leukemia, acute myeloid, 601626 (3)
CLDN1, SEMP1, ILVASC | Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis,
OPA1, NTG, NPG | Optic atrophy 1, 165500 (3); {Glaucoma, normal tension,
DEL3q29, MICRODEL3q29 | Chromosome 3q29 microdeletion syndrome (4)
DUP3q29, MICRODUP3q29 | Chromosome 3q29 microduplication syndrome (4)
LEPREL1, P3H2, MCVD | Myopia, high, with cataract and vitreoretinal degeneration, 614292
RNF168 | RIDDLE syndrome, 611943 (3)
RPL35A, DBA5 | Diamond-Blackfan anemia 5, 612528 (3)
ADD1 | {Hypertension, essential, salt-sensitive}, 145500 (3)
FGFR3, ACH | Achondroplasia, 100800 (3); Hypochondroplasia, 146000 (3); Thanatophoric dysplasia, type I, 187600 (3);
HTT, HD, IT15 | Huntington disease, 143100 (3)
IDUA, IDA | Mucopolysaccharidosis Ih, 607014 (3); Mucopolysaccharidosis Is,
MDCMP | Muscular dystrophy, congenital, merosin-positive (2)
NAT8L, CML3, NACED | N-acetylaspartate deficiency, 614063 (3)
PDE6B, PDEB, RP40, CSNBAD2 | Night blindness, congenital stationary, autosomal dominant 2, 163500
RNF212, ZHP3 | Recombination rate QTL 1, 612042 (3)
SH3BP2, CRPM | Cherubism, 118400 (3)
TACC3 | {?Bladder cancer susceptibility}, 109800 (2)
WHS | Wolf-Hirschhorn syndrome (4)
DOK7, C4orf25, CMS1B | Myasthenia, limb-girdle, familial, 254300 (3); Fetal akinesia
ADRA2C, ADRA2L2 | {Congestive heart failure and beta-blocker response, modifier of} (3)
HMX1, H6 | Oculoauricular syndrome, 612109 (3)
MSX1, HOX7, HYD1, OFC5, STHAG1 | Tooth agenesis, selective, 1, with or without orofacial cleft, 106600
NKX3-2, BAPX1, SMMD | Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3)
WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL | Wolfram syndrome, 222300 (3); Deafness, autosomal dominant 6/14/38,
DRD5, DRD1B, DRD1L2 | {Blepharospasm, primary benign}, 606798 (3); Dystonia, primary
CRSA, CRS3 | Craniosynostosis, Adelaide type (2)
EVC | Ellis-van Creveld syndrome, 225500 (3); Weyers acrodental dysostosis,
LBN, EVC2 | Ellis-van Creveld syndrome, 225500 (3)
PLSA1, PLSA | Primary lateral sclerosis, adult, 1 (2)
SLC2A9, GLUT9, UAQTL2 | {Uric acid concentration, serum, QTL 2}, 612076 (3); Hypouricemia,
SLEB3 | {Systemic lupus erythematosus, susceptibility to, 3} (2)
MNDEC | Microtia with nasolacrimal duct imperforation and eye coloboma (1)
SPG38 | Spastic paraplegia-38 (2)
INTLQ1 | {Intelligence QTL1} (2)
QDPR, DHPR | Hyperphenylalaninemia, BH4-deficient, C, 261630 (3)
SLC34A2 | Pulmonary alveolar microlithiasis, 265100 (3); ?Testicular
CC2D2A, KIAA1345, MKS6 | Joubert syndrome 9, 612285 (3); Meckel syndrome, type 6, 612284 (3);
HDL3, HLN2 | Huntington disease-like 3 (2)
PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4 | Retinitis pigmentosa 41, 612095 (3); Cone-rod dystrophy 12, 612657
STQTL13 | {Stature QTL 13} (2)
SOD3 | [Superoxide dismutase, elevated extracellular] (3)
SEPSECS, SLA, LP, PCH2D | Pontocerebellar hypoplasia type 2D, 613811 (3)
NPC1, NPCA1 | {Nasopharyngeal carcinoma 1} (2)
EPPS | Epilepsy, partial, with pericentral spikes (2)
BMIQ7 | {Obesity, susceptibility to, BMIQ7} (2)
APBB2, FE65L1 | {Alzheimer disease, late-onset}, 104300 (3)
LIAS, PDHLD | Pyruvate dehydrogenase lipoic acid synthetase deficiency, 614462 (3)
TLR1, TIL. LPRS5 | {Leprosy, protection against}, 613223 (3); {Leprosy, susceptibility
UCHL1, PARK5 | {Parkinson disease 5, susceptibility to}, 613643 (3)
WDR19, ATD5, NPHP13, CED4 | Asphyxiating thoracic dystrophy 5, 614376 (3); Nephronophthisis 13,
GRXCR1 | Deafness, autosomal recessive 25, 613285 (3)
GABRA2 | {Alcohol dependence, susceptibility to}, 103780 (3)
NRCLP2 | Narcolepsy 2 (2)
PMX2B, NBPHOX, PHOX2B, NBLST2 | Central hypoventilation syndrome, congenital, with or without
CNGA1, CNCG1, RP49 | Retinitis pigmentosa 49, 613756 (3)
MHW1 | {Mental health wellness-1} (2)
STGD4 | Stargardt disease 4 (2)
MHW2 | {Mental health wellness-2} (2)
PSORS3 | {Psoriasis susceptibility 3} (2)
WM2 | {Macroglobulinemia, Waldenstrom, susceptibility to, 2} (2)
CHIC2, BTL | {Leukemia, acute myeloid}, 601626 (3)
AFP, HPAFP | [AFP deficiency, congenital] (1); [Hereditary persistence of
ALB | Analbuminemia (3); [Dysalbuminemic hyperthyroxinemia] (3);
GC, DBP, GRD3 | {Graves disease, susceptibility to, 3} (3)
IGFBP7, MAC25, RAMSVPS | Retinal arterial macroaneurysm with supravalvular pulmonic stenosis,
MYP9 | Myopia 9 (2)
SGCB, LGMD2E | Muscular dystrophy, limb-girdle, type 2E, 604286 (3)
KDR | Hemangioma, capillary infantile, somatic, 602089 (3); {Hemangioma,
KIT, PBT | Piebaldism (3); Mast cell leukemia (3); Mastocytosis with associated
PDGFRA | Gastrointestinal stromal tumor, somatic, 606764 (3);
SRD5A3, SRD5A2L, CDG1Q, KRIZI | Congenital disorder of glycosylation, type Iq, 612379 (3);
TAPVR1 | Total anomalous pulmonary venous return (2)
MRT31 | Mental retardation, autosomal recessive 31 (2)
DFNA27 | Deafness, autosomal dominant 27 (2)
DFNB55 | Deafness, autosomal recessive 55 (2)
AIS4, VAMAS5 | {Autoimmune disease, susceptibility to, 4} (2)
MUC7 | {Asthma, protection against}, 600807 (3)
SCARB2, CD36L2, LIMPII, AMRF, EPM4 | Epilepsy, progressive myoclonic 4, with or without renal failure,
FMTLE, ETL3 | Epilepsy, familial mesial temporal lobe (2)
ANTXR2, CMG2, JHF, ISH | Fibromatosis, juvenile hyaline, 228600 (3); Hyalinosis, infantile
DEL4q21, C4DELq21 | Chromosome 4q21 deletion syndrome (4)
DMP1, ARHR, ARHP | Hypophosphatemic rickets, AR, 241520 (3)
ENAM, AIH2, AI1C | Amelogenesis imperfecta, type IB, 104500 (3);
FRAS1 | Fraser syndrome, 219000 (3)
LGMD1G | Limb-girdle muscular dystrophy, type 1G (2)
SLC4A4, NBC1, KNBC, SLC4A5 | Renal tubular acidosis, proximal, with ocular abnormalities,
SNCA, NACP, PARK1, PARK4 | Parkinson disease 4, 605543 (3); Dementia, Lewy body, 127750 (3);
COQ2 | Coenzyme Q10 deficiency, 607426 (3)
PKD2 | Polycystic kidney disease 2, 613095 (3)
RAP1GDS1 | Lymphocytic leukemia, acute T-cell (3)
OFC4 | Orofacial cleft 4 (2)
GNRHR, LHRHR | Hypogonadotropic hypogonadism (3); Fertile eunuch syndrome, 228300
DSPP, DPP, DGI1, DFNA39, DTDP2 | Dentinogenesis imperfecta, Shields type II, 125490 (3); Deafness,
MAPK10, PRKM10, JNK3 | Epileptic encephalopathy, Lennox-Gastaut type, 606369 (3)
ADH1B, ADH2 | {Alcohol dependence, protection against}, 103780 (3);
ADH1C, ADH3 | {Alcohol dependence, protection against}, 103780 (3); {Parkinson
MUSQTL1 | [Musical aptitude QTL 1] (2)
UAQTL3, GOUT3 | [Uric acid concentration, serum, QTL3] (2)
SMARCAD1, KIAA1122, ETL1, HEL1, ADERM | Adermatoglyphia, 136000 (3)
BANK1, FLJ20706, BANK | {Systemic lupus erythematosus, association with}, 152700 (3)
MTP | Abetalipoproteinemia, 200100 (3); {Metabolic syndrome, protection
CISD2, WFS2, ZCD2, ERIS | Wolfram syndrome 2, 604928 (3)
MANBA, MANB1 | Mannosidosis, beta, 248510 (3)
HADHSC, SCHAD, HHF4 | 3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3);
MYP11 | Myopia 11 (2)
TYS, HRZ | Huriez syndrome (2)
BMPR1B, ALK6 | Brachydactyly, type A2, 112600 (3); Chrondrodysplasia, acromesomelic,
LEF1 | Sebaceous tumors, somatic (3)
AIMP1, SCYE1, EMAP2, EMAPII, HLD3 | Leukodystrophy, hypomyelinating, 3, 260600 (3)
MGR1, MA | {Migraine with or without aura, susceptibility to, 1} (2)
TET2, KIAA1546, MDS | Myelodysplastic syndrome, somatic, 614286 (3)
HWE2 | Epilepsy, hot water, 2 (2)
ATFB5 | {Atrial fibrillation, familial, 5} (2)
CFI, FI, AHUS3 | Complement factor I deficiency, 610984 (3); {Hemolytic uremic
EGF, URG, HOMG4 | Hypomagnesemia 4, renal, 611718 (3)
GOUT1 | {Gout, susceptibility to} (2)
LGV1 | [Longevity 1] (2)
TACR3, NK3R | Hypogonadotropic hypogonadism, 146110 (3)
PITX2, IDG2, RIEG1, RGS, IGDS2 | Axenfeld-Rieger syndrome, type 1, 180500 (3); Iridogoniodysgenesis,
PRSS12, BSSP3, MRT1 | Mental retardation, autosomal recessive 1, 249500 (3)
ANK2, LQT4 | Long QT syndrome-4, 600919 (3); Cardiac arrhythmia,
IL2 | Severe combined immunodeficiency due to IL2 deficiency (1)
MYOZ2, CMH16 | Cardiomyopathy, familial hypertrophic, 16, 613838 (3)
BBS7 | Bardet-Biedl syndrome 7, 209900 (3)
BBS12, FLJ35630, C4orf24 | Bardet-Biedl syndrome 12, 209900 (3)
CELIAC6, AIS5 | {Celiac disease, susceptibility to, 6} (2); {Autoimmune disease,
IDDM23 | {Diabetes mellitus, insulin-dependent, 23} (2)
PRDM5, BCS2 | Brittle cornea syndrome 2, 614170 (3)
MRT29 | Mental retardation, autosomal recessive 29 (2)
DFNA52 | Deafness, autosomal dominant 52 (2)
FGA | Dysfibrinogenemia, alpha type, causing bleeding diathesis (3);
FGB | Dysfibrinogenemia, beta type (3); Afibrinogenemia, congenital,
FGG | Dysfibrinogenemia, gamma type (3); Hypofibrinogenemia, gamma
GYPB, SS, MNS | [Blood group, Ss] (3)
SF | [Blood group, Stoltzfus system] (2)
MFSD8, MGC33302, CLN7 | Ceroid lipofuscinosis, neuronal, 7, 610951 (3)
GYPA, MN, GPA | [Blood group, MN] (3); {Malaria, resistance to}, 611162 (3)
AAA2 | Aortic aneurysm, familial abdominal 2 (2)
DFNB26 | Deafness, autosomal recessive 26 (2)
LRAT, LCA14 | Retinal dystrophy, early-onset severe, 613341 (3); Leber congenital
STQTL12 | {Stature QTL 12} (2)
UCP1 | {Obesity, susceptibility to}, 601665 (3)
PAND3 | Panic disorder 3 (2)
PSORS9 | {Psoraisis susceptibility 9} (2)
NR3C2, MLR, MCR | Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3);
MMAA | Methylmalonic aciduria, vitamin B12-responsive, 251100 (3)
EDNRA | Migraine, resistance to, 157300 (3)
GLRB | Hyperekplexia, autosomal recessive, 149400 (3)
HSCR9 | {Hirschsprung disease, susceptibility to, 9} (2)
TLR2, TIL4 | {Leprosy, susceptibility to}, 246300 (3); {Colorectal cancer,
AGA | Aspartylglucosaminuria, 208400 (3)
TLL1, TLL, ASD6 | Atrial septal defect 6, 613087 (3)
RP29 | Retinitis pigmentosa 29 (2)
ETFDH, MADD | Glutaric acidemia IIC, 231680 (3)
TRIP4q32.1q32.2, C4TRIPq32.1q32.2 | Chromosome 4q32.1-q32.2 triplication syndrome (4)
CINN | [Cinnamon odor, pleasantness of] (2)
HDLCQ4 | [High density lipoprotein cholesterol level QTL 4] (2)
PALLD, KIAA0992, PNCA1 | {Pancreatic cancer, susceptibility to, 1}, 606856 (3)
NEK1, SRPS2 | Short rib-polydactyly syndorme, type II, 263520 (3)
HCA1 | Hypercalciuria, absorptive (2)
SCA30 | ?Spinocerebellar ataxia 30 (2)
HPGD, PGDH1, PHOAR1 | Cranioosteoarthropathy, 259100 (3); Hypertrophic osteoarthropathy,
BHD, BFHD | Hip dysplasia, Beukes type (2)
DKBI | Dyskeratosis, hereditary benign intraepithelial (2)
F11 | Factor XI deficiency, autosomal recessive, 612416 (3); Factor XI
FSHMD1A, FSHD1A | Facioscapulohumeral muscular dystrophy-1A (4)
KLKB1, KLK3 | Fletcher factor deficiency, 612423 (3)
TLR3, IIAE2 | Herpes simplex encephalitis, susceptibility to, 2, 613002 (3)
DFNA24 | Deafness, autosomal dominant 24 (2)
CYP4V2, BCD | Bietti crystalline corneoretinal dystrophy, 210370 (3)
SLC25A4, ANT1, T1, PEO3, PEO2 | Progressive external ophthalmoplegia with mitochondrial DNA
LAG5 | Neutropenia, neonatal alloimmune (1)
NDUFS6 | Complex I, mitochondrial respiratory chain, deficiency of, 252010 (3)
SLC6A3, DAT1 | {Attention-deficit hyperactivity disorder, susceptibility to}, 143465
BCC3 | {Basal cell carcinoma, susceptibility to, 3} (2)
GLM8 | {Glioma susceptibility 8} (2)
LNCR3 | {Lung cancer susceptibility 3} (2)
SLC6A19, HND | Hartnup disorder, 234500 (3); Iminoglycinuria, digenic, 242600 (3);
TERT, TCS1, EST2, DKCA2, DKCB4 | {Aplastic anemia, susceptibility to}, 609135 (3); {Pulmonary
MYP16 | Myopia 16 (2)
MCDR3 | Macular dystrophy, retinal, 3 (2)
FAME3, FCMTE3 | Epilepsy, myoclonic, familial adult, 3 (2)
MTRR | Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3);
CCT5, KIAA0098, CCTE | Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3)
CTNND2, NPRAP | Mental retardation in cri-du-chat syndrome, 123450 (2)
ADIPQTL2, CAQ5 | {Adiponectin, serum level of, QTL2} (2)
ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD | Craniometaphyseal dysplasia, 123000 (3); Chondrocalcinosis 2,
ANIB4 | Aneurysm, intracranial berry, 4 (2)
FAM134B, HSAN2B | Neuropathy, hereditary sensory and autonomic, type IIB, 613115 (3)
PVNH3 | Periventricular nodular heterotopia 3 (2)
MYP19 | Myopia 19 (2)
SDHA, SDH1, SDHF, CMD1GG, PGL5 | Leigh syndrome, 256000 (3); Mitochondrial respiratory chain complex
TST2 | [Tuberculin skin test reactivity QTL] (2)
DNAH5, HL1, PCD, CILD3 | Ciliary dyskinesia, primary, 3, with or without situs inversus,
MRT5 | Mental retardation, autosomal recessive, 5 (2)
NPR3, ANPRC | ?Hypertension, salt-resistant (1)
SLC45A2, MATP, AIM1, SHEP5 | Oculocutaneous albinism, type IV, 606574 (3); [Skin/hair/eye
BDA1B | Brachydactyly, type A1, 112500 (2)
MS3 | {Multiple sclerosis, susceptibility to, 3} (2)
AMACR, CBAS4, AMACRD | Alpha-methylacyl-CoA racemase deficiency, 614307 (3);
IBD18 | {Inflammatory bowel disease 18} (2)
LIFR, STWS, SWS, SJS2 | Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3)
OSMR, OSMRB, PLCA1 | Amyloidosis, primary localized cutaneous, 1, 105250 (3)
NIPBL, CDLS1 | Cornelia de Lange syndrome 1, 122470 (3)
GDNF, HSCR3 | Central hypoventilation syndrome, 209880 (3); {Pheochromocytoma,
ADHD4 | {Attention deficit-hyperactivity disorder}, 143465 (2)
C6 | C6 deficiency, 612446 (3); Combined C6/C7 deficiency (3)
C7 | C7 deficiency, 610102 (3)
C9 | C9 deficiency, 613825 (3); C9 deficiency with dermatomyositis,
DUP5p13, C5DUPp13 | Chromosome 5p13 duplication syndrome (4)
IL7R, IL7RA, CD127 | Severe combined immunodeficiency, T-cell negative, B-cell/natural
KYPSC1 | Kyphoscoliosis 1 (2)
OXCT1, OXCT, SCOT | Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)
SLC1A3, EAAT1, EA6 | Episodic ataxia, type 6, 612656 (3)
FGF10 | Aplasia of lacrimal and salivary glands, 180920 (3); LADD syndrome,
GHR | Laron dwarfism, 262500 (3); Short stature, 604271 (3);
HYT6 | {Hypertension, essential, susceptibility to, 6}, 145500 (2)
ASD1 | Atrial septal defect 1 (2)
MHS6 | {Malignant hyperthermia susceptibility 6} (2)
BSZQTL2 | {Bone size QTL} (2)
PROP1, CPHD2 | Pituitary hormone deficiency, combined, 2, 262600 (3)
MOCS2, MPTS | Molybdenum cofactor deficiency, type B, 252150 (3)
MSH3 | Endometrial carcinoma (3)
ARSB, MPS6 | Mucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3)
NDUFS4, AQDQ | Leigh syndrome, 256000 (3); Mitochondrial complex I deficiency,
HSPB3, HSPL27, HMN2C, DHMN2C | Neuronopathy, distal hereditary motor, type IIC, 613376 (3)
IL31RA, GLMR, GPL, PLCA2 | Amyloidosis, primary localized cutaneous, 2, 613955 (3)
KFS2, KFM | ?Klippel-Feil syndrome 2, autosomal recessive (2)
MAP3K1, MEKK1, MEKK, SRXY6 | 46XY sex reversal 6, 613762 (3)
DHFR | Megaloblastic anemia due to dihydrofolate reductase deficiency,
ERCC8, CKN1, CSA | Cockayne syndrome, type A, 216400 (3)
PDE4D, DPDE3, STRK1 | {Stroke, susceptibility to, 1}, 606799 (3)
MCCC2, MCCB | 3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3)
EJM4 | Myoclonic epilepsy, juvenile, 4 (2)
VCAN, CSPG2, WGN, WGN1, ERVR | Wagner syndrome 1, 143200 (3)
NDUFAF2, NDUFA12L, MMTN, B17.2L | Mitochondrial complex I deficiency, 252010 (3); Leigh syndrome,
DMGDH, DMGDHD | Dimethylglycine dehydrogenase deficiency, 605850 (3)
SMN1, SMA1, SMA2, SMA3, SMA4 | Spinal muscular atrophy-1, 253300 (3); Spinal muscular atrophy-2,
SMN2 | {Spinal muscular atrophy, type III, modifier of}, 253400 (3)
HEXB | Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3)
PDE8B, PPNAD3, ADSD | Pigmented nodular adrenocortical disease, primary, 3, 614190 (3);
TSHQTL1 | [Thyroid-stimulating hormone level QTL 1] (2)
AAT2, FAA2 | Aortic aneurysm, familial thoracic 2 (2)
CMAL | Capillary malformations, hereditary (2)
GINGF2, GGF2, HGF2 | Fibromatosis, gingival, 2 (2)
MARVELD2, MARVD2, TRIC, DFNB49 | Deafness, autosomal recessive 49, 610153 (3)
OCLN, BLCPMG | Band-like calcification with simplified gyration and
CART | {Obesity, susceptibility to}, 601665 (3)
RASA1, GAP, CMAVM, PKWS | Parkes Weber slndrome, 608355 (3); Capillary
HMGCR, LDLCQ3 | [Statins, attenuated cholesterol lowering by] (3); [Low density
MEF2C, C5DELq14.3; DEL5q14.3 | Mental retardation, stereotypic movements, epilepsy, and/or
AP3B1, ADTB3A, HPS2 | Hermansky-Pudlak syndrome 2, 608233 (3)
VUR4 | Vesicoureteral reflux 4 (2)
GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C | Febrile seizures, familial, 4, 604352 (3); Usher syndrome, type
PVNH5 | Periventricular nodular heterotopia 5 (2)
PCSK1, NEC1, PC1, PC3, BMIQ12 | Obesity with impaired prohormone processing, 600955 (3); {Obesity,
HSD17B4 | D-bifunctional protein deficiency, 261515 (3); Perrault syndrome,
MCC | Colorectal cancer (3)
MGR8 | {Migraine, susceptibility to, 8} (2)
APC, GS, FPC, BTPS2 | Adenomatous polyposis coli, 175100 (3); Gastric cancer, somatic,
WDR36, TAWDRP, GLC1G | Glaucoma 1, open angle, G, 609887 (3)
EOE2 | {Esophagitis, eosinophilic, 2} (2)
GLC1M | Glaucoma 1, open angle, M (2)
ADAMTS2, NPI | Ehlers-Danlos syndrome, type VIIC, 225410 (3)
HBEGF, DTR, DTSF, HEGFL | {Diphtheria, susceptibility to} (1)
FBN2, CCA | Contractural arachnodactyly, congenital, 121050 (3)
ITGA2, CD49B, BR, BDPLT9 | ?Glycoprotein Ia deficiency, 614200 (1)
UBE2B, RAD6B | ?Male infertility (1)
SCZD1 | {Schizophrenia}, 181500 (2)
MEGF10, KIAA1780, EMARDD | Myopathy, early-onset, areflexia, respiratory distress, and
LMNB1 | Leukodystrophy, adult-onset, autosomal dominant, 169500 (3)
ACSL6, FACL6, ACS2 | Myelodysplastic syndrome (3); Myelogenous leukemia, acute (3)
ALDH7A1, ATQ1, EPD, PDE | Epilepsy, pyridoxine-dependent, 266100 (3)
ARHGAP26, GRAF | Leukemia, juvenile myelomonocytic, 607785 (3)
DIAPH1, DFNA1, LFHL1 | Deafness, autosomal dominant 1, 124900 (3)
IBD5 | {Inflammatory bowel disease 5} (2)
IL13, ALRH, BHR1 | {Asthma, susceptibility to}, 600807 (3); {Allergic rhinitis,
KLHL3, PHA2D | Pseudohypoaldosteronism, type IID, 614495 (3)
NR3C1, GCR, GRL | Cortisol resistance (3)
PDB4 | Paget disease of bone, 602080 (2)
PITX1, PTX1, BFT, POTX, CCF | Clubfoot, congenital, 119800 (3)
POU4F3, BRN3C | Deafness, autosomal dominant 15, 602459 (3)
RAD50, NBSLD | Nijmegen breakage syndrome-like disorder, 613078 (3)
SIL1, BAP, MSS | Marinesco-Sjogren syndrome, 248800 (3)
SLC22A4, OCTN1 | {Rheumatoid arthritis, susceptibility to}, 180300 (3)
TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD | Corneal dystrophy, Groenouw type I, 121900 (3); Corneal dystrophy,
TTID, MYOT | Muscular dystrophy, limb-girdle, type 1A, 159000 (3); Myotilinopathy,
PDGFRB, PDGFR | Myeloproliferative disorder with eosinophilia, 131440 (3);
AITD2 | {Autoimmune thyroid disease, susceptibility to, 2} (2)
ATOD6 | {Dermatitis, atopic, susceptibility to, 6} (2)
CELIAC2 | {Celiac disease, susceptibility to, 2} (2)
EOS | Eosinophilia, familial (2)
PFBI | {Malaria, intensity of infection} (2)
PPP2R2B | Spinocerebellar ataxia 12, 604326 (3)
SM1 | {Schistosoma mansoni infection, susceptibility/resistance to} (2)
SCGB3A2, UGRP1 | {Asthma, susceptibility to}, 600807 (3)
IGES | {?Allergy and asthma susceptibility} (2)
IRF1, MAR | Myelodysplastic syndrome, preleukemic (3); Myelogenous leukemia,
RIL | {Osteoporosis, susceptibility to}, 166710 (3)
SAR1B, CMRD, SARA2, ANDD | Chylomicron retention disease, 246700 (3)
SLC22A5, OCTN2, CDSP, SCD | Carnitine deficiency, systemic primary, 212140 (3)
UQCRQ, QPC | Mitochondrial complex III deficiency, 124000 (3)
GABRG2, GEFSP3, CAE2, ECA2 | Epilepsy, generalized, with febrile seizures plus, type 3, 611277
IDDM18 | {Diabetes mellitus, insulin-dependent, 18} (2)
IL12B, NKSF2 | BCG and salmonella infection, disseminated, 209950 (1); {Asthma,
PSORS11 | {Psoriasis susceptibility 11} (2)
MATR3, MPD2 | Myopathy, distal 2, 606070 (3)
NDUFA2 | Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)
PDE6A, PDEA, RP43 | Retinitis pigmentosa 43, 613810 (3)
HARS, USH3B | Usher syndrome 3B, 614504 (3)
HHT3, ORW3 | Telangiectasia, hereditary hemorrhagic, type 3 (2)
GM2A | GM2-gangliosidosis, AB variant, 272750 (3)
GLRA1, STHE | Startle disease/hyperekplexia, autosomal dominant, 149400 (3);
ITK, EMT | Lymphoproliferative syndrome, EBV-associated, autosomal, 1, 613011
RPS14, EMTB | Macrocytic anemia, refractory, due to 5q deletion, somatic, 153550
SH3TC2, KIAA1985, MNMN | Charcot-Marie-Tooth disease, type 4C, 601596 (3); Mononeuropathy of
SPINK1, PSTI, PCTT, TATI, TCP | Pancreatitis, hereditary, 167800 (3); {Fibrocalculous pancreatic
SPINK5, LEKTI | Netherton syndrome, 256500 (3); Atopy, 147050 (3)
SLC26A2, DTD, DTDST, D5S1708, EDM4 | Diastrophic dysplasia, 222600 (3); Atelosteogenesis II, 256050 (3);
TCOF1, MFD1, TCS1 | Treacher Collins syndrome 1, 154500 (3)
ADRB2 | {Asthma, nocturnal, susceptibility to}, 600807 (3); {Obesity,
NIPAL4, ICHYN | Ichthyosis, congenital, autosomal recessive, 612281 (3)
PPARGC1B, PGC1B, PERC | {Obesity, variation in}, 601665 (3)
SGCD, SGD, LGMD2F, CMD1L | Muscular dystrophy, limb-girdle, type 2F, 601287 (3); Cardiomyopathy,
F12, HAF, HAE3 | Factor XII deficiency, 234000 (3); Angioedema, hereditary, type III,
IRGM, LRG47, IFI1, IBD19 | {Mycobacterium tuberculosis, protection against}, 607948 (3);
SLC36A2, PAT2 | Iminoglycinuria, digenic, 242600 (3); Hyperglycinuria, 138500 (3)
FECD5, FCD3 | Corneal dystrophy, Fuchs endothelial, 5 (2)
HAVCR1, HAVCR | {Atopy, resistance to}, 147050 (3)
HMMR | {Breast cancer, susceptibility to}, 114480 (3)
CSF1R, FMS, HDLS | Leukoencephalopathy, diffuse hereditary, with spheroids, 221820 (3)
FOXI1, FKHL10, FREAC6 | Enlarged vestibular aqueduct, 600791 (3)
KCNMB1 | {Hypertension, diastolic, resistance to}, 608622 (3)
NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2 | Atrial septal defect 7, with or without AV conduction defects,
GABRA1, EJM5, ECA4 | {Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3);
MSX2, CRS2, HOX8 | Craniosynostosis, type 2, 604757 (3); Parietal foramina 1, 168500
NIDDM4 | {Diabetes mellitus, noninsulin-dependent}, 125853 (2)
WWC1, KIBRA, KIAA0869 | [Memory, enhanced, association with] (3)
AMCN, AMCN1 | Arthrogryposis multiplex congenita, neurogenic (2)
GRM6, MGLUR6, CSNB1B | Night blindness, congenital stationary, type 1B, 257270 (3)
LTC4S | Leukotriene C4 synthase deficiency, 614037 (1)
NSD1, ARA267, STO | Sotos syndrome, 117550 (3); Leukemia, acute myeloid, 601626 (1);
NPM1 | Leukemia, acute promyelocytic, NPM/RARA type (3); Leukemia, acute
SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2 | Nephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3);
SNCB | Dementia, Lewy body, 127750 (3)
SQSTM1, P62, PDB3 | Paget disease of bone, 602080 (3)
SH3PXD2B, TKS4, KIAA1295, FTHS | Frank-ter Haar syndrome, 249420 (3)
FGFR4 | {Cancer progression/metastasis} (3)
MENOQ4 | {Menopause, natural, age at, QTL4} (2)
B4GALT7, XGALT1, XGPT1 | Ehlers-Danlos syndrome, progeroid form, 130070 (3)
FLT4, VEGFR3, PCL, LMPH1A | Lymphedema, hereditary I, 153100 (3); Hemangioma, capillary
NOLA2, NHP2, DKCB2 | Dyskeratosis congenita, autosomal recessive 2, 613987 (3)
DEL6pter, C6DELpter | Chromosome 6pter-p24 deletion syndrome (4)
ITPR3 | {Diabetes, type 1, susceptibility to}, 222100 (2)
SHEP8 | [Skin/hair/eye pigmentation 8, freckling] (2)
INTLQ3 | {Intelligence QTL3} (2)
TUBB2B | Polymicrogyria, asymmetric, 610031 (3)
CLLS4 | {Leukemia, chronic lymphocytic susceptibility to, 4} (2)
FOXC1, FKHL7, FREAC3, IRID1, RIEG3 | Iridogoniodysgenesis, type 1, 601631 (3); Rieger or Axenfeld
LRSL | Larsen-like syndrome (2)
NQO2, NMOR2 | {?Breast cancer susceptibility}, 114480 (1)
SERPINB6, PI6, PTI, SPI3, DFNB91 | Deafness, autosomal recessive 91, 613453 (3)
F13A1, F13A | Factor XIIIA deficiency, 613225 (3); {Myocardial infarction,
IRF4, LSIRF | Multiple myeloma, 254500 (3)
OFC1, CL | Orofacial cleft-1 (2)
GCMB | Hypoparathyroidism, familial isolated, 146200 (3)
MAK, RP62 | REtinitis pigmentosa 62, 614181 (3)
DFNA21 | Deafness, autosomal dominant 21 (2)
DSP, KPPS2, PPKS2 | Keratosis palmoplantaris striata II, 612908 (3); Dilated
TFAP2A, AP2TF, BOFS | Branchiooculofacial syndrome, 113620 (3)
EDN1, HDLCQ7 | [High density lipoprotein cholesterol level QTL 7] (3)
GCNT2 | [Blood group, Ii], 110800 (3); Adult i phenotype with congenital
ATXN1, ATX1, SCA1 | Spinocerebellar ataxia 1, 164400 (3)
DEK, D6S231E | Leukemia, acute nonlymphocytic (2)
SCZD3 | {Schizophrenia}, 181500 (2)
SCAR3, SCABD | Spinocerebellar ataxia, autosomal recessive 3 (2)
CDKAL1 | {Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853
CIHL | {?Hearing loss, cisplatin-induced, susceptibility to} (2)
DTNBP1, HPS7 | {Schizophrenia}, 181500 (2); Hermansky-Pudlak syndrome 7, 614076 (3)
NHLRC1, EPM2A, EPM2B | Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3)
POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3 | Treacher Collins syndrome 3, 248390 (3)
OTSC3 | Otosclerosis 3 (2)
TPMT | 6-mercaptopurine sensitivity, 610460 (3)
DFNB66 | Deafness, autosomal recessive 66 (2)
KIAA0319, DYX2, DYLX2, DLX2 | {Dyslexia, susceptibility to, 2}, 600202 (3)
STQTL18 | {Stature QTL 18} (2)
ZFP57, TNDM1 | Diabetes mellitus, transient neonatal, 1, 601410 (3)
ALDH5A1, SSADH | Succinic semialdehyde dehydrogenase deficiency, 271980 (3)
ALPQTL3 | {Alkaline phosphatase, plasma level of, QTL3} (2)
NBLST4 | {Neuroblastoma, susceptibility to, 4} (2)
FANCE, FACE | Fanconi anemia, complementation group E, 600901 (3)
ATPLS | ?Antiphospholipid syndrome, familial (2)
FL1 | {Follicular lymphoma, susceptibility to, 1} (2)
LNCR4 | {Lung cancer susceptibility 4} (2)
STQTL19 | {Stature QTL 19} (2)
BTNL2, SS2 | {Sarcoidosis, susceptibility to, 2}, 612387 (3)
C2 | C2 deficiency, 217000 (3); {Macular degeneration, age-related,
C4A, C4S, C4AD | C4a deficiency, 614380 (3); [Blood group, Rodgers], 614374 (3);
C4B, C4F, C4BD | C4B deficiency, 614379 (3)
CDSN, HTSS1, PSS | Hypotrichosis simplex of scalp 1, 146520 (3); Peeling skin syndrome,
CFB, BF, GBG, AHUS4 | {Macular degeneration, age-related, reduced risk of}, 603075 (3);
COL11A2, STL3, DFNA13, DFNB53 | Stickler syndrome, type III, 184840 (3); Otospondylomegaepiphyseal
CTEPH1 | {Pulmonary hypertension, chronic thromboembolic, without deep vein
CYP21A2, CYP21, CA21H | Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency,
DFNA31 | Deafness, autosomal dominant 31 (2)
HFE, HLA-H, HFE1, MVCD7, TFQTL2 | Hemochromatosis, 235200 (3); {Microvascular complications of diabetes
HLA-A | {Hypersensitivity syndrome, carbamazepine-induced, susceptibility
HLA-B, SPDA1 | {Spondyloarthropathy, susceptibility to, 1}, 106300 (3); {Abacavir
HLA-C, PSORS1 | {Psoriasis susceptibility 1}, 177900 (3); {HIV-1
HLA-DPB1 | {Beryllium disease, chronic, susceptibility to} (3)
HLA-DQA1, CELIAC1 | {Celiac disease, susceptibility to}, 212750 (3)
HLA-DQB1, CELIAC1 | {Creutzfeldt-Jakob disease, variant, resistance to}, 123400 (3);
HLA-DRB1, SS1 | {Pemphigoid, susceptibility to} (2); {Sarcoidosis, susceptibility
HLA-G | {Asthma, susceptibility to}, 600807 (2)
IBD3 | {Inflammatory bowel disease 3} (2)
IDDM1 | {Diabetes mellitus, insulin-dependent-1} (2)
IGAD1 | Immunoglobulin A deficiency (2)
LHFPL5, TMHS, DFNB67 | Deafness, autosomal recessive 67, 610265 (3)
LTA, TNFB | {Myocardial infarction, susceptibility to}, 608446 (3); {Psoriatic
MOCS1, MOCOD | Molybdenum cofactor deficiency, type A, 252150 (3)
MOG, NRCLP7 | Narcolepsy 7, 614250 (3)
MYAS1 | Myasthenia gravis with thymus hyperplasia (2)
NCR3, 1C7, NKP30, CD337, MALS | {Malaria, mild, susceptibility to}, 609148 (3)
NEU1, NEU, SIAL1 | Sialidosis, type I, 256550 (3); Sialidosis, type II, 256550 (3)
NFKBIL1 | {Rheumatoid arthritis, susceptibility to}, 180300 (3)
NPCA2 | {Nasopharyngeal carcinoma, susceptibility to, 2} (2)
PBC2 | {Biliary cirrhosis, primary, 2} (2)
PBCA | ?Diabetes mellitus, insulin-dependent, neonatal (2)
PBLT | Panbronchiolitis, diffuse (2)
PDB | ?Paget disease of bone (2)
PSMB8, LMP7, RING10, JMP, NKJO | Nakajo syndrome, 256040 (3)
RWS | ?Ragweed sensitivity (2)
SLC17A3, NPT4 | ?Glycogen storage disease Ic, 232240 (3)
SPGF3, AZON | Spermatogenic failure 3 (2)
SYNGAP, MRD5 | Mental retardation, autosomal dominant 5, 612621 (3)
TAP1, ABCB2, TAP1, RING4, PSF1 | Bare lymphocyte syndrome, type I, 604571 (3)
TAP2, ABCB3, PSF2, RING11 | Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);
TAPBP, TPSN | Bare lymphocyte syndrome, type I, 604571 (3)
TNF, TNFA | {Malaria, cerebral, susceptibility to}, 611162 (3); {Septic shock,
TNXB, TNX, TNXB1, TNXBS, TNXB2, EDS3 | Ehlers-Danlos syndrome, autosomal recessive, due to tenascin X
TULP1, RP14, LCA15 | Retinitis pigmentosa 14, 600132 (3); Leber congenital amaurosis 15,
VAMAS6 | {Vitiligo-associated multiple autoimmune disease susceptiblity 6} (2)
WG | Wegener granulomatosis (2)
WM1 | {Macroglobulinemia, Waldenstrom, susceptibility to, 1} (2)
FKBP5, FKBP51 | {Major depressive disorder and accelerated response to antidepressant
LAP | ?Laryngeal adductor paralysis (2)
TREM2 | Nasu-Hakola disease, 221770 (3)
PLA2G7, PAFAH, PAFAD | Platelet-activating factor acetylhydrolase deficiency, 614278 (3);
AARS2, KIAA1270, MTALARS, COXPD8 | Combined oxidative phosphorylation deficiency 8, 614096 (3)
CUL7 | 3-M syndrome 1, 273750 (3)
GUCA1A, GCAP, COD3, CORD14 | Cone dystrophy-3, 602093 (3); Cone-rod dystrophy 14, 602093 (3)
GUCA1B, GCAP2, GUCA2, RP48 | Retinitis pigmentosa 48, 613827 (3)
PEX6, PXAAA1, PAF2 | Peroxisomal biogenesis disorder, complementation group 4 (3);
PPR1 | Photoparoxysmal response 1 (2)
RSPH9, CILD12 | Ciliary dyskinesia, primary, 12, 612650 (3)
MGR3 | {Migraine with or without aura, susceptibility to, 3} (2)
FCYT, PKHD1, ARPKD | Polycystic kidney and hepatic disease, 263200 (3)
POLH, XPV | Xeroderma pigmentosum, variant type, 278750 (3)
RHAG, RH50A | Anemia, hemolytic, Rh-null, regulator type, 268150 (3); Rh-mod
PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2 | Retinitis pigmentosa 7, 608133 (3); Retinitis punctata albescens,
EJM3 | Epilepsy, juvenile myoclonic 3 (2)
HMGA1, HMGIY | {Diabetes mellitus, noninsulin-dependent, susceptibility to},
MUT, MCM | Methylmalonic aciduria, mut(0) type, 251000 (3)
RLS6 | {Restless legs syndrome 6} (2)
RUNX2, CBFA1, PEBP2A1, AML3 | Cleidocranial dysplasia, 119600 (3); Dental anomalies, isolated (3)
UAQTL4, GOUT4 | [Uric acid concentration, serum, QTL4] (2)
ICK, MRK, KIAA0936, ECO | Endocrine-cerebroosteodysplasia, 612651 (3)
SCA34 | Spinocerebellar ataxia 34 (2)
MRT24 | Mental retardation, autosomal recessive 24 (2)
CD2AP, CMS | Glomerulosclerosis, focal segmental, 3, 607832 (3)
GCLC, GLCLC | Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency,
GNMT | Glycine N-methyltransferase deficiency, 606664 (3)
IL17F, ML1, CANDF6 | Candidiasis, familial, 6, autosomal dominant, 613956 (3)
NYS2, NYSA | Nystagmus-2, autosomal dominant (2)
TFAP2B, CHAR | Char syndrome, 169100 (3)
VEGF, MVCD1 | {Microvascular complications of diabetes 1}, 603933 (3)
EFHC1, FLJ10466, EJM1, JAE, EJA1 | {Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3);
ARCC1 | {Cataract, age-related cortical, susceptibility to} (2)
AITD1 | {Autoimmune thyroid disease, susceptibility to, 1} (2)
RAB23 | Carpenter syndrome, 201000 (3)
PUJO | Pelviureteric junction obstruction (2)
RPS10, DBA9 | Diamond-Blackfan anemia 9, 613308 (3)
BPPV | Vestibulopathy, familial (2)
DEL6q11q14, C6DELq11q14 | Chromosome 6q11-q14 deletion syndrome (4)
ADHD3 | {Attention deficit-hyperactivity disorder}, 143465 (2)
EYS, RP25 | Retinitis pigmentosa 25, 602772 (3)
RIMS1, RIM1, RIM, KIAA0340, CORD7 | Cone-rod dystrophy 7, 603649 (3)
MRT30 | Mental retardation, autosomal recessive 30 (2)
CMD1K | Cardiomyopathy, dilated, 1K (2)
C6orf221, ECAT1, HYDM2 | Hydatidiform mole, recurrent, 2, 614293 (3)
COL9A1, EDM6, STL4 | Epiphyseal dysplasia, multiple, 6, 614135 (3); Stickler syndrome,
LMBRD1, LMBD1, NESI | Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3)
MYO6, DFNA22, DFNB37 | Deafness, autosomal dominant 22, 606346 (3); Deafness, autosomal
OTSC7 | Otosclerosis 7 (2)
SCZD5 | {Schizophrenia}, 181500 (2)
BCKDHB, E1B | Maple syrup urine disease, type Ib, 248600 (3)
ELOVL4, ADMD, STGD2, STGD3, ISQMR | Stargardt disease 3, 600110 (3); Macular dystrophy, autosomal
SLC17A5, SIASD, SLD | Salla disease, 604369 (3); Sialic acid storage disorder, infantile,
ATFB2 | Atrial fibrillation, familial, 2 (2)
PBCRA, CRAPB | Chorioretinal atrophy, progressive bifocal (2)
MCDR1 | Macular dystrophy, North Carolina type (2)
NT5E, NT5 | Calcification of joints and arteries, 211800 (3)
LCA5, C6orf152 | Leber congenital amaurosis 5, 604537 (3)
SHFLD2 | Split-hand/foot malformation with long deficiency 2 (2)
SLC35A1, CST, CDG2F | Congenital disorder of glycosylation, type IIf, 603585 (3)
NDUFAF4, HRPAP20, C6orf66 | Mitochondrial complex I deficiency, 252010 (3)
RARS2, RARSL, PCH6 | Pontocerebellar hypoplasia, type 6, 611523 (3)
LMPH1B | Lymphedema, hereditary, IB (2)
SIM1 | Obesity, severe, 601665 (3)
BOP | Polymicrogyria, bilateral occipital (2)
GEFSP8 | Generalized epilepsy with febrile seizures plus, type 8 (2)
CD24 | {Multiple sclerosis, susceptibility to}, 126200 (3)
FIG4, KIAA0274, SAC3, ALS11 | Charcot-Marie-Tooth disease, type 4J, 611228 (3); Amyotrophic lateral
GOPC, PIST, FIG, CAL | ?Globozoospermia, 102530 (1)
GRIK2, GLUR6, MRT6 | Mental retardation, autosomal recessive, 6, 611092 (3)
HTX3 | ?Heterotaxy, visceral, 3, autosomal (2)
IDDM15 | {Diabetes mellitus, insulin-dependent, 15} (2)
LGV2 | [Longevity 2] (2)
MCOPS8, MMEP | Microphthalmia, syndromic 8 (2)
MENAQ2 | {Menarche, age at, QTL2} (2)
OSTM1, GL, OPTB5 | Osteopetrosis, autosomal recessive 5, 259720 (3)
PDSS2, DLP1, C6orf210 | Coenzyme Q10 deficiency, 607426 (3)
SEC63 | Polycystic liver disease, 174050 (3)
SOBP, JXC1, MRAMS | Mental retardation, anterior maxillary protrusion, and strabismus,
TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13 | {Psoriasis susceptibility 13}, 614070 (3)
ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2 | Immunodeficiency-centromeric instability-facial anomalies syndrome-2,
CMDR | Craniometaphyseal dysplasia, autosomal recessive (2)
PLF | {Pulmonary function} (2)
COL10A1 | Metaphyseal chondrodysplasia, Schmid type, 156500 (3)
GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1 | Oculodentodigital dysplasia, 164200 (3); Syndactyly, type III,
MYB | {T-cell acute lymphoblastic leukemia} (3)
ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2 | Ossification of posterior longitudinal ligament of spine, 602475 (3);
IGAN1 | Nephropathy, IgA type (2)
LAMA2, LAMM | Muscular dystrophy, congenital merosin-deficient, 607855 (3);
SM2 | {Hepatic fibrosis susceptibility due to Schistosoma mansoni
TSPYL1, TSPYL, SIDDT | Sudden infant death with dysgenesis of the testes syndrome, 608800
WISP3, PPAC, PPD | Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3);
FEB5 | Febrile seizures, familial, 5 (2)
FIQTL1 | [Fasting insulin level quantitative trait locus 1] (2)
PEX7, RCDP1 | Rhizomelic chondrodysplasia punctata, type 1, 215100 (3); Refsum
PLN, PLB, CMD1P, CMH18 | Cardiomyopathy, dilated, 1P, 609909 (3); Cardiomyopathy, familial
RSPH4A, CILD11 | Ciliary dyskinesia, primary, 11, 612649 (3)
HBFQTL2, FCP | Fetal hemoglobin quantitative trait locus 2 (2)
ARG1 | Argininemia, 207800 (3)
CMD1F, CDCD3, LGMD1D | Cardiomyopathy, dilated, 1F and limb-girdle muscular dystrophy
EYA4, DFNA10, CMD1J | Deafness, autosomal dominant 10, 601316 (3); Cardiomyopathy, dilated,
HCHGQ1 | [Hematocrit/hemoglobin quantitative trait locus 1] (2)
RP63 | Retinitis pigmentosa 63 (2)
RA | {Rheumatoid arthritis, susceptibility to} (2)
SLEB13 | {Systemic lupus erythematosus, susceptibility to, 13} (2)
IFNGR1 | Mycobacterial infection, atypical, familial disseminated, 209950 (3);
MAFD6, BPAD | {Major affective disorder 6} (2)
PEX3 | Zellweger syndrome, complementation group G, 214100 (3)
VNN1, HDLCQ8 | [High density lipoprotein cholesterol level QTL 8] (3)
SPG25 | Spastic paraplegia 25 (2)
BMIQ3 | [Body mass index QTL3] (2)
LNCR1 | {Lung cancer susceptibility} (2)
MED23, MRT18 | Mental retardation, autosomal recessive 18, 614249 (3)
AHI1 | Joubert syndrome-3, 608629 (3)
CITED2, MRG1, P35SRJ, VSD2, ASD8 | Ventricular septal defect 2, 614431 (3); Atrial septal defect 8,
EPM2A, MELF, EPM2 | Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3)
PLAGL1, ZAC, LOT1 | {Diabetes mellitus, transient neonatal}, 601410 (1)
STX11, FHL4, HPLH4, HLH4 | Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3)
DEL6q24q25, C6DELq25q25 | Chromosome 6q25-q25 deletion syndrome (4)
IYD, DEHAL1, TDH4 | Thyroid dyshormonogenesis 4, 274800 (3)
STQTL1 | {Stature QTL 1} (2)
DUH1, DUH | Dyschromatosis universalis hereditaria 1 (2)
BMND11 | [Bone mineral density QTL 11] (2)
IDDM21 | {Diabetes mellitus, insulin-dependent, 21} (2)
SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4 | Spinocerebellar ataxia, autosomal recessive 8, 610743 (3);
SUMO4, IDDM5 | {Diabetes mellitus, insulin-dependent, 5}, 600320 (3)
TAB2, MAP3K7IP2, KIAA0733, CHTD2 | Congenital heart disease, nonsyndromic, 2, 612863 (3)
RCD1 | ?Retinal cone dystrophy-1 (2)
IDDM8 | {Diabetes mellitus, insulin-dependent, 8} (2)
ESR1, ESR | Breast cancer (1); Estrogen resistance (3); {HDL response to hormone
PRKN, PARK2, PDJ, LPRS2 | Parkinson disease, juvenile, type 2, 600116 (3); Adenocarcinoma of
CELIAC12 | {Celiac disease, susceptibility to, 12} (2)
GTF2H5, TTDA, TFB5, C6orf175 | Trichothiodystrophy, complementation group A, 601675 (3)
SOD2, MNSOD, MVCD6 | {Microvascular complications of diabetes 6}, 612634 (3)
ACAT2 | ?ACAT2 deficiency, 614055 (1)
IGF2R, MPRI | Hepatocellular carcinoma (3)
PLG | Plasminogen Tochigi disease (3); Thrombophilia, dysplasminogenemic
DFNB38 | Deafness, autosomal recessive 38 (2)
MRT28 | Mental retardation, autosomal recessive 28 (2)
FGFR1OP, FOP | Myeloproliferative disorder (2)
LPA | {Coronary artery disease, susceptibility to} (1); [LPA deficiency,
RNASET2, RNASE6PL | Leukoencephalopathy, cystic, without megalencephaly, 612951 (3)
SMOC2, SMAP2, DTDP1 | Dentin dysplasia, type I, with microdontia and misshapen teeth,
T, TFT | {Neural tube defects, susceptibility to}, 182940 (3)
TBP, SCA17, HDL4 | Spinocerebellar ataxia 17, 607136 (3); {Parkinson disease,
THBS2 | {Lumbar disc herniation, susceptibility to}, 603932 (3)
HYP10 | Hypotrichosis 10 (2)
KIAA0415, SPG48 | Spastic paraplegia 48, autosomal recessive, 613647 (3)
STBMS1 | {Strabismus, susceptibility to, 1} (2)
FHII | Hyperaldosteronism, familial, type II (2)
GLCCI1, TSSN1, GCTR | {Glucocorticoid therapy, response to}, 614400 (3)
LFNG, SCDO3 | Spondylocostal dysostosis, autosomal recessive 3, 609813 (3)
MAD1L1, TXBP181 | Lymphoma, somatic (3); Prostate cancer, somatic, 176807 (3)
FAM20C, DMP4 | Raine syndrome, 259775 (3)
PMS2, PMSL2, HNPCC4 | Mismatch repair cancer syndrome, 276300 (3); Colorectal cancer,
CPVT3 | Ventricular tachycardia, catecholaminergic polymorphic, 3 (2)
ACTB | Dystonia, juvenile-onset, 607371 (3)
SCA21 | Spinocerebellar ataxia 21 (2)
FGQTL4 | [Fasting plasma glucose level QTL 4] (2)
EDSS2 | Ectodermal dysplasia-syndactyly syndrome 2 (2)
DNAH11, DNAHC11, CILD7, DNAHBL | Ciliary dyskinesia, primary, 7, with or without situs inversus,
IL6, IFNB2, BSF2, HSF, HGF | {Rheumatoid arthritis, systemic juvenile}, 604302 (3); {Kaposi
TWIST1, ACS3, SCS, CRS1 | Saethre-Chotzen syndrome, 101400 (3); Saethre-Chotzen syndrome with
MDDC | Macular dystrophy, dominant cystoid (2)
FAM126A, DRCTNNB1A, HLD5 | Leukodystrophy, hypomyelinating, 5, 610532 (3)
HOXA1, HOX1F, BSAS | Bosley-Salih-Alorainy syndrome, 601536 (3); Athabaskan brainstem
KLHL7, RP42 | Retinitis pigmentosa 42, 612943 (3)
CYCS, CYC, THC4 | Thrombocytopenia 4, 612004 (3)
PSP, PSPHD | Phosphoserine phosphatase deficiency, 614023 (3)
DFNA5 | Deafness, autosomal dominant 5, 600994 (3)
GARS, SMAD1, CMT2D, HMN5 | Charcot-Marie-Tooth disease, type 2D, 601472 (3); Neuropathy, distal
GSBS | {Hypercholesterolemia, susceptibility to}, 143890 (3)
JAZF1, TIP27 | Endometrial stromal tumors (2)
MYP17, MYP4 | Myopia 17 (2)
STQTL17 | {Stature QTL 17} (2)
GHRHR, GHRFR, IGHD1B | Growth hormone deficiency, isolated, type IB, 612781 (3)
HOXA11, HOX1I | Radioulnar synostosis with amegakaryocytic thrombocytopenia, 605432
HOXA13, HOX1J | Hand-foot-uterus syndrome, 140000 (3); Guttmacher syndrome, 176305
HOXA2 | Microtia, hearing impairment, and cleft palate, 612290 (3)
NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2 | {Asthma, susceptibility to, 2}, 608584 (3)
NT5C3, UMPH1, PSN1 | Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3)
TBX20, ASD4 | Atrial septal defect 4, 611363 (3)
FGQTL2, BWQTL1 | [Fasting plasma glucose level QTL 2] (2); [Birth weight QTL 1] (2)
GCK, HHF3 | MODY, type II, 125851 (3); Diabetes mellitus, noninsulin-dependent,
BMPER, CV2 | Diaphanospondylodysostosis, 608022 (3)
RP9 | Retinitis pigmentosa 9, 180104 (3)
DFNB44 | Deafness, autosomal recessive 44 (2)
AQP1, CHIP28, CO | [Blood group, Colton], 110450 (3); [Aquaporin-1 deficiency] (3)
C7orf10 | [Glutaric aciduria III], 231690 (3)
C7orf11, ABHS, TTDN1 | Trichothiodystrophy, nonphotosensitive 1, 234050 (3)
HHT4 | Telangiectasia, hereditary hemorrhagic, type 4 (2)
PTHB1, BBS9 | Bardet-Biedl syndrome 9, 209900 (3)
OGDH | Alpha-ketoglutarate dehydrogenase deficiency, 203740 (1)
POU6F2, WTSL, WT5 | {Wilms tumor susceptibility-5}, 601583 (3)
TXNDC3, SPTRX2, CILD6 | Ciliary dyskinesia, primary, 6, 610852 (3)
BLVRA | Hyperbiliverdinemia, 614156 (3)
C7orf22, CCM2, MGC4067 | Cerebral cavernous malformations-2, 603284 (3)
GLI3, PAPA, PAPB | Greig cephalopolysyndactyly syndrome, 175700 (3); Pallister-Hall
NPC1L1 | [Ezetimibe, nonresponse to] (3)
PGAM2, PGAMM, GSD10 | Glycogen storage disease X, 261670 (3)
EGFR | Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in,
ALL2 | {Leukemia, acute lymphoblastic, susceptibility to, 2} (2)
IKZF1, ZNFN1A1, IK1, LYF1 | Leukemia, acute lymphoblastic (3)
NYS3 | Nystagmus 3, congenital (2)
SRS, RSS | Silver-Russell syndrome (4)
DDC | Aromatic L-amino acid decarboxylase deficiency, 608643 (3)
ASL | Argininosuccinic aciduria, 207900 (3)
MLSM7, DEL7q, C7DELq | Myelodysplasia and leukemia syndrome with monosomy 7 (4)
LGMD1E | Muscular dystrophy, limb-girdle, type 1E (2)
SBDS, SDS | Shwachman-Bodian-Diamond syndrome, 260400 (3)
PCH3, CLAM | Pontocerebellar hypoplasia, type 3 (2)
HPC4 | {Prostate cancer, susceptibility to, 4}, 176807 (2)
ANIB1 | Aneurysm, intracranial berry, 1 (2)
CD36, CHDS7, BDPLT10 | [Macrothrombocytopenia] (1); Platelet glycoprotein IV deficiency,
ELN | Supravalvar aortic stenosis, 185500 (3); Cutis laxa, AD, 123700 (3)
EOE1, EE | {Esophagitis, eosinophilic, 1} (2)
POR | Antley-Bixler syndrome with genital anomalies and disordered
CCM1, CAM, KRIT1 | Cerebral cavernous malformations-1, 116860 (3); Hyperkeratotic
EEC1 | ?EEC syndrome-1 (2)
KCTD7, EPM3 | Epilepsy, progressive myoclonic 3, 611726 (3)
DEL7q11.23, C7DELq11.23 | Chromosome 7q11.23 deletion syndrome, distal, 1.2Mb (4)
DUP7q11.23, C7DUPq11.23 | Chromosome 7q11.23 duplication syndrome (4)
HIP1 | {Prostate cancer, progression of}, 176807 (1)
HSPB1, HSP27, CMT2F, HMN2B | Neuropathy, distal hereditary motor, type IIB, 608634 (3);
NCF1 | Chronic granulomatous disease due to deficiency of NCF-1, 233700 (3)
PTPN12, PTPG1 | Colon cancer (3)
WBS, WMS, WS, DEL7q11, C7DELq11 | Williams-Beuren syndrome (4)
PPP1R3A, PPP1R3 | Insulin resistance, severe, digenic, 604367 (3)
EPO, MVCD2 | {Microvascular complications of diabetes 2}, 612623 (3)
SAMD9, NFTC | Tumoral calcinosis, familial, normophosphatemic, 610455 (3)
SGCE, DYT11 | Dystonia-11, myoclonic, 159900 (3)
STQTL11 | {Stature QTL 11} (2)
AKAP9, YOTIAO, AKAP450 | Long QT syndrome-11, 611820 (3)
MHS3 | {Malignant hyperthermia susceptibility 3} (2)
PEX1, ZWS1 | Zellweger syndrome-1, 214100 (3); Adrenoleukodystrophy, neonatal,
ABCB4, PGY3, MDR3 | Cholestasis, progressive familial intrahepatic 3, 602347 (3);
ABCB1, PGY1, MDR1, IBD13 | Colchicine resistance (3); {Inflammatory bowel disease 13},
HGF, DFNB39 | Deafness, autosomal recessive 39, 608265 (3)
GUSB, MPS7 | Mucopolysaccharidosis VII, 253220 (3)
SEMA3E, SEMAH, KIAA0331 | CHARGE syndrome, 214800 (3)
SHFM1, SHFD1, SHSF1 | Split hand/foot malformation 1 (4)
CALCR, CRT | {Osteoporosis, postmenopausal, susceptibility}, 166710 (3)
PON1, PON, ESA, MVCD5 | {Coronary artery disease, susceptibility to} (3); {Coronary artery
PON2 | {Coronary artery disease, susceptibility to} (3)
SLC25A13, CTLN2 | Citrullinemia, adult-onset type II, 603471 (3); Citrullinemia,
PAI1, PLANH1, SERPINE1 | Plasminogen activator inhibitor-1 deficiency, 613329 (3);
ACHE, YT | [Blood group, Yt system], 112100 (3)
AUTS1 | {Autism susceptibility 1} (2)
DLX5, SHFM1D | Split-hand/foot malformation 1 with sensorineural hearing loss,
EKV3 | Erythrokeratodermia variabilis 3 (2)
IBD11 | {Inflammatory bowel disease 11} (2)
PAPA4 | Polydactyly, postaxial, type A4 (2)
PLOD3, LH3 | Lysyl hydroxylase 3 deficiency, 612394 (3)
RELN, RL, LIS2 | Lissencephaly 2 (Norman-Roberts type), 257320 (3)
TFR2, HFE3 | Hemochromatosis, type 3, 604250 (3)
SLC26A3, DRA, CLD | ?Colon cancer (1); Chloride diarrhea, congenital, Finnish type,
SCA18, SMNA | Spinocerebellar ataxia 18 (2)
AP4M1, CPSQ3 | Cerebral palsy, spastic quadriplegic, 3, 612936 (3)
COL1A2 | Ehlers-Danlos syndrome, type VIIB, 130060 (3); Osteogenesis
CYP3A5, P450PCN3 | {Hypertension, salt-sensitive essential, susceptibility to}, 145500
SLC26A5, PRES | Deafness, autosomal recessive 61, 613865 (3)
CMD1Q | Cardiomyopathy, dilated, 1Q (2)
COG5, GOLTC1, GTC90, CDG2I | Congenital disorder of glycosylation, type IIi, 613612 (3)
DFNB14 | Deafness, autosomal recessive 14 (2)
DFNB17 | Deafness, autosomal recessive 17 (2)
MET, AUTS9 | Renal cell carcinoma, papillary, familial and somatic, 605074 (3);
SLC26A4, PDS, DFNB4, EVA, TDH2B | Pendred syndrome, 274600 (3); Enlarged vestibular aqueduct, 600791
FOXP2, SPCH1, TNRC10, CAGH44 | Speech-language disorder-1, 602081 (3)
TAS2R16, T2R16 | {Alcohol dependence}, 103780 (3)
DLD, LAD, PHE3 | Maple syrup urine disease, type III, 248600 (3); Leigh syndrome,
SMOH, SMO | Basal cell carcinoma, somatic (3)
BPGM | Erythrocytosis due to bisphosphoglycerate mutase deficiency,
CAV1, BSCL3, CGL3 | Lipodystrophy, congenital generalized, type 3, 612526 (3)
TSPAN12, NET2, EVR5 | Exudative vitreoretinopathy 5, 613310 (3)
LAMB1 | ?Cutis laxa, marfanoid neonatal type, 614100 (1)
CFTR, ABCC7, CF, MRP7 | Cystic fibrosis, 219700 (3); Congenital bilateral absence of vas
AASS | Hyperlysinemia, 238700 (3); Saccharopinuria, 268700 (1)
LEP, OB | Obesity, severe, due to leptin deficiency (3); Obesity, morbid, with
PTPRZ1, PTP18 | {H. pylori infection, susceptibility to}, 600263 (1)
STQTL2 | {Stature QTL 2} (2)
IMPDH1, RP10, LCA11 | Retinitis pigmentosa 10, 180105 (3); Leber congenital amaurosis 11,
OPN1SW, BCP, CBT | Colorblindness, tritan, 190900 (3)
BCC6 | {Basal cell carcinoma, susceptibility to, 6} (2)
CEP41, TSGA14, JBTS15 | Joubert syndrome 15, 614464 (3)
FLNC, FLN2, ABPA, ABPL, MFM5, MPD4 | Myopathy, myofibrillar, 5, 609524 (3); Myopathy, distal, 4, 614065
IRF5, IBD14, SLEB10 | {Inflammatory bowel disease 14}, 612245 (3);
PAX4, MODY9, KPD | Maturity-onset diabetes of the young, type IX, 612225 (3);
PBC4 | Biliary cirrhosis, primary, 4 (2)
PPR3 | Photoparoxysmal response 3 (2)
AKR1D1, SRD5B1, CBAS2 | Bile acid synthesis defect, congenital, 2, 235555 (3)
SCA32 | Spinocerebellar ataxia 32 (2)
CSS | ?Coffin-Siris syndrome (2)
TRIM24, TIF1, TIF1A, PTC6 | Thyroid carcinoma, papillary, 188550 (3)
RBM28 | Alopecia, neurologic defects, and endocrinopathy syndrome, 612079 (3)
LGMD1F | Muscular dystrophy, limb-girdle, type 1F (2)
MIR96, MIRN96, DFNA50 | Deafness, autosomal dominant 50, 613074 (3)
HYSP3 | Hypospadias 3, autosomal (2)
BMIQ1 | [Body mass index QTL1] (2)
CHDM | {Chordoma, susceptibility to} (4)
KEL | [Blood group, Kell], 110900 (3)
ATP6V0A4, ATP6N1B, VPP2, RTA1C, RTADR | Renal tubular acidosis, distal, autosomal recessive, 602722 (3)
AGK, MULK, MTDPS10 | Sengers syndrome, 212350 (3)
BRAF, NS7 | Melanoma, malignant, somatic (3); Colorectal cancer, somatic (3);
TBXAS1, GHOSAL, CYP5, BDPLT14 | Ghosal hematodiaphyseal syndrome, 231095 (3); ?Thromboxane synthase
TAS2R38, T2R61, PTC | [Phenylthiocarbamide tasting], 171200 (3)
TPK1, THMD5 | Thiamine metabolism dysfunction syndrome 5 (episodic
DFNB13 | Deafness, autosomal recessive 13 (2)
OTSC2 | Otosclerosis 2 (2)
CLCN1 | Myotonia congenita, recessive, 255700 (3); Myotonia congenita,
EZH2, EZH1, WVS2 | Weaver syndrome 2, 614421 (3)
NOBOX, POF5 | Premature ovarian failure 5, 611548 (3)
PRSS1, TRY1 | Pancreatitis, hereditary, 167800 (3);
PRSS2, TRY2 | {Pancreatitis, chronic, protection against}, 167800 (3)
CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1 | Cortical dysplasia-focal epilepsy syndrome, 610042 (3); {Autism
GLC1F | Glaucoma 1F (2)
GPDS1, PDS1 | Pigment dispersion syndrome (2)
KCNH2, LQT2, HERG, SQT1 | Long QT syndrome-2, 613688 (3); {Long QT syndrome-2, acquired,
SLI4 | {Specific language impairment 4} (2)
ACRPS | Acropectoral syndrome (2)
AD10 | Alzheimer disease-10, 104300 (2)
EN2, AUTS10 | {Autism susceptibility 10}, 611016 (3)
HBFQTL5 | [Fetal hemoglobin QTL5] (2)
LMBR1, ACHP, C7orf2, PPD2 | Acheiropody, 200500 (3); Polydactyly, preaxial type II, 174500 (3);
MNX1, HLXB9, HOXHB9, SCRA1 | Currarino syndrome, 176450 (3)
NOS3 | {Coronary artery spasm 1, susceptibility to} (3); {Alzheimer disease,
PACIP1, PAXIP1L, PTIP | {Alzheimer disease, susceptibility to}, 104300 (3)
PRKAG2, WPWS, CMH6 | Wolff-Parkinson-White syndrome, 194200 (3); Cardiomyopathy, familial
SHH, HPE3, HLP3, SMMCI, MCOPCB5 | Holoprosencephaly-3, 142945 (3); Single median maxillary central
DPP6, VF2 | Ventricular fibrillation, paroxysmal familial, 2, 612956 (3)
SCZD16, C16DUPq36.3, DUP7q36.3 | Schizophrenia 16 (4)
AIS2, VAMAS3 | {Autoimmune disease, susceptibility to, 2} (2)
DBA2 | Diamond-Blackfan anemia 2 (2)
DIH2 | Hernia, congenital diaphragmatic 2 (2)
MFHAS1, MASL1 | Malignant fibrous histiocytoma (2)
SLEB12 | {Systemic lupus erythematosus, susceptibility to, 12} (2)
NAT2, AAC2 | [Acetylation, slow], 243400 (3)
GATA4, ASD2, VSD1 | Atrial septal defect 2, 607941 (3); Ventricular septal defect 1,
ARHGEF10, KIAA0294 | Slowed nerve conduction velocity, AD, 608236 (3)
CLN8, EPMR | Ceroid lipofuscinosis, neuronal, 8, 600143 (3); Ceroid
MCPH1 | Microcephaly, primary autosomal recessive, 1, 251200 (3)
MYP10 | Myopia 10 (2)
RP1L1 | Occult macular dystrophy, 613587 (3)
WS2C | Waardenburg syndrome, type 2C (2)
BLK, MODY11 | Maturity-onset diabetes of the young, type 11, 613375 (3)
KWE | Keratolytic winter erythema (2)
GEFSP6 | Generalized epilepsy with febrile seizures plus, type 6 (2)
ANIB11 | Aneurysm, intracranial berry, 11 (2)
CHDS9 | {Coronary heart disease, susceptibility to, 9} (2)
LPL, LIPD, HDLCQ11 | Lipoprotein lipase deficiency, 238600 (3); Combined hyperlipidemia,
LZTS1, F37, FEZ1 | Esophageal squamous cell carcinoma, 133239 (3)
MSR1, SCARA1, SRA | Prostate cancer, hereditary, 176807 (3); Barrett
TUSC3, M33, D8S1992, MRT7, MRT22 | Mental retardation, autosomal recessive 7, 611093 (3)
ASAH1, AC | Farber lipogranulomatosis, 228000 (3)
DFNB71 | Deafness, autosomal recessive 71 (2)
DLC1 | Colorectal cancer, somatic (3)
PCM1, PTC4 | Thyroid carcinoma, papillary, 188550 (3)
PDGFRL, PDGRL, PRLTS | Hepatocellular cancer, 114550 (3); Colorectal cancer, 114500 (3)
TNFRSF10B, DR5, TRAILR2 | Squamous cell carcinoma, head and neck, 275355 (3)
MPD3 | Myopathy, distal 3 (2)
NRG1, HGL, HRGA, ARIA | {?Schizophrenia, susceptibility to}, 603013 (1)
HR, AU, MUHH1 | Alopecia universalis, 203655 (3); Atrichia with papular lesions,
ESCO2 | Roberts syndrome, 268300 (3); SC phocomelia syndrome, 269000 (3)
GSR | Hemolytic anemia due to glutathione reductase deficiency (1)
GULOP, GULO | Scurvy (3)
SPG37 | Spastic paraplegia-37 (2)
CHRNA2 | Epilepsy, nocturnal frontal lobe, type 4, 610353 (3)
TRICY1 | Trichilemmal cyst 1 (2)
NEFL, CMT2E, CMT1F | Charcot-Marie-Tooth disease, type 2E, 607684 (3);
NKX2-6, CSX2 | Persistent truncus arteriosus, 217095 (3)
SCZD6 | {Schizophrenia}, 181500 (2)
SFTPC, SFTP2, SMDP2 | Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3)
EPHX2 | {Hypercholesterolemia, familial, due to LDLR defect, modifier of},
GNRH1, LNRH | ?Hypogonadotropic hypogonadism due to GNRH deficiency,
PLAT, TPA | Thrombophilia, familial, due to decreased release of PLAT, 612348
THPH9 | ?Thrombophilia due to decreased release of tissue plasminogen (1)
WHSC1L1, NSD3 | Leukemia, acute myeloid, 601626 (3)
ADRB3 | {Obesity, susceptibility to}, 601665 (3)
RECQL2, RECQ3, WRN | Werner syndrome, 277700 (3)
SNAX1, ADSA | Ataxia, sensory, autosomal dominant (2)
AD12 | {Alzheimer disease 12} (2)
ADAM9, MDC9, MCMP, CORD9 | Cone-rod dystrophy 9, 612775 (3)
NKCD | Natural killer cell deficiency, familial isolated (2)
THAP1, DYT6 | Dystonia 6, torsion, 602629 (3)
ANK1, SPH2 | Spherocytosis, type 1, 182900 (3)
ERLIN2, SPFH2, C8orf2, SPG18 | Spastic paraplegia-18, 611225 (3)
STAR | Lipoid adrenal hyperplasia, 201710 (3)
FGFR1, FLT2, KAL2, OGD | Pfeiffer syndrome, 101600 (3); Jackson-Weiss syndrome, 123150 (3);
HGSNAT, TMEM76, MPS3C | Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3)
SCLL | Chromosome 8p11 myeloproliferative syndrome (4)
CCAL1 | Chondrocalcinosis with early-onset osteoarthritis (2)
HBFQTL4 | Fetal hemoglobin quantitative trait locus 4 (2)
RB1CC1, CC1, KIAA0203 | Breast cancer, somatic, 114480 (3)
SNAI2, SLUG, WS2D | Waardenburg syndrome, type 2D, 608890 (3); Piebaldism, 172800 (3)
CA8, CALS, CARP, CAMRQ3 | Cerebellar ataxia and mental retardation with or without
RP1, ORP1 | Retinitis pigmentosa 1, 180100 (3); {Hypertriglyceridemia,
GCCD3, FGD3, GCCD2 | Glucocorticoid deficiency 3 (2)
PAFC | ?Preauricular fistulae, congenital (2)
PLAG1, SGPA, PSA | Adenomas, salivary gland pleomorphic, 181030 (3)
MTBS2 | {Mycobacterium tuberculosis, susceptibility to, 2} (2)
SOX17, VUR3 | Vesicoureteral reflux 3, 613674 (3)
ANIB10 | {Aneurysm, intracranial berry, 10} (2)
CHD7, IS3, KAL5 | CHARGE syndrome, 214800 (3); {Scoliosis, idiopathic 3}, 608765 (3);
IMPAD1, GPAPP, IMPA3 | Chondrodysplasia with joint dislocations, GRAPP type, 614078 (3)
CPA6, CPAH, ETL5, FEB11 | Epilepsy, familial temporal lobe, 5, 614417 (3); Febrile seizures,
DEL8q13, C8DELq13 | Mesomelia-synostoses syndrome (4)
DURS1, DUS | Duane syndrome (2)
FEB1 | Febrile seizures, familial, 1 (2)
GDAP1, CMT4A, CMT2K, CMTRIA | Charcot-Marie-Tooth disease, type 4A, 214400 (3); Charcot-Marie-Tooth
TTPA, TTP1, AVED | Ataxia with isolated vitamin E deficiency, 277460 (3)
EYA1, BOR | Branchiootorenal syndrome, 113650 (3); Branchiootic syndrome (3);
CNGB3, ACHM3, ACHM1 | Achromatopsia-3, 262300 (3); Macular degeneration, juvenile, 248200
OPA6 | Optic atrophy 6 (2)
CYP11B1, P450C11, FHI | Adrenal hyperplasia, congenital, due to 11-beta-hydroxylase
CYP11B2 | Hypoaldosteronism, congenital, due to CMO II deficiency, 610600 (3);
NBS1, NBS | Nijmegen breakage syndrome, 251260 (3); Leukemia, acute
PXMP3, PAF1, PMP35, PEX2 | Zellweger syndrome-3 (3); Refsum disease, infantile, 266510 (3)
DEL8q21.11, C8DELq21.11 | Chromosome 8q21.11 deletion syndrome (4)
TMEM70, MC5DN2 | Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2,
ZFHX4, ZFH4 | ?Ptosis, congenital, 178300 (2)
STQTL15 | {Stature QTL 15} (2)
TMEM67, MKS3, JBTS6, NPHP11 | Meckel syndrome, type 3, 607361 (3); Joubert syndrome 6, 610688 (3);
CYP7B1, CBAS3, SPG5A | Bile acid synthesis defect, congenital, 3, 613812 (3); Spastic
DECR1 | ?DECR deficiency (2)
RAD54B | Lymphoma, non-Hodgkin (3); Colon adenocarcinoma (3)
CA2 | Osteopetrosis, autosomal recessive 3, with renal tubular acidosis,
DPYS, DHP | Dihydropyrimidinuria, 222748 (3)
GRHL2, TFCP2L3, DFNA28 | Deafness, autosomal dominant 28, 608641 (3)
ITC1 | ?Hypertrichosis universalis congenita, Ambras type (2)
UQCRB, UQBP, QPC | Mitochondrial complex III deficiency, 124000 (3)
COH1 | Cohen syndrome, 216550 (3)
C8orf37, CORD16, RP64 | Retinitis pigmentosa 64, 614500 (3); Cone-rod dystrophy 16, 614500
C8orf38 | Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3)
GDF6, MCOP4, KFS1, MCOPCB6 | Klippel-Feil syndrome 1, autosomal dominant, 118100 (3);
PDP1, PPM2C, PDP1, PDPC | Pyruvate dehydrogenase phosphatase deficiency, 608782 (3)
CTHRC1 | Barrett esophagus/esophageal adenocarcinoma, 614266 (3)
KTWS, KTS | Klippel-Trenaunay-Weber syndrome (2)
MMD2 | Miyoshi muscular dystrophy 2 (2)
FZD6, NDNC10 | Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails),
CRCS6 | {Colorectal cancer, susceptibility to, 6} (2)
GLC1D | Glaucoma 1D, primary open angle (2)
HDLCQ2 | [High density lipoprotein cholesterol level QTL 2] (2)
LBMQTL1 | [Lean body mass QTL 1] (2)
MYMY3 | Moyamoya disease 3 (3)
TRHR | Thyrotropin-releasing hormone resistance, generalized (3)
ZFPM2, FOG2, DIH3 | Tetralogy of Fallot, 187500 (3); Diaphragmatic hernia 3, 610187 (3)
HT | Hashimoto thyroiditis (2)
MGS | Mungen syndrome (2)
ZFAT1, ZNF406, AITD3 | {Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3)
RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B | Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type
BSZQTL3 | [Bone size quantitative trait locus 3] (2)
CRCS2 | {Colorectal cancer, susceptibility to, 2} (2)
ECA1 | Epilepsy, childhood absence, 1 (2)
EIG1 | {Epilepsy, idiopathic generalized, susceptibility to, 1} (2)
HPC10 | {Prostate cancer, hereditary, 10} (2)
KCNQ3, EBN2, BFNC2 | Seizures, benign neonatal, type 2, 121201 (3)
FAME1, BAFME1, MEBA | Epilepsy, myoclonic, adult familial, 1 (2)
PLEC1, PLEC, PLTN, EBS1, LGMD2Q | Muscular dystrophy with epidermolysis bullosa simplex, 226670 (3);
TNFRSF11B, OPG, OCIF | Paget disease, juvenile, 239000 (3)
VMD1 | Macular dystrophy, atypical vitelliform (2)
RNF139, TRC8, RCA1 | Renal cell carcinoma, 144700 (3)
THM | ?Tibial hemimelia (2)
KCNK9, TASK3 | Birk-Barel mental retardation dysmorphism syndrome, 612292 (3)
SLC30A8, ZNT8 | {Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853
EXT1 | Exostoses, multiple, type 1, 133700 (3); Chondrosarcoma, 215300 (3)
TRPS2, LGCR, LGS | Trichorhinophalangeal syndrome, type II (4)
TRPS1 | Trichorhinophalangeal syndrome, type I, 190350 (3);
MYC | Burkitt lymphoma, 113970 (3)
KIAA0196, SPG8 | Spastic paraplegia-8, 603563 (3)
ARHI1 | {Age-related hearing impairment 1} (2)
TG, AITD3, TDH3 | Thyroid dyshormonogenesis 3, 274700 (3); {Autoimmune thyroid disease,
FAM83H, AI3 | Amelogenesis imperfecta, type 3, 130900 (3)
NDRG1, HMSNL, CMT4D | Charcot-Marie-Tooth disease, type 4D, 601455 (3)
OFC12 | Orofacial cleft 12 (2)
RECQL4, RTS, RECQ4 | Rothmund-Thomson syndrome, 268400 (3); RAPADILINO syndrome, 266280
SLC39A4, ZIP4 | Acrodermatitis enteropathica, 201100 (3)
TRAPPC9, NIBP, KIAA1882, MRT13 | Mental retardation, autosomal recessive 13, 613192 (3)
SLURP1, MDM | Meleda disease, 248300 (3)
AIS3, VAMAS4 | {Autoimmune disease, susceptibility to, 3} (2)
DEL9p24.3, C9DELp24.3, SRXY4 | 46XY sex reversal 4 (4)
KANK1, KANK, ANKRD15, KIAA0172, CPSQ2 | Cerebral palsy, spastic quadriplegic, 2, 612900 (3)
GLIS3, ZNF515 | Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199
KCNV2, KV11.1, RCD3B | Retinal cone dystrophy 3B, 610356 (3)
FECD7, FCD4 | Corneal dystrophy, Fuchs endothelial, 7 (2)
DOCK8, MRD2 | Mental retardation, autosomal dominant 2, 614113 (3);
SLC1A1, EAAC1 | ?Dicarboxylicaminoaciduria, 222730 (1)
JAK2 | Polycythemia vera, 263300 (3); Thrombocythemia, essential, 187950
VLDLR, CARMQ1 | Cerebellar hypoplasia and mental retardation with or without
RLS3 | {Restless legs syndrome 3} (2)
SHEP11 | [Skin/hair/eye pigmentation 11, blue/nonblue eyes] (2)
TYRP1, CAS2, GP75 | Albinism, oculocutaneous, type III, 203290 (3)
MRT16 | Mental retardation, autosomal recessive 16 (2)
FRDA2 | Friedreich ataxia 2 (2)
DFNB83 | Deafness, autosomal recessive 83 (2)
FREM1, C9orf154, BNAR, MOTA, TRIGNO2 | Bifid nose with or without anorectal and renal anomalies, 608980 (3);
AD11 | Alzheimer disease-11 (2)
GLDC, HYGN1, GCSP, GCE, NKH | Glycine encephalopathy, 605899 (3)
IFNA1, IFNA@ | Interferon, alpha, deficiency (1)
DFNA47, DFNB83 | Deafness, autosomal dominant 47 (2)
DMSMFH, BDMF | Diaphyseal medullary stenosis with malignant fibrous histiocytoma (2)
LALL | Leukemia, acute lymphoblastic (2)
LGMBF | Myopathy, limb-girdle, with bone fragility (2)
SPG46 | Spastic paraplegia-46 (2)
ALSFTD1 | Amyotrophic lateral sclerosis with frontotemporal dementia 1 (2)
HMNJ, MNDJ | Neuropathy, distal hereditary motor, Jerash type (2)
AAA3 | {Aneurysm, familial abdominal 3} (2)
ANIB6 | {Aneurysm, intracranial berry, 6} (2)
BCC5 | {Basal cell carcinoma, susceptibility to, 5} (2)
C9orf72, FTDALS, ALSFTD | Amyotrophic lateral sclerosis with frontotemporal dementia, 105550
CDKN2A, MTS1, P16, MLM, CMM2 | {Melanoma, cutaneous malignant, 2}, 155601 (3); Li-Fraumeni syndrome,
CHDS8 | {Coronary heart disease, susceptibility to, 8} (2)
MFT2, TEM | Trichoepithelioma, multiple familial, 2 (2)
GLM5 | {Glioma susceptibility 5} (2)
TEK, TIE2, VMCM | Venous malformations, multiple cutaneous and mucosal, 600195 (3)
TOPORS, P53BP3, LUN, RP31 | Retinitis pigmentosa 31, 609923 (3)
DNAI1, CILD1, ICS, PCD | Ciliary dyskinesia, primary, 1, with or without situs inversus,
NPR2, ANPRB, AMDM | Acromesomelic dysplasia, Maroteaux type, 602875 (3)
RMRP, RMRPR, CHH | Cartilage-hair hypoplasia, 250250 (3); Metaphyseal dysplasia without
OTSC8 | Otosclerosis 8 (2)
APTX, AOA, AOA1 | Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia,
GNE, GLCNE, IBM2, DMRV, NM | Sialuria, 269921 (3); Inclusion body myopathy, autosomal recessive,
TPM2, TMSB, AMCD1, DA1, DA2B, NEM4 | Arthrogryposis multiplex congenita, distal, type 1, 108120 (3);
AQP3 | [Blood group GIL], 607457 (3)
AQP7, GLYCQTL | [Glycerol quantitative trait locus], 614411 (3)
B4GALT1, GGTB2, GT1, GTB, CDG2D | Congenital disorder of glycosylation, type IId, 607091 (3)
GALT | Galactosemia, 230400 (3)
IL11RA, CRSDA | Craniosynostosis and dental anomalies, 614188 (3)
PAX5, BSAP | Lymphoplasmacytoid lymphoma (1)
PEE3 | Preeclampsia/eclampsia 3 (2)
SIGMAR1, SRBP, ALS16 | Amyotrophic lateral sclerosis 16, juvenile, 614373 (3)
XRCC9, FANCG | Fanconi anemia, complementation group G, 614082 (3)
VCP, IBMPFD, ALS14 | Inclusion body myopathy with early-onset Paget disease and
ACP | Cerebral palsy, ataxic, autosomal recessive (2)
MROS | ?Melkersson-Rosenthal syndrome (2)
DEL9p, C9DELp | Chromosome 9p deletion syndrome (4)
HDLCQ1 | [High density lipoprotein cholesterol level QTL 1] (2)
MMS | {Malignant mesothelioma, susceptibility to} (2)
GRHPR, GLXR | Hyperoxaluria, primary, type II, 260000 (3)
HCHGQ2 | [Hematocrit/hemoglobin quantitative trait locus 2] (2)
SPG19 | Spastic paraplegia-19 (2)
TJP2, ZO2 | Hypercholanemia, familial, 607748 (3)
CMD1B, CMPD1, FDC | Cardiomyopathy, dilated 1B (2)
FXN, FRDA, FARR, X25 | Friedreich ataxia, 229300 (3); Friedreich ataxia with retained
GSM1, GSP | Geniospasm (2)
TMC1, DFNB7, DFNB11, DFNA36 | Deafness, autosomal recessive 7, 600974 (3); Deafness, autosomal
CAAR | Cataract, autosomal recessive, early-onset, pulverulent (2)
GNAQ | Bleeding diathesis due to GNAQ deficiency (1)
PVOP2 | {Pelvic organ prolapse, susceptibility to, 2} (2)
VPS13A, CHAC | Choreoacanthocytosis, 200150 (3)
ETL4, ETOLM | Epilepsy, familial temoral lobe, 4 (2)
DFNA51, C9DUPq21.11, DUP9q21.11 | Deafness, autosomal dominant 51 (4)
ASPN, PLAP1, OS3 | {Osteoarthritis susceptibility 3}, 607850 (3); {Lumbar disc
FHL1, HPLH1, HLH1 | Hemophagocytic lymphohistiocytosis, familial, 1 (2)
PSAT1, PSAT, EPIP | Phosphoserine aminotransferase deficiency, 610992 (3)
ALG2, CDGII | Congenital disorder of glycosylation, type Ii,  607906 (3)
CSMF | Chondrosarcoma, extraskeletal myxoid, 612237 (3)
FOXE1, FKHL15, TITF2, TTF2 | Bamforth-Lazarus syndrome, 241850 (3)
GALNT12, CRCS1 | {Colorectal cancer, susceptibility to, 1}, 608812 (3)
HSD17B3, EDH17B3 | Pseudohermaphroditism, male, with gynecomastia, 264300 (3)
JOAG2 | Glaucoma, primary open angle, juvenile-onset, 2 (2)
ROR2, BDB1, BDB, NTRKR2 | Brachydactyly, type B1, 113000 (3); Robinow syndrome, autosomal
STQTL8 | {Stature QTL 8} (2)
TGFBR1, ALK5, AAT5, LDS2A, LDS1A, MSSE | Loeys-Dietz syndrome, type 1A, 609192 (3); Loeys-Dietz syndrome,
TRPM6, CHAK2, HOMG1 | Hypomagnesemia 1, intestinal, 602014 (3)
ABCA1, ABC1, HDLDT1, TGD | Tangier disease, 205400 (3); HDL deficiency, type 2, 604091 (3);
GPR51, GABBR2 | {Nicotine dependence, susceptibility to}, 188890 (3); {Nicotine
NTRK2, TRKB | Obesity, hyperphagia, and developmental delay, 613886 (3)
SPTLC1, LBC1, SPT1, HSN1, HSAN | Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3)
SECISBP2, SBP2 | Thyroid hormone metabolism, abnormal, 609698 (3)
FBP1 | Fructose-1,6-bidphosphatase deficiency, 229700 (3)
ALDOB | Fructose intolerance, 229600 (3)
BAAT | Hypercholanemia, familial, 607748 (3)
FANCC, FACC | Fanconi anemia, complementation group C, 227645 (3)
PTCH1, NBCCS, BCNS, HPE7 | Basal cell nevus syndrome, 109400 (3); Basal cell carcinoma,
XPA, XPAC | Xeroderma pigmentosum, group A, 278700 (3)
TDRD7, KIAA1529, TRAP, CATC4 | Cataract, autosomal recessive congenital 4, 613887 (3)
FKTN, FCMD, CMD1X, LGMD2M, MDDGA4, MDDGB4, MDDGC4 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye
HSCR5 | {Hirschsprung disease, susceptibility to, 5} (2)
IKBKAP, IKAP | Dysautonomia, familial, 223900 (3)
INVS, INV, NPHP2, NPH2 | Nephronophthisis 2, infantile, 602088 (3)
PAND2 | Panic disorder 2 (2)
TAL2 | Leukemia-2, T-cell acute lymphoblastic (3)
HNP1 | Hypertensive nephropathy (2)
SPDA2 | {Spondyloarthropathy, susceptibility to, 2} (2)
TRIM32, HT2A, LGMD2H, BBS11 | Muscular dystrophy, limb-girdle, type 2H, 254110 (3); Bardet-Biedl
MENAQ3 | {Menarche, age at, QTL3} (2)
IS4 | {Scoliosis, idiopathic, susceptibility to, 4} (2)
MUSK | Myasthenic syndrome, congenital, associated with acetylcholine
AFD1, AFDN | ?Acrofacial dysostosis, Nager type (2)
DEC1 | Esophageal squamous cell carcinoma, 133239 (1)
IBD16 | {Inflammatory bowel disease 16} (2)
EIG3 | {Epilepsy, idiopathic generalized, susceptibility to, 3} (2)
TLR4, ARMD10 | Endotoxin hyporesponsiveness (3); {Macular degeneration, age-related,
WHRN, CIP98, KIAA1526, DFNB31, USH2D | Deafness, autosomal recessive 31, 607084 (3); Usher syndrome, type
ASRT8 | {Asthma-related traits, susceptibility to, 8} (2)
NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8 | 46XY sex reversal 3, 612965 (3); Premature ovarian failure 7, 612964
LAMC3, OCCM | Cortical malformations, occipital, 614115 (3)
SARDH, SARD, SAR | [Sarcosinemia], 268900 (2)
SPTAN1, NEAS, EIEE5 | Epileptic encephalopathy, early infantile, 5, 613477 (3)
BMND10 | [Bone mineral density QTL 10] (2)
CDK5RAP2, KIAA1633, MCPH3 | Microcephaly, primary autosomal recessive, 3, 604804 (3)
LRSAM1, TAL, RIFLE, CMT2P | Charcot-Marie-Toothe disease, axonal, type 2P, 614436 (3)
ABO | [Blood group, ABO system] (3)
ADAMTS13, VWFCP, TTP | Thrombotic thrombocytopenic purpura, familial, 274150 (3)
ALAD, ALADH, PBGS | Porphyria, acute hepatic, 612740 (3); {Lead poisoning,
DBH | [Dopamine-beta-hydroxylase activity levels, plasma] (3);
DYT1, TOR1A | Dystonia-1, torsion, 128100 (3); Dystonia, early-onset atypical,
GSN | Amyloidosis, Finnish type, 105120 (3)
GLE1, GLE1L, LCCS, LCCS1 | Lethal congenital contracture syndrome 1, 253310 (3); Arthrogryposis,
SETX, SCAR1, AOA2, ALS4 | Ataxia-ocular apraxia-2, 606002 (3); Amyotrophic lateral sclerosis
SLC27A4, FATP4, IPS | Ichthyosis prematurity syndrome, 608649 (3)
SLC34A3, NPTIIC, HHRH | Hypophosphatemic rickets with hypercalciuria, 241530 (3)
SURF1 | Leigh syndrome, due to COX deficiency, 256000 (3)
TSC1, LAM | Tuberous sclerosis-1, 191100 (3); Lymphangioleiomyomatosis, 606690
SCAR2, CPD3 | Spinocerebellar ataxia, autosomal recessive 2 (2)
ABL1 | Leukemia, Philadelphia chromosome-positive, resistant to imatinib (3)
AK1 | Hemolytic anemia due to adenylate kinase deficiency, 612631 (3)
ASS1, ASS | Citrullinemia, 215700 (3)
C5 | C5 deficiency, 609536 (3)
CLLS3 | {Leukemia, chronic lymphocytic, susceptibility to, 3} (2)
CRAT, CAT1 | ?Carnitine acetyltransferase deficiency (1)
ENG, END, HHT1, ORW | Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3)
EPB72 | ?Stomatocytosis I, 185000 (1)
LMX1B, NPS1 | Nail-patella syndrome, 161200 (3)
NUP214, D9S46E, CAN, CAIN | Leukemia, acute myeloid, 601626 (3); Leukemia, T-cell acute
POMT1, MDDGA1, MDDGB1, MDDGC1 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye
STXBP1, UNC18, EIEE4 | Epileptic encephalopathy, early infantile, 4, 612164 (2)
MIR2861, MIRN2861, BMND15 | [Bone mineral density QTL 15], 613418 (3)
TMEM15, DK1, SEC59, KIAA1094, CDG1M | Congenital disorder of glycosylation, type Im, 610768 (3)
ALPQTL1 | {Alkaline phosphatase, plasma level of, QTL1} (2)
LRRC8A, KIAA1437, AGM5 | Agammaglobulinemia 5, 613506 (3)
ADAMTSL2, KIAA0605, GPHYSD1 | Geleophysic dysplasia 1, 231050 (3)
COL5A1 | Ehlers-Danlos syndrome, type II, 130010 (3); Ehlers-Danlos syndrome,
AGPAT2, LPAAB, BSCL, BSCL1 | Lipodystrophy, congenital generalized, type 1, 608594 (3)
CARD9, CANDF2 | Candidiasis, familial, 2, autosomal recessive, 212050 (3)
CEL, BSSL, CELL, MODY8 | Maturity-onset diabetes of the young, type VIII, 609812 (3)
EHMT1, EUHMTASE1, DEL9q34 | Kleefstra syndrome, 610253 (3)
GRIN1, NMDAR1, MRD8 | Mental retardation, autosomal dominant 8, 614254 (3)
INPP5E, MORMS, JBTS1, CORS1 | Mental retardation, truncal obesity, retinal dystrophy, and
LHX3, CPHD3 | Pituitary hormone deficiency, combined, 3, 221750 (3)
MAN1B1, MRT15 | Mental retardation, autosomal recessive 15, 614202 (3)
NELF | Hypogonadotropic hypogonadism, 146110 (3)
NOTCH1, TAN1 | Aortic valve disease, 109730 (3); Leukemia, T-cell acute
TPRN, C9orf75, DFNB79 | Deafness, autosomal recessive 79, 613307 (3)
AUH | 3-methylglutaconic aciduria, type I, 250950 (3)
PHYH, PAHX | Refsum disease, 266500 (3)
RDPA | Refsum disease, adult, with increased pipecolicacidemia (2)
ST12, PAC1 | Prostate adenocarcinoma (2)
IL2RA, IL2R, IDDM10 | Interleukin-2 receptor, alpha chain, deficiency of, 606367 (3);
MS2 | {Multiple sclerosis, susceptibility to, 2} (2)
GATA3, HDR, HDRS | Hypoparathyroidism, sensorineural deafness, and renal dysplasia,
KLF6, COPEB, BCD1, ZF9 | Prostate cancer, somatic, 176807 (3); Gastric cancer, somatic,
AKR1C2, DDH2, DD2, HAKRD, SRXY8 | Obesity, hyperphagia, and developmental delay (3); 46XY sex
AKR1C4, CHDR, CDR, HAKRA, DD4 | {46XY sex reversal 8, modifier of}, 614279 (3)
OPTN, GLC1E, FIP2, HYPL, NRP, ALS12 | Glaucoma 1, open angle, E, 137760 (3); {Glaucoma, normal tension,
CRCS5 | {Colorectal cancer, susceptibility to, 5} (2)
DGCR2, DGS2 | DiGeorge syndrome/velocardiofacial syndrome complex-2 (2)
ARVD6 | Arrhythmogenic right ventricular dysplasia 6 (2)
AD7 | Alzheimer disease-7 (2)
LPRS | {Leprosy, paucibacillary type, susceptibility to} (2)
VIM | Cataract, pulverulent, autosomal dominant (3)
PTF1A | Diabetes mellitus, permanent neonatal, with cerebellar agenesis,
ANKRD26, KIAA1074, THC2 | Thrombocytopenia 2, 188000 (3)
CUBN, IFCR, MGA1 | Megaloblastic anemia-1, Finnish type, 261100 (3)
MASTL, FLJ14813, GWL, THC2 | Thrombocytopenia-2, 188000 (3)
PDSS1, TPT, COQ1 | Coenzyme Q10 deficiency, 607426 (3)
RAB18, WARBM3 | Warburg micro syndrome 3, 614222 (3)
AF10 | Leukemia, acute myeloid, 601626 (3); Leukemia, acute T-cell
CACNB2 | Brugada syndrome 4, 611876 (3)
MTPAP, PAPD1, SPAX4 | Ataxia, spastic, 4, 613672 (3)
DFNB33 | Deafness, autosomal recessive 33 (2)
EIG5 | Epilepsy, idiopathic generalized, susceptibility to, 5 (2)
MAP3K8, COT, EST, TPL2 | Lung cancer, somatic, 211980 (3)
ZEB1, TCF8, NIL2A, PPCD3, FECD6 | Corneal dystrophy, posterior polymorphous, 3, 609141 (3); Corneal
MYO3A, DFNB30 | Deafness, autosomal recessive 30, 607101 (3)
BULN | {Bulimia nervosa, susceptibility to} (2)
DCLRE1C, ARTEMIS, SCIDA | Severe combined immunodeficiency, Athabascan type, 602450 (3);
BMIQ8 | {Obesity, susceptibility to, BMIQ8} (2)
AITD4 | {Autoimmune thyroid disease, susceptibility to, 4} (2)
BMIQ10 | {Obesity, susceptibility to, BMIQ10} (2)
ERCC6, CKN2, COFS1, CSB, ARMD5 | Cockayne syndrome, type B, 133540 (3); Cerebrooculofacioskeletal
ADK | Hypermethioninemia due to adenosine kinase deficiency, 614300 (3)
CXCL12, SDF1 | {AIDS, resistance to}, 609423 (3)
ALOX5 | {Atherosclerosis, susceptibility to} (3); {Asthma, diminished
CHAT, CMS1A2 | Myasthenic syndrome, congenital, associated with episodic apnea,
MSMB, HPC13 | {Prostate cancer, hereditary, 13}, 611928 (3)
NCOA4, ELE1, PTC3 | Thyroid carcinoma, papillary, 188550 (3)
RET, MEN2A, HSCR1 | Multiple endocrine neoplasia IIA, 171400 (3); Medullary thyroid
MBL2, MBL, MBP1, MBL2D | {Chronic infections, due to MBL deficiency}, 614372 (3)
STHAG5 | Tooth agenesis, selective, 5 (2)
HYPT9 | Hypotrichosis 9 (2)
ALL1 | {Leukemia, acute lymphocytic, susceptibility to, 1} (2)
ALPQTL4 | {Alkaline phosphatase, plasma level of, QTL4} (2)
CCDC6, D10S170, H4, TST1, PTC, TPC | Thyroid papillary carcinoma, 188550 (1)
IBD15 | {Inflammatory bowel disease 15} (2)
MAFD8 | {Major affective disorder-8, susceptibility to} (2)
RNANC, NCRNA | Retinal nonattachment, nonsyndromic congenital (2)
CDH23, USH1D | Usher syndrome, type 1D, 601067 (3); Deafness, autosomal recessive
PCDH15, DFNB23, USH1F | Usher syndrome, type 1F, 602083 (3); Deafness, autosomal recessive
MYP15 | Myopia 15 (2)
EGR2, KROX20 | Neuropathy, congenital hypomyelinating, 1, 605253 (3);
BICC1, BICC, CYSRD | {Renal dysplasia, cystic, susceptibility to}, 601331 (3)
ZNF365, UAN | {Nephrolithiasis, uric acid, susceptibility to}, 605990 (3)
NEUROG3, NGN3, ATOH5 | Diarrhea 4, malabsorptive, congenital, 610370 (3)
MBS3 | Moebius syndrome-3 (2)
HWE1 | Epilepsy, hot water, 1 (2)
HK1 | Hemolytic anemia due to hexokinase deficiency, 235700 (3)
KAT6B, MYST4, MORF | SBBYSS syndrome, 603736 (3)
MAT1A, MATA1, SAMS1 | Hypermethioninemia, persistent, autosomal dominant, due to
MRT8 | Mental retardation, autosomal recessive, 8 (2)
PCBD, DCOH | Hyperphenylalaninemia, BH4-deficient, D, 264070 (3)
PRF1, HPLH2, FLH2 | Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3);
SQTL1 | {Smoking as a quantitative trait locus 1} (2)
MGR12 | {Migraine, with or without aura, susceptibility to, 12} (2)
SFTPA2, SPA2, COLEC5 | Pulmonary fibrosis, idiopathic, 178500 (3)
RPS24, DBA3 | Diamond-blackfan anemia 3, 610629 (3)
ACTA2, ACTSA, AAT6, MYMY5 | Aortic aneurysm, familial thoracic 6, 611788 (3); Multisystemic
PAPSS2, ATPSK2 | SEMD, Pakistani type, 612847 (3)
ATFB1 | Atrial fibrillation, familial, 1 (2)
ASCC1, p50 | Barrett esophagus/esophageal adenocarcinoma, 614266 (3)
CHST3, C6ST, C6ST1, HSD | Spondyloepiphyseal dysplasia with congenital joint dislocations,
KIAA1279 | Goldberg-Shprintzen megacolon syndrome, 609460 (3)
MRPS16, COXPD2 | Combined oxidative phosphorylation deficiency 2, 610498 (3)
NODAL, HTX5 | Heterotaxy, visceral, 5, 270100 (3)
PSAP, SAP1 | Metachromatic leukodystrophy due to SAP-b deficiency, 249900 (3);
SLC29A3, ENT3, PHID | Hyperpigmentation, cutaneous, with hypertrichosis,
STOX1, PEE4 | Preeclampsia/eclampsia 4, 609404 (3)
VCL, CMD1W, CMH15 | Cardiomyopathy, dilated, 1W, 611407 (3); Cardiomyopathy, familial
SPG27 | Spastic paraplegia-27 (2)
SFTPA1, SFTP1 | {Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)
LDB3, ZASP, CYPHER, KIAA01613, CMD1C, LVNC3 | Myopathy, myofibrillar, ZASP-related, 609452 (3); Cardiomyopathy,
ARVD7, ARVC7 | Arrhythmogenic right ventricular dysplasia 7 (2)
BMPR1A, ACVRLK3, ALK3 | Polyposis, juvenile intestinal, 174900 (3); Polyposis syndrome,
KCNMA1, SLO | Generalized epilepsy and paroxysmal dyskinesia, 609446 (3)
POLR3A, RPC1, RPC155, ADDH, HLD7 | Leukodystrophy, hypomyelinating, 7, with or without oligodontia
SCZD11 | {Schizophrenia}, 181500 (2)
SLEN1 | {Systemic lupus erythematosus with nephritis, susceptibility to, 1}
SS3 | {Sarcoidosis, susceptibility to, 3} (2)
DEL10q23, C10DELq23 | Chromosome 10q23 deletion syndrome (4)
MINPP1, HIPER1 | Thyroid carcinoma, follicular, 188470 (3)
PLCE1, KIAA1516, NPHS3 | Nephrotic syndrome, type 3, 610725 (3)
RGR, RP44 | Retinitis pigmentosa 44, 613769 (3)
CPROTQ | [C-reactive protein QTL] (2)
HPSE2, HPA2, UFS | Urofacial syndrome, 236730 (3)
IBD20 | {Inflammatory bowel disease 20} (2)
CDHR1, PCDH21, PRCAD, CORD15 | Cone-rod dystrophy 15, 613660 (3)
HPS1 | Hermansky-Pudlak syndrome 1, 203300 (3)
BLNK, SLP65, AGM4 | Agammaglobulinemia 4, 613502 (3)
NMSR, HMSNR | Neuropathy, motor and sensory, Russe type (2)
CYP2C8 | Rhabdomyolysis, cerivastatin-induced (3)
GLUD1 | Hyperinsulinism-hyperammonemia syndrome, 606762 (3)
RCM2 | Cardiomyopathy, familial restrictive, 2 (2)
SLC16A12, MCT12, CJMG | Cataract, juvenile, with microcornea and glucosuria, 612018 (3)
SPG9 | Spastic paraplegia-9 (2)
IDDM24 | {Diabetes mellitus, insulin-dependent, 24} (2)
LIPA, CESD | Wolman disease, 278000 (3); Cholesteryl ester storage disease, 278000
LIPN, LIPL4, LI4 | Ichthyosis, lamellar, 4, 613943 (3)
PTEN, MMAC1, GLM2 | Cowden disease, 158350 (3); Lhermitte-Duclos syndrome, 158350 (3); Bannayan-Riley-Ruvalcaba syndrome, 153480 (3); {Meningioma}, 607174 (3);
ABCC2, CMOAT | Dubin-Johnson syndrome, 237500 (3)
AD6 | Alzheimer disease 6, 104300 (2)
C10orf2, TWINKLE, PEO1, PEOA3, IOSCA, MTDPS7 | Progressive external ophthalmoplegia, autosomal dominant, 3, 609286
CDB2, CDTB | Corneal dystrophy, Thiel-Behnke type (2)
CHUK, IKBKA, NFKBIKA, IKKA, IKK1 | Cocoon syndrome, 613630 (3)
COX15 | Cardiomyopathy, hypertrophic, early-onset fatal (3); Leigh syndrome
CYP2C9 | Tolbutamide poor metabolizer (3); Warfarin sensitivity, 122700 (3)
FGF8, KAL6 | Kallmann syndrome 6, 612702 (3)
LGI1, EPT, ETL1, ADLTE, ADPAEF | Epilepsy, familial temporal lobe, 1, 600512 (3)
PDE6C, PDEA2, COD4 | Cone dystrophy 4, 613093 (3)
PLAU, URK, QPD, BDPLT5 | {Alzheimer disease, late-onset, susceptibility to}, 104300 (3);
RBP4 | Retinol binding protein, deficiency of (3)
SHFM3, SHSF3, DUP10q24, C10DUPq24 | Split-hand/foot malformation 3, gene duplication syndrome (4)
SUFU, SUFUXL, SUFUH | Medulloblastoma, desmoplastic, 155255 (3)
ADRB1, ADRB1R, RHR | [Resting heart rate], 607276 (3); {Congestive heart failure and
TNFRSF6, APT1, FAS, CD95, ALPS1A | {Autoimmune lymphoproliferative syndrome}, 601859 (3); Squamous
CYP2C, CYP2C19 | Mephenytoin poor metabolizer, 609535 (3); Opremazole poor
CMTDI2 | Charcot-Marie-Tooth disease, dominant intermediate 2 (2)
GOT1, ASTQTL1 | Aspartate aminotransferase, serum level of, QTL1, 614419 (3)
CPN1, SCPN, CPN | Carboxypeptidase N deficiency, 212070 (3)
DHDPSL, HP3 | Hyperoxaluria, primary, type III, 613616 (3)
ZFYVE27, SPG33 | Spastic paraplegia 33, 610244 (3)
ALDH18A1, PYCS, GSAS, ARCL3A | Cutis laxa, autosomal recessive, type IIIA, 219150 (3)
COL17A1, BPAG2 | Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3)
CYP17A1, CYP17, P450C17 | 17-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3); 17,20-lyase
PDZD7 | {Retinal disease in Usher syndrome type IIA, modifier of}, 276901
PAX2 | Optic nerve coloboma with renal disease, 120330 (3); Renal
SPG45 | Spastic paraplegia 45 (2)
HPS6, RU | Hermansky-Pudlak syndrome 6, 614075 (3)
CNNM2, ACDP2 | Hypomagnesemia 6, renal, 613882 (3)
CSPG6, SMC3, HCAP, BAM, CDLS3 | Cornelia de Lange syndrome 3, 610759 (3)
IDDM17 | {Diabetes mellitus, insulin-dependent, 17} (2)
MXI1 | Neurofibrosarcoma (3);
PITX3, CTPP4 | Anterior segment mesenchymal dysgenesis, 107250 (3); Cataract,
SHOC2, SIAA0862, SOC2, SUR8 | Noonan-like syndrome with loose anagen hair, 607721 (3)
ACADSB, SBCAD | 2-methylbutyrylglycinuria, 610006 (3)
EIG4 | Epilepsy, idiopathic generalized, susceptibility to 4 (2)
HABP2, PHBP, HGFAL, FSAP | {Carotid stenosis, susceptibility to} (3); {Venous thromboembolism,
RBM20 | Cardiomyopathy, dilated, 1DD, 613172 (3)
BAG3 | Myopathy, myofibrillar, BAG3-related, 612954 (3); Cardiomyopathy,
UROS | Porphyria, congenital erythropoietic, 263700 (3)
KCNK18, TRESK, TRIK, MGR13 | {Migraine, with or without aura, susceptibility to, 13}, 613656 (3)
TCF7L2, TCF4 | {Diabetes mellitus, type 2, susceptibility to}, 125853 (3)
HTRA1, PRSS11, ARMD7 | {Macular degeneration, age-related, 7}, 610149 (3); {Macular
PLEKHA1, TAPP1 | {Age-related maculopathy, susceptibility to}, 603075 (2)
DEL10q26, C10q26DEL | Chromosome 10q26 deletion syndrome (4)
ENDO1 | {Endometriosis, susceptibility to, 1} (2)
FGFR2, BEK, CFD1, JWS | Crouzon syndrome, 123500 (3); Jackson-Weiss syndrome, 123150 (3); Beare-Stevenson cutis gyrata syndrome, 123790 (3); Pfeiffer syndrome, 101600
OAT, GACR | Gyrate atrophy of choroid and retina with or without
RRIS | [Respiratory rhythmicity in sleep] (2)
EMX2 | Schizencephaly, 269160 (3)
PNLIP, PNLIPD | Pancreatic lipase deficiency, 614338 (1)
LOC387715, ARMD8 | {Macular degeneration, age-related, 8}, 613778 (3)
OMS | {Otitis media, susceptibility to} (2)
ALG8, CDG1H | Congenital disorder of glycosylation, type Ih, 608104 (3)
RRAS2, TC21 | Ovarian carcinoma (3)
AMPD3 | [AMP deaminase deficiency, erythrocytic], 612874 (3)
CD44, MDU2, MDU3, MIC4 | [Blood group, Indian system] (3)
CD151, PETA3, SFA1, MER2 | Nephropathy with pretibial epidermolysis bullosa and deafness,
CDKN1C, KIP2, BWS | Beckwith-Wiedemann syndrome, 130650 (3)
CTSD, CPSD, CLN10 | Ceroid lipofuscinosis, neuronal, 10, 610127 (3)
DRD4 | Autonomic nervous system dysfunction (3); [Novelty seeking
H19, D11S813E, ASM1, BWS, WT2 | Beckwith-Wiedemann syndrome, 130650 (3); Silver-Russell syndrome,
KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2 | Long QT syndrome-1, 192500 (3); Jervell and Lange-Nielsen syndrome,
LCRB | Thalassemia, Hispanic gamma-delta-beta, 613985 (3)
HBB | Sickle cell anemia, 603903 (3); Thalassemias, beta-, 613985 (3);
HBD | Thalassemia, delta- (3); Thalassemia due to Hb Lepore (3)
HBG1 | Fetal hemoglobin quantitative trait locus 1, 141749 (3)
HBG2, TNCY | Fetal hemoglobin quantitative trait locus 1, 141749 (3); Cyanosis,
HRAS | {Bladder cancer, somatic}, 109800 (3); Costello syndrome, 218040 (3);
IGF2 | Intrauterine and postnatal growth retardation (1)
INS, MODY10, IDDM2 | Hyperproinsulinemia, familial, with or without diabetes (3);
KCNQ10T1, LIT1 | Beckwith-Wiedemann syndrome, 130650 (3)
PNPLA2, TTS2, ATGL | Neutral lipid storage disease with myopathy, 610717 (3)
SLC22A1L, BWSCR1A, IMPT1 | Breast cancer, somatic, 114480 (3); Rhabdomyosarcoma, somatic, 268210
SLC25A22, GC1, EIEE3 | Epileptic encephalopathy, early infantile, 3, 609304 (3)
SLEN3 | {Systemic lupus erythematosus with nephritis, susceptibility to, 3}
STIM1 | Immune dysfunction, with T-cell inactivation due to calcium entry
TH, TYH | Segawa syndrome, recessive, 605407 (3)
TNNI2, AMCD2B, DA2B, FSSV | Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3)
TNNT3, AMCD2B, DA2B, FSSV | Arthyrgryposis, distal, type 2B, 601680 (3)
TPP1, CLN2 | Ceroid lipofuscinosis, neuronal, 2, 204500 (3)
TALDO1 | Transaldolase deficiency, 606003 (3)
LDHA, LDH1, GSD11 | Glycogen storage disease XI, 612933 (3)
MMVP2 | Mitral valve prolapse, myxomatous 2 (2)
SMPD1, NPD | Niemann-Pick disease, type A, 257200 (3); Niemann-Pick disease, type
PTH | Hypoparathyroidism, autosomal dominant, 146200 (3);
CYP2R1 | Rickets due to defect in vitamin D 25-hydroxylation, 600081 (3)
TEAD1, TCF13, REF1 | Sveinsson choreoretinal atrophy, 108985 (3)
SLC6A5, GLYT2 | Hyperekplexia, 149400 (3)
TSG101 | Breast cancer, somatic, 114480 (3)
ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2 | Hyperinsulinemic hypoglycemia, familial, 1, 256450 (3);
CSRP3, CRP3, CLP, CMD1M, CMH12 | Cardiomyopathy, dilated, 1M, 607482 (3); Cardiomyopathy,
KCNJ11, BIR, PHHI, HHF2, TNDM3 | Hyperinsulinemic hypoglycemia, familial, 2, 601820 (3);
USH1C, DFNB18 | Usher syndrome, type 1C, 276904 (3); Deafness, autosomal recessive
FANCF | Fanconi anemia, complementation group F, 603467 (3)
GINGF4, HGF4, GGF4 | Fibromatosis, gingival, 4 (2)
IH, HHP | Hemihypertrophy (2)
LMO1, RBTN1, RHOM1 | Leukemia, T-cell acute lymphoblastic (2)
LVNC2 | Left ventricular noncompaction 2 (2)
MRT17, MRT21 | Mental retardation, autosomal recessive 17/21 (2)
MUC5B | {Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3)
NUP98 | Leukemia, lymphocytic, acute T-cell (1)
SBF2, MTMR13, CMT4B2 | Charcot-Marie-Tooth disease, type 4B2, 604563 (3)
SCAR7 | Spinocerebellar ataxia, autosomal recessive 7 (2)
DEL11p15p14, C11DELp15p14 | Chromosome 11p15-p14 deletion syndrome (4)
HPS5, RU2, KIAA1017 | Hermansky-Pudlak syndrome 5, 614074 (3)
ANO5, TMEM16E, GDD1, LGMD2L | Gnathodiaphyseal dysplasia, 166260 (3); Muscular dystrophy,
DFNA59 | Deafness, autosomal dominant 59 (2)
SPG41 | ?Spastic paraplegia 41 (2)
TST1 | [Tuberculin skin test reactivity, absence of] (2)
GPR48, LGR4 | {Schizophrenia, susceptibility to}, 181500 (3)
BDNF | {Memory impairment, susceptibility to} (3); Central hypoventilation
DEL11p13, C11DELp13, WAGR | Wilms tumor, aniridia, genitourinary anomalies and mental retardation
CAT | Acatalasemia, 614097 (3)
CD59, MIC11 | CD59 deficiency, 612300 (3)
ECT, BECTS | Centrotemporal epilepsy (2)
FSHB | Follicle-stimulating hormone deficiency, isolated, 229070 (3)
LMO2, RBTNL1, RHOM2, TTG2 | Leukemia, acute T-cell (2)
MYP7 | Myopia 7 (2)
PAX6, AN2, MGDA | Aniridia, 106210 (3); Peters anomaly, 604229 (3); Cataract with
PDX1 | Lacticacidemia due to PDX1 deficiency, 245349 (3)
RAG1 | Severe combined immunodeficiency, B cell-negative, 601457 (3);
RAG2 | Severe combined immunodeficiency, B cell-negative, 601457 (3);
WT1, NPHS4 | Wilms tumor, type 1, 194070 (3); Denys-Drash syndrome, 194080 (3);
DFNB51 | Deafness, autosomal recessive 51 (2)
EVR3 | Exudative vitreoretinopathy-3 (2)
WAGRO, DEL11p14p12 | WAGRO syndrome (4)
CANDF3, CANDN1, FCNC | Candidiasis, familial, 3 (2)
MRT23 | Mental retardation, autosomal recessive 23 (2)
BMND8 | {Osteoporosis}, 166710 (2)
LRP4, MEGF7, CLSS, SOST2 | Cenani-Lenz syndactyly syndrome, 212780 (3); Sclerosteosis 2,
MAPK8IP1, IB1 | {Diabetes mellitus, noninsulin-dependent}, 125853 (3)
PEX16 | Zellweger syndrome, complementation group 9 (3)
DDB2 | Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3)
EXT2 | Exostoses, multiple, type 2, 133701 (3)
PSNP3 | Supranuclear palsy, progressive, 3 (2)
ACP2 | ?Lysosomal acid phosphatase deficiency, 200950 (1)
ALX4, PFM2, FPP, FND2 | Parietal foramina 2, 609597 (3); Frontonasal dysplasia 2, 613451 (3)
CD82, SAR2, KAI1, ST6 | {Prostate cancer, susceptibility to}, 176807 (2)
MYBPC3, CMH4 | Cardiomyopathy, familial hypertrophic, 4, 115197 (3);
PSS | Potocki-Shaffer syndrome (4)
PTPRJ, DEP1 | Colon cancer, somatic, 114500 (3)
SLC35C1, FUCT1, CDG2C | Congenital disorder of glycosylation, type IIc, 266265 (3)
SLC39A13 | Spondylocheirodysplasia, Ehlers-Danlos syndrome-like, 612350 (3)
RAPSN, CMS1D, CMS1E | Myasthenic syndrome, congenital, associated with acetylcholine
NDUFS3 | Leigh syndrome, 256000 (3)
F2, THPH1 | Hypoprothrombinemia, 613679 (3); Dysprothrombinemia, 613679 (3);
CD81, TAPA1, CVID6 | Immunodeficiency, common variable, 6, 613496 (3)
HYPLIP2 | Hyperlipidemia, combined, 2 (2)
NNO1 | Nanophthalmos-1 (2)
C1NH, HAE1, HAE2, SERPING1 | Angioedema, hereditary, types I and II, 106100 (3); Complement
KIND3, URP2, MIG2B, FERMT3 | Leukocyte adhesion deficiency, type III, 612840 (3)
LTBP3, LTBP2, STHAG6 | Tooth agenesis, selective, 6, 613097 (3)
SCA20, DUP11q12, C11DUPq12 | Spinocerebellar ataxia 20 (4)
B3GAT3, GLCATI | Multiple joint dislocations, short stature, craniofacial dysmorphism,
DDB1 | Xeroderma pigmentosum, group E, subtype 2 (1)
DHCR7, SLOS | Smith-Lemli-Opitz syndrome, 270400 (3)
FTH1, FTHL6 | Iron overload, autosomal dominant (3)
PURAQTL1 | [Polyunsaturated fatty acids plasma level QTL1] (2)
TMEM138, JBTS16 | Joubert syndrome 16, 614465 (3)
TMEM216, JBTS2, CORS2, MKS2 | Joubert syndrome 2, 608091 (3); Meckel syndrome, type 2, 603194 (3)
SCGB1A1, UGB, CC10, CCSP, SCGB1A1 | {Asthma, susceptibility to}, 600807 (3)
BBS1 | Bardet-Biedl syndrome 1, 209900 (3)
BSCL2, SPG17, HMN5 | Lipodystrophy, congenital generalized, type 2, 269700 (3); Silver
CCND1, PRAD1, BCL1 | {Colorectal cancer, susceptibility to}, 114500 (3);
CPT1A | CPT deficiency, hepatic, type IA, 255120 (3)
EFEMP2, FBLN4, UPH1, ARCL1B | Cutis laxa, autosomal recessive, type IB, 614437 (3)
FGF3, INT2 | Deafness, congenital with inner ear agenesis, microtia, and
GIF, IF | Intrinsic factor deficiency, 261000 (3)
HPC14 | {Prostate cancer, hereditary, 14} (2)
IDDM4 | {Diabetes mellitus, insulin-dependent, 4} (2)
MEN1 | Multiple endocrine neoplasia 1, 131100 (3); Carcinoid tumor of lung
MS4A2, FCER1B | {Atopy, susceptibility to}, 147050 (3)
MS4A1, CD20, CVID5 | Immunodeficiency, common variable, 5, 613495 (3)
NDUFS8 | Leigh syndrome, 256000 (3)
NDUFV1, UQOR1 | Mitochondrial complex I deficiency, 252010 (3)
NUMA1 | Leukemia, acute promyelocytic, NUMA/RARA type (3)
UNC93B1, IIAE1 | Herpes simplex encephalitis, susceptibility to, 1, 610551 (3)
PYGM | McArdle disease, 232600 (3)
ROM1, ROSP1, RP7 | Retinitis pigmentosa 7, digenic (3)
SLC22A12, OAT4L, URAT1 | Hypouricemia, renal, 220150 (3)
SMAR | Spinal muscular atrophy, chronic distal, autosomal recessive (2)
SPOAN | Spastic paraplegia, optic atrophy, and neuropathy (2)
SPTBN2, SCA5 | Spinocerebellar ataxia 5, 600224 (3)
ST3 | Cervical carcinoma (2)
UCP2, BMIQ4 | {Obesity, susceptibility to, BMIQ4}, 607447 (3)
UCP3 | {Obesity, severe, and type II diabetes}, 601665 (3)
BEST1, VMD2, ARB, RP50 | Best macular dystrophy, 153700 (3); Maculopathy, bull's-eye (3);
VRNI | Vitreoretinopathy, neovascular inflammatory (2)
ACTN3 | [Alpha-actinin-3 deficiency] (3); [Sprinting performance] (3)
KCNE3, HOKPP, HYPP | Brugada syndrome 6, 613119 (3)
BANF1, BAF, NGPS | Nestor-Guillermo progeria syndrome, 614008 (3)
CABP4, CSNB2B | Night blindness, congenital stationary, type 2B, 610427 (3)
CATSPER1, CATSPER, SPGF7 | Spermatogenic failure 7, 612997 (3)
SDHAF2, SDH5, PGL2 | Paragangliomas 2, 601650 (3)
RNASEH2C, AYP1, FLJ20974, AGS3 | Aicardi-Goutieres syndrome 3, 610329 (3)
TPCN2, TPC2, SHEP10 | [Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3)
IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6 | Neuronopathy, distal hereditary motor, type VI, 604320 (3)
AIP, XAP2, ARA9 | Pituitary adenoma, growth hormone-secreting, 102200 (3);
CLCF1, BSF3, CLC | Cold-induced sweating syndrome 1, 610313 (3)
CLLS1 | {Leukemia, chronic lymphocytic, susceptibility to, 1} (2)
FADD | Infections, recurrent, with encephalopathy, hepatic dysfunction,
SIPA1, SPA1 | Metastasis efficiency, modification of (1)
LRTOMT, LRTOMT1, LRTOMT2, DFNB63 | Deafness, autosomal recessive 63, 611451 (3)
PHOX2A, ARIX, CFEOM2 | Fibrosis of extraocular muscles, congenital, 2, 602078 (3)
SHANK2, CORTBP1, AUTS17 | {Autism susceptibility 17}, 613436 (3)
FOLR1 | Neurodegeneration due to cerebral folate transport deficiency,
LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4 | Osteoporosis-pseudoglioma syndrome, 259770 (3); [Bone mineral density
PC | Pyruvate carboxylase deficiency, 266150 (3)
TCIRG1, TIRC7, OC116, OPTB1 | Osteopetrosis, autosomal recessive 1, 259700 (3)
ATOD7 | {Dermatitis, atopic, susceptibility to, 7} (2)
DYNC2H1, DNCH2, DHC2, ATD3 | Asphyxiating thoracic dystrophy 3, 613091 (3); Short rib-polydactyly
MYO7A, USH1B, DFNB2, DFNA11 | Usher syndrome, type 1B, 276900 (3); Deafness, autosomal recessive 2,
SERPINH2, PPROM, CBP2, CBP1, OI10 | {Preterm premature rupture of the membranes, susceptibility to},
PICALM, CALM, CLTH, LAP | Leukemia, acute myeloid, 601626 (3); Leukemia, acute T-cell
SLEH1 | {Systemic lupus erythematosus with hemolytic anemia} (2)
SCZD2 | {?Schizophrenia}, 181500 (2)
FZD4, EVR1 | Exudative vitreoretinopathy, 133780 (3); Retinopathy of prematurity,
TYR, SHEP3, CMM8 | Albinism, oculocutaneous, type IA, 203100 (3); Waardenburg
IHPS3 | Pyloric stenosis, infantile hypertrophic, 3 (2)
CTSC, CPPI, PALS, PLS, HMS, JPD | Papillon-Lefevre syndrome, 245000 (3); Haim-Munk syndrome, 245010
TMEM126A, OPA7 | Optic atrophy-7, 612989 (3)
CEP57, PIG8, TSP57, KIAA0092, MVA2 | Mosaic variegated aneuploidy syndrome 2, 614114 (3)
MAML2, MAM3 | Mucoepidermoid salivary gland carcinoma (3)
MED17, CRSP6, CRSP77, TRAP80, DRIP80 | Microcephaly, postnatal progressive, with seizures and brain
MRE11A, MRE11, ATLD | Ataxia-telangiectasia-like disorder, 604391 (3)
FGQTL3 | [Fasting plasma glucose level QTL 3] (2)
TRPC6, TRP6, FSGS2 | Glomerulosclerosis, focal segmental, 2, 603965 (3)
MTMR2, CMT4B1 | Charcot-Marie-Tooth disease, type 4B1, 601382 (3)
PGR | ?Progesterone resistance, 264080 (2)
MMP1, CLG | COPD, rate of decline of lung function in, 606963 (3); {Epidermolysis
PPP2R1B | Lung cancer, 211980 (3)
TECTA, DFNA8, DFNA12, DFNB21 | Deafness, autosomal dominant 8/12, 601543 (3); Deafness, autosomal
ANC | ?Anal canal carcinoma (2)
ATM, ATA, AT1 | Ataxia-telangiectasia, 208900 (3); Lymphoma, B-cell non-Hodgkin,
CASP12, CASP12P1 | {Sepsis, susceptibility to} (3)
MMP13, CLG3, MANDP1 | Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3);
MMP20, AI2A2 | Amelogenesis imperfecta, type IIA2, 612529 (3)
ACAT1 | Alpha-methylacetoacetic aciduria, 203750 (3)
CRYAB, CRYA2, CTPP2 | Myopathy, myofibrillar, alpha-B crystallin-related, 608810 (3);
PTS | Hyperphenylalaninemia, BH4-deficient, A, 261640 (3)
ALG9, DIBD1, CDG1L | Congenital disorder of glycosylation, type Il, 608776 (3)
APOA1 | ApoA-I and apoC-III deficiency, combined (3);
APOC3, HALP2 | Hyperalphalipoproteinemia 2, 614028 (3)
APOA5 | {Hypertriglyceridemia, susceptibility to}, 145750 (3);
BMND5 | [Bone mineral density QTL 5] (2)
BRCATA | Breast cancer, 11:22 translocation associated (1)
CD3D, T3D | Severe combined immunodeficiency, T cell-negative, B-cell/natural
CD3E | Immunodeficiency due to defect in CD3-epsilon (3); Severe combined
CD3G | Immunodeficiency due to defect in CD3-gamma (3)
CRCS7 | {Colorectal cancer, susceptibility to, 7} (2)
FXYD2, ATP1G1, HOMG2 | Hypomagnesemia-2, renal, 154020 (3)
GTS | Tourette syndrome (2)
JBS | Jacobsen syndrome (4)
MFRP, MCOP5 | Microphthalmia, isolated 5, 611040 (3)
MLL, HRX, HTRX1 | Leukemia, myeloid/lymphoid or mixed-lineage (2)
MMP3, STMY1, CHDS6 | {Coronary heart disease, susceptibility to, 6}, 614466 (3)
NAFLD2 | {Fatty liver disease, nonalcoholic, susceptibility to, 2} (2)
RDX, DFNB24 | Deafness, autosomal recessive 24, 611022 (3)
SCN4B | Long QT syndrome-10, 611819 (3)
SDHD, PGL1 | Paragangliomas 1, with or without deafness, 168000 (3);
SLC37A4, G6PT1 | Glycogen storage disease Ib, 232220 (3); Glycogen storage disease Ic,
TCPT | ?Thrombocytopenia, Paris-Trousseau type (4)
TREH | Trehalase deficiency, 612119 (1)
TSG11 | {Nonsmall cell lung cancer} (2)
ADIPQTL4 | {Adiponectin, serum level of, QTL4} (2)
HVEC, PVRL1, PVRR1, PRR1, ED4, OFC7, CLPED1 | Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3);
TIRAP, BACTS1 | {Pneumococcal disease, invasive, protection against}, 610799 (3);
ROBO3, RBIG1, RIG1, HGPPS | Gaze palsy, horizontal, with progressive scoliosis, 607313 (3)
DLAT, PDCE2 | Pyruvate dehydrogenase E2 deficiency, 245348 (3)
DRD2 | Dystonia, myoclonic, 159900 (3)
NNMT | Homocysteine plasma level (2)
ZBTB16, ZNF145, PLZF | Leukemia, acute promyelocytic, PL2F/RARA type (3); Skeletal defects,
ANKK1 | Dopamine receptor D2, reduced brain density of (3)
SORL1, LR11, SORLA | {Alzheimer disease, pathogenesis, association with}, 104300 (3)
ARHGEF12, LARG, KIAA0382 | Leukemia, acute myeloid, 601626 (3)
C1QTNF5, CTRP5, LORD | Retinal degeneration, late-onset, autosomal dominant, 605670 (3)
CBL, CBL2, NSLL | Noonan syndrome-like disorder with or without juvenile
DPAGT2, DGPT, CDG1J | Congenital disorder of glycosylation, type Ij, 608093 (3)
HYALP, HDLD3 | Hypoalphalipoproteinemia, primary (2)
HMBS, PBGD, UPS | Porphyria, acute intermittent, 176000 (3); Porphyria, acute
IL10RA, IL10R, IBD28 | Inflammatory bowel disease 28, early onset, autosomal recessive,
SC5DL, ERG3 | Lathosterolosis, 607330 (3)
SCN3B, SCNB3 | Brugada syndrome 7, 613120 (3)
AAT1, FAA1 | Aortic aneurysm, familial thoracic 1 (2)
HEPACAM, MLC2A, MLC2B | Megalencephalic leukoencephalopathy with subcortical cysts 2A,
KCNJ1, ROMK1 | Bartter syndrome, type 2, 241200 (3)
KCNJ5, GIRK4, KATP1, LQT13 | Long QT syndrome 13, 613485 (3); Hyperaldosteronism, familial, type
MGR9 | {Migraine with aura, susceptibility to, 9} (2)
NEDE | Nephropathy, progressive, with deafness (2)
SIAE, AIS6 | {Autoimmune disease, susceptibility to, 6}, 613551 (3)
ANIB7 | Aneurysm, intracranial berry, 7 (2)
ST14, MTSP1 | Ichthyosis with hypotrichosis, 610765 (3)
CLLS5 | {Leukemia, chronic lymphocytic susceptibility to, 5} (2)
CDON, CDO, HPE11 | Holoprosencephaly 11, 614226 (3)
FOXRED1 | Leigh syndrome due to mitochondrial complex I deficiency, 256000 (3);
HYLS1, FLJ32915 | Hydrolethalus syndrome, 236680 (3)
KIRREL3, NEPH2, KIAA1867, KIRRE, MRD4 | Mental retardation, autosomal dominant 4, 612581 (3)
ACAD8 | Isobutyryl-CoA dehydrogenase deficiency, 611283 (3)
HJCD | Faisalabad histiocytosis (2)
JAM3 | Hemorrhagic destruction of the brain, subependymal calcification,
OPCML | {Ovarian cancer, somatic}, 167000 (3)
DFNB20 | Deafness, autosomal recessive 20 (2)
AOCH | Acromegaloid features, overgrowth, cleft palate, and hernia (2)
ATN1, DRPLA, HRS, NOD | Dentatorubro-pallidoluysian atrophy, 125370 (3)
CD4 | OKT4 epitope deficiency, 613949 (3)
CACNA1C, CACNL1A1, CCHL1A1, TS | Timothy syndrome, 601005 (3); Brugada syndrome 3, 611875 (3)
CACNA2D4, RCD4 | Retinal cone dystrophy 4, 610478 (3)
FGF23, ADHR, HPDR2, PHPTC | Hypophosphatemic rickets, autosomal dominant, 193100 (3);
MAFD9 | {Major affective disorder-9, susceptibility to} (2)
PEX5, PXR1, PTS1R | Adrenoleukodystrophy, neonatal, 202370 (3); Zellweger syndrome,
VWF, F8VWF | von Willebrand disease, type 2A, 2B, 2M, and 2N, 613554 (3); von
A2M , A2MD | Alpha-2-macroglobulin deficiency, 614036 (1); {Alzheimer
LRP6, ADCAD2 | {Coronary artery disease, autosomal dominant, 2}, 610947 (3)
MRT10, MRT20 | Mental retardation, autosomal recessive 10/20 (2)
TNFRSF1A, TNFR1, TNFAR, FPF | Periodic fever, familial, 142680 (3)
CLEC7A, CLECSF12, DECTIN1, CANDF4 | Candidiasis, familial, 4, autosomal dominant, 613108 (3);
DFNB62 | Deafness, autosomal recessive 62 (2)
IBD2 | {Inflammatory bowel disease 2} (2)
GDF3, KFS3, MCOPCB6, MCOP7 | Klippel-Feil syndrome 3, autosomal dominant, 613702 (3);
MGP, NTI | Keutel syndrome, 245150 (3); {Natural teeth remaining intact} (2)
AICDA, AID, HIGM2 | Immunodeficiency with hyper-IgM, type 2, 605258 (3)
C1R | C1r/C1s deficiency, combined, 216950 (1)
C1S | C1s deficiency, 613783 (3)
CDKN1B, KIP1, CDKN4, MEN4 | Multiple endocrine neoplasia, type IV, 610755 (3)
EDS8 | Ehlers-Danlos syndrome, type VIII (2)
EMG1, NEP1, C2F, BWCNS | Bowen-Conradi syndrome, 211180 (3)
ETV6, TEL | Leukemia, acute myeloid, somatic, 601626 (3)
GNB3 | {Hypertension, essential, susceptibility to}, 145500 (3)
KCNA1, AEMK, EA1 | Episodic ataxia/myokymia syndrome, 160120 (3)
KCNA5, ATFB7 | Atrial fibrillation, familial, 7, 612240 (3)
PDE6H, RCD3 | Retinal cone dystrophy 3, 610024 (3)
SPAX1 | Spastic ataxia 1, autosomal dominant (2)
SCNN1A, BESC2 | Pseudohypoaldosteronism, type I, 264350 (3); Bronchiectasis with
TPI1 | Hemolytic anemia due to triosephosphate isomerase deficiency (3)
WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2 | Pseudohypoaldosteronism, type IIC, 614492 (3); Neuropathy,
ART4, DO, DOK1 | [Blood group, Dombrock] (3)
OLR1, LOX1 | {Myocardial infarction, susceptibility to}, 608446 (3)
PTPRO, GLEPP1, NPHS6 | Nephrotic syndrome, type 6, 614196 (3)
GYS2 | Glycogen storage disease, type 0, 240600 (3)
SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR | Hyperbilirubinemia, Rotor type, digenic, 237450 (3)
HYT4 | {Hypertension, essential, susceptibility to, 4}, 145500 (2)
LDHB, LDHBD | Lactate dehydrogenase-B deficiency, 614128 (3)
HTNB | Hypertension with brachydactyly (2)
ABCC9, SUR2, CMD1O, ATFB12 | Cardiomyopathy, dilated, 1O, 608569 (3); Atrial fibrillation,
KRAS, KRAS2, RASK2, NS | Lung cancer, 211980 (3); Bladder cancer, 109800 (3); Breast cancer,
BHLHE41, BHLHB3, DEC2, SHARP1 | [Short sleeper], 612975 (3)
PTHLH, BDE2 | Humoral hypercalcemia of malignancy (1); Brachydactyly, type E2,
BCAT1, BCT1 | ?Hyperleucinemia-isoleucinemia or hypervalinemia (1)
GRIN2B, NMDAR2B, MRD6 | Mental retardation, autosomal dominant 6, 613970 (3)
SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR | Hyperbilirubinemia, Rotor type, digenic, 237450 (3)
DNM1L, DRP1, DVLP, DYMPLE, EMPF | Encephalopahty, lethal, due to defective mitochondrial peroxisomal
YARS2, TYRRS, MLASA2 | Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3)
KCNJ8 | ?Prinzmetal angina (1)
AD5 | Alzheimer disease-5, 104300 (2)
FGD4, FRABIN, CMT4H | Charcot-Marie-Tooth disease, type 4H, 609311 (3)
STQTL3 | {Stature QTL 3} (2)
ALG10, KCR1 | {Acquired long QT syndrome, reduced susceptibility to}, 613688 (3)
SPG26 | Spastic paraplegia 26 (2)
DDX11, CHLR1, KRG2 | Warsaw breakage syndrome, 613398 (3)
PKP2, ARVD9 | Arrhythmogenic right ventricular dysplasia 9, 609040 (3)
NDUFA9 | Leigh syndrome due to mitochondrial complex I deficiency, 256000
CODA | Cavitary optic disc anomalies (2)
IHPS1, IHPS | Pyloric stenosis, infantile hypertrophic 1 (2)
RPS26, DBA10 | Diamond-Blackfan anemia 10, 613309 (3)
CNTN1 | Myopathy, congenital, Compton-North, 612540 (3)
KRT2, KRT2A, KRT2E | Ichthyosis bullosa of Siemens, 146800 (3)
PPKB | Palmoplantar keratoderma, Bothnia type (2)
ACVRL1, ACVRLK1, ALK1, HHT2 | Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3)
ANO6, TMEM16F, SCTS, BDPLT7 | Scott syndrome, 262890 (3)
IRAK4, REN64, IPD1 | IRAK4 deficiency, 607676 (3); Invasive pneumococcal disease,
KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B | Fibrosis of extraocular muscles, congenital, 1, 135700 (3);
LRRK2, PARK8 | Parkinson disease-8, 607060 (3)
PRICKLE1, RILP, EPM1B | Epilepsy, progressive myoclonic 1B, 612437 (3)
GPD1, HTGTI | Hypertriglyceridemia, transient infantile, 614480 (3)
PRPH | {Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)
CMT2G | Charcot-Marie-Tooth disease, axonal, type 2G (2)
MLL2, ALR, KABUK1 | Kabuki syndrome 1, 147920 (3)
TUBA1A, TUBA3, LIS3 | Lissencephaly 3, 611603 (3)
VDR | Rickets, vitamin D-resistant, type IIA, 277440 (3);
RLS1 | {Restless legs syndrome 1} (2)
AAAS, AAA | Achalasia-addisonianism-alacrimia syndrome, 231550 (3)
ACVR1B, ACVRLK4, ALK4 | Pancreatic cancer, somatic (3)
AMHR2, AMHR | Persistent Mullerian duct syndrome, type II, 261550 (3)
AQP2 | Diabetes insipidus, nephrogenic, 125800 (3)
BCC4 | {Basal cell carcinoma, susceptibility to, 4} (2)
ERBB3, LCCS2 | Lethal congenital contractural syndrome 2, 607598 (3)
ITGA7 | Muscular dystrophy, congenital, due to ITGA7 deficiency, 613204 (3)
KIF5A, NKHC, SPG10 | Spastic paraplegia 10, 604187 (3)
KRT1, EPPK, NEPPK, EHK | Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with
KRT3 | Meesmann corneal dystrophy, 122100 (3)
KRT4, CYK4 | White sponge nevus, 193900 (3)
KRT5, DDD | Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3);
KRT6A | Pachyonychia congenita, Jadassohn-Lewandowsky type, 167200 (3)
KRT6B, PC2 | Pachyonychia congenita, Jackson-Lawler type, 167210 (3)
KRT8 | Cirrhosis, cryptogenic (3); {Cirrhosis, noncryptogenic,
KRT18 | Cirrhosis, cryptogenic (3); {Cirrhosis, noncryptogenic,
KRT74, K6IRS4, KRT6IRS4, HTSS2 | Woolly hair, autosomal dominant, 194300 (3); Hypotrichosis simplex
KRT75, K6HF, PFB | {Pseudofolliculitis barbae, susceptibility to}, 612318 (3)
KRT81, KRTHB1, HB1 | Monilethrix, 158000 (3)
KRT83, KRTHB3, HB3 | Monilethrix, 158000 (3)
KRT85, KRTHB5, HB5 | Ectodermal dysplasia, 'pure' hair-nail type, 602032 (3)
KRT86, KRTHB6, HB6 | Monilethrix, 158000 (3)
MIP, AQP0 | Cataract, polymorphic and lamellar, 604219 (3)
NRAMP2 | Anemia, hypochromic microcytic, 206100 (3)
SCN8A, CIAT | Cognitive impairment with or without cerebellar ataxia, 614306 (3)
WNT10B, SHFM6 | Split-hand/foot malformation 6, 225300 (3)
RDH5 | Fundus albipunctatus, 136880 (3)
TSFM, COXPD3 | Combined oxidative phosphorylation deficiency 3, 610505 (3)
MYO1A, DFNA48 | Deafness, autosomal dominant 48, 607841 (3)
ENUR2 | Enuresis, nocturnal, 2 (2)
TAC3, NKNB | Hypogonadotropic hypogonadism, 146110 (3)
DHH, SRXY7, GDXYM | 46XY partial gonadal dysgenesis, with minifascicular neuropathy,
DDIT3, GADD153, CHOP10 | Myxoid liposarcoma, 613488 (1)
CYP27B1, VDD1, PDDR | Vitamin D-dependent rickets, type I, 264700 (3)
COL2A1 | Stickler syndrome, type I, 108300 (3); Kniest dysplasia, 156550 (3);
MRT25 | Mental retardation, autosomal recessive 25 (2)
C12orf62 | Mitochondrial complex IV deficiency, 220110 (3)
DIP2B, KIAA1463 | Mental retardation, FRA12A type, 136630 (3)
SP7, OSX, OI12 | Osteogenesis imperfecta, type XII, 613849 (3)
AAA4 | Aortic aneurysm, familial abdominal, 4 (2)
PFKM, GSD7 | Glycogen storage disease VII, 232800 (3)
CDK4, CMM3 | {Melanoma, cutaneous malignant, 3}, 609048 (3)
ARHGAP9 | {Coronary artery spasm 3, susceptibility to} (3)
GNS, G6S | Mucopolysaccharidosis type IIID, 252940 (3)
IFNG, IFG, IFI | {TSC2 angiomyolipomas, renal, modifier of}, 613254 (3); {Aplastic
LEMD3, MAN1 | Osteopoikilosis, 166700 (3); Buschke-Ollendorff syndrome, 166700 (3);
AUTS13 | {Autism susceptibility 13} (2)
DPY19L2, SPGF9 | Spermatogenic failure 9, 613958 (3)
HMGA2, HMGIC, BABL | Leiomyoma, uterine, somatic, 150699 (2)
IRAK3, IRAKM, ASRT5 | {Asthma susceptibility 5}, 611064 (3)
MSRB3, DFNB74 | Deafness, autosomal recessive 74, 613718 (3)
STQTL9 | {Stature QTL 9} (2)
MDM2, ACTFS | {Accelerated tumor formation, susceptibility to}, 614401 (3)
IBD26 | {Inflammatory bowel disease 26} (2)
LYZ | Amyloidosis, renal, 105200 (3)
MYF6, CNM3 | Myopathy, centronuclear, 3, 614408 (3)
DUH2 | Dyschromatosis universalis hereditaria 2 (2)
MYP3 | Myopia-3 (2)
TPH2, NTPH, ADHD7 | {Unipolar depression, susceptibility to}, 608516 (3); {Attention
BBS10, C12orf58, FLJ23560 | Bardet-Biedl syndrome 10, 209900 (3)
PTPRQ, PTPGMC1, DFNB84 | Deafness, autosomal recessive 84, 613391 (3)
CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14 | Joubert syndrome 5, 610188 (3); Senior-Loken syndrome 6, 610189 (3);
DCN, CSCD | Corneal dystrophy, congenital stromal, 610048 (3)
ALX1, CART1, FND3 | Frontonasal dysplasia 3, 613456 (3)
KERA, CNA2 | Cornea plana congenita, recessive, 217300 (3)
KITLG, MGF, SF, SCF, SHEP7 | [Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3);
MGCT | Male germ cell tumor (2)
TMPO, LAP2, CMD1T | Cardiomyopathy, dilated, 1T, 613740 (3)
ASCL1, ASH1 | Central hypoventilation syndrome, congenital, 209880 (3); Haddad
HAL, HSTD | [Histidinemia], 235800 (3)
MDD1 | Major depressive disorder 1, 608516 (2)
ETL2, FTLE | Epilepsy, familial temporal lobe, 2 (2)
IGF1 | Growth retardation with deafness and mental retardation due to
ACADS, SCAD | Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3)
SLC17A8, VGLUT3, DFNA25 | Deafness, autosomal dominant 25, 605583 (3)
SLC25A3, PHC | Micochondrial phosphate carrier deficiency, 610773 (3)
SYCP3, SCP3, COR1, SPGF4 | Spermatogenic failure 4, 270960 (3); {Pregnancy loss,
SMAL | Spinal muscular atrophy, congenital nonprogressive, of lower limbs
SPG36 | Spastic paraplegia-36 (2)
ATP2A2, ATP2B, DAR | Darier disease, 124200 (3); Acrokeratosis verruciformis, 101900 (3)
UNG, DGU, HIGM4 | Immunodeficiency with hyper IgM, type 4, 608106 (3)
MYL2, CMH10 | Cardiomyopathy, familial hypertrophic, 10, 608758 (3)
MYBPC1 | Arthrogryposis, distal, type 1B, 614335 (3)
GNPTAB, GNPTA | Mucolipidosis III alpha/beta, 252600 (3); Mucolipidosis II
POLR3B, RPC2, C128, HLD8 | Leukodystrophy, hypomyelinating, 8, with or without oligodontia
ATXN2, ATX2, SCA2 | Spinocerebellar ataxia 2, 183090 (3)
CELIAC13 | {Celiac disease, susceptibility to, 13} (2)
CIMT | Carotid intimal medial thickness (2)
DAO, DAMOX | {Schizophrenia}, 181500 (2)
HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A | Neuropathy, distal hereditary motor, type IIA, 158590 (3);
MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025 | Transposition of the great arteries, dextro-looped 1, 608808 (3)
MMAB | Methylmalonic aciduria, vitamin B12-responsive, due to defect in
MVK, MVLK | Mevalonic aciduria, 610377 (3); Hyper-IgD syndrome, 260920 (3)
ORAI1, TMEM142A, CRACM1 | Immune dysfunction with T-cell inactivation due to calcium entry
SH2B3, LNK | Myelofibrosis, somatic, 254450 (3); Thrombocythemia, somatic,
SLEB4 | {Systemic lupus erythematosus, susceptibility to, 4} (2)
HPD | Tyrosinemia, type III, 276710 (3); Hawkinsinuria, 140350 (3)
BCL7A, BCL7 | B-cell non-Hodgkin lymphoma, high-grade (3)
ISCU, HML | Myopathy with lactic acidosis, hereditary, 255125 (3)
PAH, PKU1 | Phenylketonuria, 261600 (3); [Hyperphenylalaninemia, non-PKU mild],
PTPN11, PTP2C, SHP2, NS1 | Noonan syndrome 1, 163950 (3); LEOPARD syndrome 1, 151100 (3);
SART3, P100, KIAA0156, TIP110, DSAP1 | Porokeratosis, disseminated superficial actinic, 1, 175900 (3)
STUT2 | Stuttering, familial persistent 2 (2)
TBX3 | Ulnar-mammary syndrome, 181450 (3)
TBX5 | Holt-Oram syndrome, 142900 (3)
TECT1, JBTS13 | Joubert syndrome 13, 614173 (3)
TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1 | Brachyolmia type 3, 113500 (3); Spondylometaphyseal dysplasia,
PPPD1 | Porokeratosis, palmar, plantar, and disseminated 1 (2)
ALDH2 | Alcohol sensitivity, acute, 610251 (3); {Hangover, susceptibility
HNF1A, TCF1, MODY3, IDDM20 | MODY, type III, 600496 (3); {Diabetes mellitus, noninsulin-dependent,
NIDDM2 | Diabetes mellitus, noninsulin-dependent, 2 (2)
OAS1, OIAS | {Viral infection, susceptibility to} (3); {Diabetes mellitus,
CCA5 | Cataract, congenital cerulean type, 5 (2)
ATP6V0A2, WSS, ARCL2A | Cutis laxa, autosomal recessive, type IIA, 219200 (3); Wrinkly skin
C12orf65, COXPD7 | Combined oxidative phosphorylation deficiency 7, 613559 (3)
SMAC, DIABLO, DFNA64 | Deafness, autosomal dominant 64, 614152 (3)
MPVQTL1 | [Mean platelet volume QTL1] (2)
SCARB1, CD36L1, CLA1, HDLQTL6 | [High density lipoprotien cholesterol level QTL6], 610762 (3)
TCTN2, TECT2, MKS8 | Meckel syndrome, type 8, 613885 (3)
DFNA41 | Deafness, autosomal dominant 41 (2)
PUS1, MLASA1 | Mitochondrial myopathy and sideroblastic anemia 1, 600462 (3)
EIF2B1, EIF2BA | Leukoencephalopathy with vanishing white matter, 603896 (3)
SUOX | Sulfite oxidase deficiency, 272300 (3)
FECD2, FCD1 | Corneal dystrophy, Fuchs endothelial, 2 (2)
CLQTL1, CLF | [Cholesterol level QTL 1] (2)
GJA3, CX46, CZP3, CAE3 | Cataract, zonular pulverulent-3, 601885 (3)
FGF9, SYNS3 | Multiple synostoses syndrome 3, 612961 (3)
GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID | Deafness, autosomal recessive 1A, 220290 (3); Deafness, autosomal
ALOX5AP, FLAP | {Stroke, susceptibility to}, 601367 (3)
FLT3 | Leukemia, acute myeloid, reduced survival in (3); Leukemia,
GJB6, CX30, DFNA3B, HED, ED2, DFNB1B | Deafness, autosomal dominant 3B, 612643 (3); Ectodermal dysplasia,
KL, KLOTHO | {Coronary artery disease, susceptibility to} (3); Tumoral calcinosis,
MCI2 | {Myocardial infarction, susceptibility to, 2} (2)
SACS, ARSACS | Spastic ataxia, Charlevoix-Saguenay type, 270550 (3)
SGCG, LGMD2C, DMDA1, SCG3 | Muscular dystrophy, limb-girdle, type 2C, 253700 (3)
ATOD5 | {Dermatitis, atopic, susceptibility to, 5} (2)
MADH9, SMAD9, MADH6 | Pulmonary hypertension, primary, 178600 (3)
IPF1, MODY4 | Pancreatic agenesis, 260370 (3); MODY, type IV, 606392 (3); {Diabetes
ADHD6 | {Attention deficit-hyperactivity disorder, susceptibility to, 6} (2)
CFEOM3C, FEOM4 | Fibrosis of extraocular muscles, congenital, 3C (2)
RNF6 | Esophageal carcinoma, somatic, 133239 (3)
MYP20 | Myopia 20, autosomal dominant (2)
CENPJ, CPAP, MCPH6, SCKL4 | Microcephaly, primary autosomal recessive, 6, 608393 (3);
POLR1D, RPA16, RPAC2, TCS2 | Treacher Collins syndrome 2, 613717 (3)
MBS, MBS1 | ?Moebius syndrome (2)
SUCLA2, MTDPS5 | Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with
B3GALTL; B3GTL, B3GLCT | Peters-plus syndrome, 261540 (3)
BRCA2, FANCD1, BROVCA2, GLM3, PNCA2 | {Breast-ovarian cancer, familial, 2}, 612555 (3); Fanconi anemia,
POMP, UMP1 | Keratosis linearis with ichthyosis congenita and sclerosing
SPG20 | Troyer syndrome, 275900 (3)
PROZ, PZ | [Protein Z deficiency], 614024 (1)
ENUR1 | Enuresis, nocturnal, 1 (2)
HPRHP | Hypophosphatemic rickets and hyperparathyroidism (2)
LGR8, GREAT | Cryptorchidism, bilateral, 219050 (3)
FREM2 | Fraser syndrome, 219000 (3)
IBD27 | {Inflammatory bowel disease 27} (2)
BMIQ2 | [Body mass index QTL2] (2)
BMND9 | [Bone mineral density QTL 9] (2)
CLLS2, D13S25, DBM | {Leukemia, chronic lymphocytic, susceptibility to, 2} (2)
DEL13q14, C13DELq14 | Chromosome 13q14 deletion syndrome (4)
GER | Gastroesophageal reflux (2)
ITM2B, BRI, ABRI, FBD | Dementia, familial British, 176500 (3); Dementia, familial Danish,
RCBTB1, CLLD7, GLP | [Beta-glycopyranoside tasting] (3); {Alcohol dependence,
RFXAP | Bare lymphocyte syndrome, type II, complementation group D, 209920
RIEG2, RGS2 | Rieger syndrome, type 2 (2)
SLC25A15, ORNT1, HHH | Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970
SPG24 | Spastic paraplegia 24 (2)
TNFSF11, OPGL, TRANCE, OPTB2 | Osteopetrosis, autosomal recessive 2, 259710 (3)
AUNA1 | Auditory neuropathy, autosomal dominant, 1 (2)
HTR2A | {Schizophrenia, susceptibility to}, 181500 (3); {Obsessive-compulsive
FOXO1A, FKHR | Rhabdomyosarcoma, alveolar, 268220 (3)
PHF11, NYREN34 | [IgE levels QTL], 147050 (3); {Asthma}, 600807 (3)
RNASEH2B, DLEU8, FLJ11712, AGS2 | Aicardi-Goutieres syndrome 2, 610181 (3)
RB1 | Retinoblastoma, 180200 (3); Osteosarcoma, somatic, 259500 (3);
LPRS6 | {Leprosy, susceptiblity to, 6} (2)
DDX26, DICE1 | {Nonsmall cell lung cancer} (2)
LPAR6, P2RY5, P2Y5, LAH3, ARWH1 | Hypotrichosis 8, 278150 (3); Woolly hair, autosomal recessive 1,
AUTS3 | {Autism susceptibility 3} (2)
ALG11, KIAA1266, CDG1P | Congenital disorder of glycosylation, type Ip, 613661 (3)
STQTL20 | {Stature QTL 20} (2)
ATP7B, WND | Wilson disease, 277900 (3)
ATXN8 | Spinocerebellar ataxia 8, 608768 (3)
ATXN8OS, SCA8, KLHL1AS | Spinocerebellar ataxia 8, 608768 (3)
BRCA3, BRCAX | ?Breast cancer, type 3 (2)
SLI3 | Specific language impairment QTL, 3 (2)
PAPA2 | Postaxial polydactyly, type A2 (2)
CLN5 | Ceroid lipofuscinosis, neuronal, 5, 256731 (3)
ACTD | Acetabular dysplasia (2)
EDNRB, HSCR2, ABCDS, WS4A | {Hirschsprung disease, susceptibility to, 2}, 600155 (3); ABCD
PAND1 | Panic disorder syndrome 1 (2)
SLITRK1, KIAA1910, TTM | Tourette syndrome, 137580 (3); Trichotillomania, 613229 (3)
MCOR | Microcoria, congenital (2)
NYS4 | Nystagmus 4, congenital (2)
MIR17HG, MIRH1, MIHG1, MIRHG1, C13orf25, FGLDS2 | Feingold syndrome 2, 614326 (3)
PPR2 | Photoparoxysmal response 2 (2)
MMVP3 | Mitral valve prolapse, myxomatous 3 (2)
GPC6, OMIMD1 | Omodysplasia 1, 258315 (3)
PCCA | Propionicacidemia, 606054 (3)
SCZD7 | {Schizophrenia}, 181500 (2)
SLEB5 | {Systemic lupus erythematosus, susceptibility to, 5} (2)
ZIC2, HPE5 | Holoprosencephaly-5, 609637 (3)
STQTL4 | {Stature QTL 4} (2)
ERCC5, XPG, COFS3 | Xeroderma pigmentosum, group G, 278780 (3); Cerebrooculofacioskeletal
SLC10A2, NTCP2, PBAM | Bile acid malabsorption, primary, 613291 (3)
OFC9 | Orofacial cleft 9 (2)
VUR5 | Vesicoureteral reflux 5 (2)
LIG4 | LIG4 syndrome, 606593 (3); {Multiple myeloma, resistance to}, 254500
COL4A1, POREN1, HANAC | Porencephaly 1, 175780 (3); Brain small vessel disease with hemorrha,
COL4A2, POREN2 | Porencephaly 2, 614483 (3)
DAOA, G72 | {Schizophrenia}, 181500 (2)
DFNA33 | Deafness, autosomal dominant 33 (2)
F7 | Factor VII deficiency, 227500 (3); {Myocardial infarction,
F10 | Factor X deficiency, 227600 (3)
FGF14, FHF4, SCA27 | Spinocerebellar ataxia 27, 609307 (3)
GRK1, RHOK, RK | Oguchi disease-2, 613411 (3)
ING1 | Squamous cell carcinoma, head and neck, somatic, 275355 (3)
IRS2 | {Diabetes mellitus, noninsulin-dependent}, 125853 (3)
ADIPQTL3, CAQ14 | {Adiponectin, serum level of, QTL3} (2)
GOLGA5, RFG5, PTC5 | Thyroid carcinoma, papillary, 188550 (3)
IBGC1 | Basal ganglia calcification, idiopathic (2)
RPGRIP1, LCA6, CORD13 | Leber congenital amaurosis 6, 613826 (3); Cone-rod dystrophy 13,
IBD4 | {Inflammatory bowel disease 4} (2)
ATL1, SPG3A, HSN1D | Spastic paraplegia-3A, 182600 (3); Neuropathy, hereditary sensory,
DEL14q11q22, C14DELq11q22 | Chromosome 14q11-q22 deletion syndrome (4)
NRL, D14S46E, RP27 | Retinitis pigmentosa 27, 613750 (3); Retinal degeneration,
ANG, RNASE5, ALS9 | Amyotrophic lateral sclerosis 9, 611895 (3)
CEBPE, CRP1 | Specific granule deficiency, 245480 (3)
NRCLP5 | {Narcolepsy 5} (2)
RSCIS | Radiation sensitivity/chromosome instability syndrome, autosomal
SLC7A7, LPI | Lysinuric protein intolerance, 222700 (3)
TCRA | Leukemia/lymphoma, T-cell (3)
TGM1, ICR2, LI1 | Ichthyosis, lamellar, autosomal recessive, 242300 (3); Ichthyosiform
DFNA53 | Deafness, autosomal dominant 53 (2)
MRT9, MRT26 | Mental retardation, autosomal recessive, 9/26 (3)
PCK2, PEPCK2 | PEPCK deficiency, mitochondrial, 261650 (1)
HHPP | Hyperhidrosis palmaris et plantaris (2)
PABPN1, PABP2, PAB2 | Oculopharyngeal muscular dystrophy, 164300 (3)
SPD3 | Synpolydactyly 3 (2)
AP4S1, CPSQ6 | Cerebral palsy, spastic quadriplegic, 6, 614067 (3)
CFL2, NEM7 | Nemaline myopathy 7, 610687 (3)
DFNB5 | Deafness, autosomal recessive 5 (2)
MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3 | Cardiomyopathy, familial hypertrophic, 14, 613251 (3); Atrial septal
MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD | Cardiomyopathy, familial hypertrophic, 1, 192600 (3); Cardiomyopathy,
NUBPL, IND1 | Mitochondrial complex I deficiency, 252010 (3)
TINF2, TIN2, DKCA3 | Dyskeratosis congenita, autosomal dominant 3, 613990 (3); Revesz
COCH, DFNA9 | Deafness, autosomal dominant 9, 601369 (3)
PAX9, STHAG3 | Tooth agenesis, selective, 3, 604625 (3)
SPG32 | Spastic paraplegia-32 (2)
ARVD3 | Arrhythmogenic right ventricular dysplasia 3 (2)
FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1 | Rett syndrome, congenital variant, 613454 (3)
HPE8 | Holoprosencephaly-8 (2)
MIPOL1 | Mirror-image polydactyly, 135750 (1)
NFKBIA, IKBA | Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency,
NKX2-1, TITF1, NKX2A, TTF1 | Goiter, familial, due to TTF-1 defect (1); Chorea, hereditary
PSMA6, PROS27, P27K | {Myocardial infarcation, susceptibility to}, 608446 (3)
TMIP | ?Tetramelic mirror-image polydactyly (2)
RLS2 | {Restless legs syndrome 2} (2)
PNP, NP | Immunodeficiency due to purine nucleoside phosphorylase deficiency,
FBXO33, FBX33, BMND12 | [Bone mineral density QTL 12], 612560 (3)
MGAT2, CDGS2, CDG2A | Congenital disorder of glycosylation, type IIa, 212066 (3)
OTX2, MCOPS5, CPHD6 | Microphthalmia, syndromic 5, 610125 (3); Pituitary hormone
SCKL3 | Seckel syndrome 3 (2)
SEC23A, CLSD | Craniolenticulosutural dysplasia, 607812 (3)
MGR4, MGOA | {Migraine without aura, susceptibility to, 4} (2)
FANCM, KIAA1596 | Fanconi anemia, complementation group M, 614087 (3)
KTU, C14orf104, CILD10 | Ciliary dyskinesia, primary, 10, 612518 (3)
SPG28 | Spastic paraplegia-28 (2)
PTGER2 | {Asthma, aspirin-induced, susceptibility to}, 208550 (3)
BMP4, BMP2B1, BMP2B, MCOPS6, OFC11 | Microphthalmia, syndromic 6, 607932 (3); Orofacial cleft 11, 600625
CTPP5 | Cataract, posterior polar, 5 (2)
PRKCH, PKCL, PRKCL | {Cerebral infarction, susceptibility to}, 601367 (3)
SPTB, SPH2, EL3, HS2 | Elliptocytosis-3 (3); Spherocytosis, type 2 (3); Anemia, neonatal
L2HGDH, C14orf160 | L-2-hydroxyglutaric aciduria, 236792 (3)
PTGDR, AS1, ASRT1 | {Asthma, susceptibility to, 1}, 607277 (3)
PYGL | Glycogen storage disease VI, 232700 (3)
GCH1, DYT5, HPABH4B | Dystonia, DOPA-responsive, with or without hyperphenylalainemia,
MYP18 | Myopia 18 (2)
CRCS8 | {Colorectal cancer, susceptibility to, 8} (2)
ANIB8 | Aneurysm, intracranial berry, 8 (2)
EIG2 | {Epilepsy, idiopathic generalized, susceptibility to, 2} (2)
MAX | {Pheochromocytoma, susceptibility to}, 171300 (3)
SIX1, BOS3, DFNA23 | Brachiootic syndrome 3, 608389 (3); Deafness, autosomal dominant 23,
SIX6, MCOPCT2 | Microphthalmia with cataract 2, 212550 (3)
SYNE2, NUANCE, KIAA1011, EDMD5 | Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3)
TELM | [Telomere length, mean leukocyte] (2)
RDH12, LCA13 | Leber congenital amaurosis 13, 612712 (3)
EIF2B2 | Leukoencephalopathy with vanishing white matter, 603896 (3);
GPHN, GPH, KIAA1385, GEPH | Molybdenum cofactor deficiency, type C, 252150 (3); Hyperekplexia,
LTBP2, LTBP3, GLC3D | Glaucoma 3, primary congenital, D, 613086 (3)
MTHFD, MTHFC | {Spina bifida, folate-sensitive, susceptibility to}, 601634 (3);
TGFB3 | Arrhythmogenic right ventricular dysplasia 1, 107970 (3)
CTAA1 | ?Cataract, anterior polar-1 (2)
ZFYVE26, KIAA0321, SPG15 | Spastic paraplegia 15, 270700 (3)
ALDH6A1, MMSDH | Methylmalonate semialdehyde dehydrogenase deficiency, 614105 (3)
CHX10, HOX10, MCOP2, MCOPCB3 | Microphthalmia with coloboma 3, 610092 (3);
DNAL1, C14orf168, CILD16 | Ciliary dyskinesia, primary, 16, 614017 (3)
ESRRB, ESRL2, DFNB35 | Deafness, autosomal recessive 35, 608565 (3)
FLVCR2, C14orf58, CCT, PVHH, EPV | Proliferative vasculopathy and hydraencephaly-hydrocephaly
GLC3C | Glaucoma 3, primary congenital, C (2)
GSTZ1, MAAI | Tyrosinemia, type Ib (1)
IFT43, C14orf179, CED3 | Cranioectodermal dysplasia 3, 614099 (3)
MUSTQTL1 | Muscle strength quantitative trait locus 1 (2)
NPC2, HE1 | Niemann-pick disease, type C2, 607625 (3)
MLH3, HNPCC7 | Colorectal cancer, somatic, 114500 (3); Colon cancer, hereditary
POMT2, MDDGA2, MDDGB2, MDDGC2 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye
PSEN1, AD3 | Alzheimer disease, type 3, 607822 (3); Alzheimer disease, type 3,
VIPAR, SPE39, C14orf133 | Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3)
ATXN3, MJD, SCA3 | Machado-Joseph disease, 109150 (3)
IDDM11 | {Diabetes mellitus, insulin-dependent, 11} (2)
SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C | Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3)
DICER1, HERNA, KIAA0928, MNG1 | Pleuropulmonary blastoma, 601200 (3); Goiter, multinodular 1, without
GALC | Krabbe disease, 245200 (3)
GRD1 | {Graves disease, susceptibility to, 1} (2)
HPPD | Hypertelorism, preauricular sinus, punctal pits, and deafness (2)
TSHR, CHNG1 | Hypothyroidism, congenital, nongoitrous, 1 275200 (3); Thyroid
TDP1 | Spinocerebellar ataxia, autosomal recessive with axonal neuropathy,
TRIP11, TRIP230, CEV14, ACG1A | Achondrogenesis, type IA, 200600 (3)
SPATA7, HSD3, LCA3 | Leber congenital amaurosis 3, 604232 (3); Retinitis pigmentosa,
AMN | Megaloblastic anemia-1, Norwegian type, 261100 (3)
CHDS4 | {Coronary heart disease, susceptibility to, 4} (2)
CKBE | [Creatine kinase, brain type, ectopic expression of] (2)
DYNC1H1, DNCL, DNECL, CMT20 | Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3)
GEVQ1 | {Gene expression, variation in, QTL} (2)
GLRX5, C14orf87, PRO1238, FLB4739 | Anemia, sideroblastic, pyridoxine-refractory, autosomal recessive,
HFM | Hemifacial microsomia (2)
MCOP1 | Microphthalmia, isolated 1 (2)
SLC24A4, NCKX4, SHEP6 | [Skin/hair/eye pigmentation 6, blond/brown hair], 210750 (3);
SMALED | Spinal muscular atrophy, lower extremity, autosomal dominant (2)
VRK1, PCH1 | Pontocerebellar hypoplasia type 1, 607596 (3)
CBG, SERPINA6 | Corticosteroid-binding globulin deficiency, 611489 (3)
FBLN5, ARMD3, ADCL2, ARCL1A | Cutis laxa, autosomal recessive, type IA, 219100 (3); Cutis laxa,
SERPINA1, PI, AAT | Emphysema due to AAT deficiency, 613490 (3); Emphysema-cirrhosis, due
SERPINA3, AACT, ACT | Alpha-1-antichymotrypsin deficiency (3); Cerebrovascular
SERPINA10, ZPI | {Venous thrombosis, susceptibility to} (3)
TCL1A, TCL1 | Leukemia/lymphoma, T-cell (2)
TCL1B, TML1 | Leukemia/lymphoma, T-cell (2)
TTC8, BBS8, RP51 | Bardet-Biedl syndrome 8, 209900 (3); Retinitis pigmentosa 51,
MRT32 | Mental retardation, autosomal recessive 32 (2)
AKT1 | Breast cancer, somatic, 114480 (3); Colorectal cancer, somatic,
XRCC3, CMM6 | {Melanoma, cutaneous malignant, 6}, 613972 (3); {Breast cancer,
IGHG2 | IgG2 deficiency, selective (3)
IGHM, MU, AGM1 | Agammaglobulinemia 1, 601495 (3)
IGHR | ?Hyperimmunoglobulin G1 syndrome (2)
INF2, FSGS5, C14orf173, CMTDIE | Glomerulosclerosis, focal segmental, 5, 613237 (3);
PHOBS | Phobia, specific (2)
SMOC1, OAS | Microphthalmia with limb anomalies, 206920 (3)
HYT2 | {Hypertension, essential, susceptibility to, 2}, 145500 (2)
LCS1, CHLS | Cholestasis-lymphedema syndrome (2)
RPS17, RPS17L1, RPS17L2, DBA4 | Diamond-Blackfan anemia 4, 612527 (3)
AUTS4 | {Autism susceptibility 4} (2)
BCL8 | Lymphoma, diffuse large cell (3)
CELIAC5, GSES | {Celiac disease, susceptibility to, 5} (2)
GLC1I | Glaucoma 1, open angle, I (2)
NDN | Prader-Willi syndrome, 176270 (3)
UBE3A, ANCR | Angelman syndrome, 105830 (3)
RCHTS | ?Roifman-Chitayat syndrome (2)
NIPA1, SPG6 | Spastic paraplegia-6, 600363 (3)
GABRB3, ECA5 | Insomnia (3); {Epilepsy, childhood absence, susceptibility to, 5},
MGR7 | {Migraine with aura, susceptibility to, 7} (2)
OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1 | Albinism, oculocutaneous, type II, 203200 (3); Albinism, brown
HTGS | {Hypertriglyceridemia, susceptibility to} (2)
HPC7 | {Prostate cancer, hereditary, 7} (2)
SNRPN | Prader-Willi syndrome, 176270 (3)
MCOPCB2 | Microphthalmia with coloboma 2 (2)
ATD1 | Asphyxiating thoracic dystrophy 1 (2)
SCZD13 | {Schizophrenia, susceptibility to, 13} (2)
SLC12A6, KCC3A, KCC3B, KCC3, ACCPN | Agenesis of the corpus callosum with peripheral neuropathy, 218000
TRPM1, MLSN1, CSNB1C | Night blindness, congenital stationary, type 1C, 613216 (3)
HERC2, SHEP1 | [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3);
CILD4 | Ciliary dyskinesia, primary, 4 (2)
SPRED1, NFLS | Legius syndrome, 611431 (3)
DEL15q13.3, MICRODEL15q13.3 | Chromosome 15q13.3 microdeletion syndrome (4)
NDUFAF1, CIA30, CGI65 | Mitochondrial complex I deficiency, 252010 (3)
ACTC1, CMD1R, CMH11, ASD5, LVNC4 | Cardiomyopathy, dilated, 1R, 613424 (3); Cardiomyopathy, familial
CHRNA7 | Schizophrenia, neurophysiologic defect in (2)
CHST14, D4ST1, ATCS | Ehlers-Danlos syndrome, musculocontractural type , 601776 (3)
EIG7, EJM2 | {Epilepsy, idiopathic generalized, susceptibility to, 7} (2);
IVD | Isovaleric acidemia, 243500 (3)
NOLA3, NOP10, DKCB1 | Dyskeratosis congenita, autosomal recessive 1, 224230 (3)
BUB1B, BUBR1 | Colorectal cancer, 114500 (3); Mosaic variegated aneuploidy syndrome,
CDAN1, CDA1 | Anemia, congenital dyserythropoietic, type I, 224120 (3)
DUOXA2, TDH5 | Thyroid dyshormonogenesis 5, 274900 (3)
EPB42, SPH5 | Spherocytosis, hereditary, type 5, 612690 (3)
PLCB2 | Platelet PLC beta-2 deficiency (1)
PLDN, PA, HPS9 | Hermansky-pudlak syndrome 9, 614171 (3)
SCZD10 | {Schizophrenia}, 181500 (2)
STRC, DFNB16 | Deafness, autosomal recessive 16, 603720 (3)
SLC12A1, NKCC2 | Bartter syndrome, type 1, 601678 (3)
UBR1, JBS | Johanson-Blizzard syndrome, 243800 (3)
RAD51A, RECA | {Breast cancer, susceptibility to}, 114480 (3)
ALS5 | Amyotrophic lateral sclerosis-5, juvenile recessive (2)
CAPN3, CANP3 | Muscular dystrophy, limb-girdle, type 2A, 253600 (3)
TGM5, TGX | Peeling skin syndrome, acral type, 609796 (3)
TTBK2, SCA11 | Spinocerebellar ataxia 11, 604432 (3)
DEL15q15.3, C15DELq15.3 | Deafness and male infertility (4)
DUOX2, THOX2, TDH6 | Thryoid dyshormonogenesis 6, 607200 (3)
FRTS1, FRTS, RFS | Fanconi renotubular syndrome 1 (2)
GATM, AGAT | AGAT deficiency, 612718 (3)
SORD, SORD1 | ?Cataract, congenital (2)
HMPS1, CRAC1, CRCS4 | Polyposis syndrome, mixed hereditary 1 (2); {Colorectal cancer,
CDAN3, CDA3 | Dyserythropoietic anemia, congenital, type III (2)
DYX1C1, DYXC1, DYX1 | {Dyslexia, susceptibility to, 1}, 127700 (3)
MAP2K1, PRKMK1, MKK1, MEK1 | Cardiofaciocutaneous syndrome, 115150 (3)
MYO5A, MYH12, GS1 | Griscelli syndrome, type 1, 214450 (3)
RAB27A, RAM, GS2 | Griscelli syndrome, type 2, 607624 (3)
TRPM7, LTRPC7, CHAK | {Amyotrophic lateral sclerosis-parkinsonism/dementia complex 1,
ACP33, MAST, SPG21 | Mast syndrome, 248900 (3)
B2M | Hypoproteinemia, hypercatabolic, 241600 (3)
CCSSO | Cataract, central saccular, with sutural opacities (2)
MADH3, SMAD3, LDS1C | Loeys-Dietz syndrome, type 1C, 613795 (3)
MYO1E, MYO1C, FSGS6 | Glomerulosclerosis, focal segmental, 6, 614131 (3)
PPIB, CYPB, OI9 | Osteogenesis imperfecta, type IX, 259440 (3)
CLN6, CLN4A | Ceroid lipofuscinosis, neuronal, 6, 601780 (3); Ceroid
CEP152, KIAA0912, MCPH4, SCKL5 | Microcephaly, primary autosomal recessive, 4, 604321 (3);
CYP19A1, CYP19, ARO | Aromatase deficiency, 613546 (3); Aromatase excess syndrome, 139300
FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD | Marfan syndrome, 154700 (3); Shprintzen-Goldberg syndrome,
SLC24A5, NCKX5, SHEP4 | [Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3)
SPG11, KIAA1840, FLJ21439 | Spastic paraplegia-11, 604360 (3)
AP4E1, CPSQ4 | Cerebral palsy, spastic quadriplegic, 4, 613744 (3)
LIPC, HL, LIPH, HDLCQ12 | [High density lipoprotein cholesterol level QTL 12], 612797 (3);
WDR72, AI2A3 | Amelogenesis imperfecta, hypomaturation type, IIA3, 613211 (3)
CA12 | Hyperchlorhidrosis, isolated, 143860 (3)
CILP | {Lumbar disc disease, susceptibility to}, 603932 (3)
LOXL1, LOXL | {Exfoliation syndrome, susceptibility to}, 177650 (3)
PML, MYL | Leukemia, acute promyelocytic, PML/RARA type (3)
SLC24A1, NCKX1, CSNB1D | Night blindness, congenital stationary, type 1D, 613830 (3)
USH1H | Usher syndrome, type 1H (2)
PPKP1 | Keratoderma, palmoplantar, punctate type 1 (2)
MPI, PMI1, CDG1B | Congenital disorder of glycosylation, type Ib, 602579 (3)
TPM1, CMH3, CMD1Y | Cardiomyopathy, familial hypertrophic, 3, 115196 (3); Cardiomyopathy,
SEMA7A, SEMAL, SEMAK1, CDW108, JMH | [Blood group, John-Milton-Hagen] (3)
BBS4 | Bardet-Biedl syndrome 4, 209900 (3)
KBTBD13, NEM6 | Nemaline myopathy 6, 609273 (3)
STQTL16 | {Stature QTL 16} (2)
NR2E3, PNR, ESCS, RP37 | Enhanced S-cone syndrome, 268100 (3); Retinitis pigmentosa 37,
CYP11A, P450SCC | Adrenal insufficiency, congenital, with 46XY sex reversal, partial
HEXA, TSD | Tay-Sachs disease, 272800 (3); GM2-gangliosidosis, several forms,
ETFA, GA2, MADD | Glutaric acidemia IIA, 231680 (3)
FAH | Tyrosinemia, type I, 276700 (3)
GLM4 | {Glioma susceptibility 4} (2)
ADAMTS17 | Weill-Marchesani-like syndrome, 613195 (3)
DEL15q24, CHR15DELq24 | Chromosome 15q24 deletion syndrome (4)
ENFL2 | Epilepsy, nocturnal frontal lobe, type 2 (2)
KIAA1199 | ?Deafness, nonsyndromic (3)
MRST | Mental retardation, severe, with spasticity and tapetoretinal
CILD8 | Ciliary dyskinesia, primary, 8 (2)
HCN4, SSS2 | Sick sinus syndrome 2, 163800 (3); Brugada syndrome 8, 613123 (3)
PSTPIP1, PSTPIP, CD2BP1, PAPAS | Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416
STRA6, MCOPS9 | Microphthalmia, syndromic 9, 601186 (3)
MRT27 | Mental retardation, autosomal recessive 27 (2)
DEL15q25, C15DELq25 | Chromosome 15q25 deletion syndrome (4)
POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS | Progressive external ophthalmoplegia, autosomal recessive, 258450
DFNA30 | Deafness, autosomal dominant 30 (2)
FANCI, KIAA1794 | Fanconi anemia, complementation group I, 609053 (3)
IGF1R | Insulin-like growth factor I, resistance to, 270450 (3)
CHRNA3, LNCR2, PAOD2 | {Lung cancer susceptibility 2}, 612052 (3)
CHRNA5, LNCR2 | {Lung cancer susceptibility 2}, 612052 (3)
MIR184, MIRN184, KTCNCT | Keratoconus with cataract, 614303 (3)
DSAP2 | Porokeratosis, disseminated superficial actinic, 2 (2)
ZNF592, KIAA0211, SCAR5, CAMOS | Spinocerebellar ataxia, autosomal recessive 5, 606937 (3)
CHNG3, RTSH | Hypothyroidism, congenital, nongoitrous, 3 (2)
MDD2 | Major depressive disorder 2, 608516 (2)
IDDM3 | {Diabetes mellitus, insulin-dependent, 3} (2)
MEF2A, ADCAD1 | {Coronary artery disease, autosomal dominant, 1}, 608320 (3)
PLIN1, PLIN, FPLD4 | Lipodystrophy, familial partial, type 4, 613877 (3)
RLBP1 | Fundus albipunctatus, 136880 (3); Retinitis punctata albescens,
DEL15q26qter, C15DELq26qter | Chromosome 15q26-qter deletion syndrome (4)
ACAN, AGC1, CSPG1, MSK16, SEDK | Spondyloepiphyseal dysplasia, Kimberley type, 608361 (3);
DIH1, HCD | Hernia, congenital diaphragmatic 1 (2)
IDH2, IDPM, D2HGA2 | D-2-hydrosyglutaric aciduria 2, 613657 (3)
KIF7, HLS2, ACLS, JBTS12 | Hydrolethalus syndrome 2, 614120 (3); Acrocallosal syndrome,
MESP2, SCDO2 | Spondylocostal dysostosis, autosomal recessive 2, 608681 (3)
MMEDF | Macrocephaly with multiple epiphyseal dysplasia and distinctive
RECQL3, RECQ2, BLM, BS | Bloom syndrome, 210900 (3)
VPS33B | Arthrogryposis, renal dysfunction, and cholestasis 1, 208085 (3)
OTSC1, OTS | Otosclerosis 1 (2)
CHSY1, KIAA0990, TPBS | Temtamy preaxial brachydactyly syndrome, 605282 (3)
HBA1, HBH | Thalassemias, alpha-, 604131 (3); Methemoglobinemias, alpha- (3);
HBA2, HBH | Thalassemia, alpha-, 604131 (3); Heinz body anemia, 140700 (3);
HBHR, ATR1 | Alpha-thalassemia/mental retardation syndrome, type 1 (4)
CHDS1 | {Coronary heart disease, susceptibility to} (2)
ABAT, GABAT | GABA-transaminase deficiency, 613163 (3)
ABCA3, ABC3, SMDP3 | Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3)
ALG1, HMAT1, HMT1, CDG1K | Congenital disorder of glycosylation, type Ik, 608540 (3)
AXIN1, AXIN | Hepatocellular carcinoma, somatic, 114550 (3); Caudal duplication
CACNA1H, EIG6, ECA6 | {Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3);
CREBBP, CBP, RSTS | Rubinstein-Taybi syndrome, 180849 (3)
DNASE1, DNL1 | {Systemic lupus erythematosus, susceptibility to}, 152700 (3)
DUP16p13.3, C16DUPq13.3 | Chromosome 16p13.3 duplication syndrome (4)
GLIS2, NPHP7 | Nephronophthisis 7, 611498 (3)
IGFALS, ALS | Acid-labile subunit, deficiency of (3)
LMF1, TMEM112 | Lipase deficiency, combined, 246650 (3)
MCOPCT1 | Microphthalmia with cataract 1 (2)
MMRFCGU | Microcephaly, mental retardation, and distinctive facies, with
PKDTS | Polycystic kidney disease, infantile severe, with tuberous sclerosis
DEL16p13.3, RSTSS | Chromosome 16p13.3 deletion syndrome (4)
SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP | Fanconi anemia, complementation group P, 613951 (3)
SSTR5 | Somatostatin analog, resistance to, 102200 (3)
TBC1D24, KIAA1171, FIME | Myoclonic epilepsy, infantile, familial, 605021 (3)
TSC2, LAM | Tuberous sclerosis-2, 191100 (3); Lymphangioleiomyomatosis,
PMM2, CDG1A | Congenital disorder of glycosylation, type Ia, 212065 (3)
ERCC4, XPF | Xeroderma pigmentosum, group F, 278760 (3); XFE progeroid syndrome,
GFER, ERV1, ALR | Myopathy, mitochondrial progressive, with congenital cataract,
PKD1 | Polycystic kidney disease, adult type I, 173900 (3)
MHAC | Microhydranencephaly (2)
LITAF, CMT1C | Charcot-Marie-Tooth disease, type 1C, 601098 (3)
MYH11, AAT4, FAA4 | Aortic aneurysm, familial thoracic 4, 132900 (3)
ACSM3, SAH | {?Hypertension, essential} (1)
CRYM, DFNA40 | Deafness, autosomal dominant 40 (3)
ABCC6, ARA, ABC34, MLP1, PXE, GACI2 | Pseudoxanthoma elasticum, 264800 (3); Pseudoxanthoma elasticum,
NDE1, NUDE, LIS4 | Lissencephaly 4 (with microcephaly), 614019 (3)
XYLT1, XT1 | {Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)
ADHD1 | {Attention deficit-hyperactivity disorder}, 143465 (2)
BMIQ5 | [Body mass index QTL5] (2)
GRIN2A, NMDAR2A, EPND | Epilepsy with neurodevelopmental defects, 613971 (3)
CLCN7, CLC7, OPTA2, OPTB4 | Osteopetrosis, autosomal recessive 4, 611490 (3); Osteopetrosis,
HAGH, GLO2 | [Glyoxalase II deficiency], 614033 (1)
MEFV, MEF, FMF | Familial Mediterranean fever, AR, 249100 (3); Familial
MHC2TA, C2TA | Bare lymphocyte syndrome, type II, complementation group A, 209920
IHPS2 | Pyloric stenosis, infantile hypertrophic, 2 (2)
SCNN1B, BESC1 | Liddle syndrome, 177200 (3); Pseudohypoaldosteronism, type I, 264350
SCNN1G, PHA1, BESC3 | Liddle syndrome, 177200 (3); Pseudohypoaldosteronism, type I, 264350
UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2 | Hyperuricemic nephropathy, familial juvenile 1, 162000 (3);
RP22 | Retinitis pigmentosa 22 (2)
OTOA, DFNB22 | Deafness, autosomal recessive 22, 607039 (3)
CILD5 | Ciliary dyskinesia, primary, 5 (2)
DEL16p12.1p11.2, C16DELp12.1p11.2 | Chromosome 16p12.2-p11.2 deletion syndrome (4)
CLN3, BTS | Ceroid lipofuscinosis, neuronal, 3, 204200 (3)
IL4R, IL4RA | {Atopy, susceptibility to}, 147050 (3); {AIDS, slow progression to},
MMVP1, MVP, PMV | Mitral valve prolapse, myxomatous 1 (2)
PHKG2, GSD9C | Glycogen storage disease IXc, 613027 (3); Cirrhosis due to liver
ATP2A1, SERCA1 | Brody myopathy, 601003 (3)
MAFD4, BPAD | Major affective disorder 4 (2)
PALB2, FANCN, PNCA3 | Fanconi anemia, complementation group N, 610832 (3); {Breast cancer,
EPRPDC | Epilepsy, rolandic, with paroxysmal exercise-induced dystonia and
HSD3B7, CBAS1 | Bile acid synthesis defect, congenital, 1, 607765 (3)
BFIS2, BFIC2 | Seizures, benign familial infantile, 2 (2)
ICCA | Convulsions, infantile and paroxysmal choreoathetosis (2)
ALDOA, GSD12 | Glycogen storage disease XII, 611881 (3)
CD19, CVID3 | Immunodeficiency, common variable, 3, 613493 (3)
BMIQ16, DEL16p.11.2, C16DELp11.2 | Chromosome 16p11.2 deletion syndrome, 220kb (4); [Body mass
DEL16p11.2, C16DELp11.2, AUTS14, DUP16p11.2, C16DUPp11.2 | Chromosome 16p11.2 deletion syndrome, 593kb (4);
FUS, TLS, ALS6 | Amyotrophic lateral sclerosis 6, autosomal recessive, with or without
ITGAM, CR3A, CD11B, MAC1A, SLEB6 | {Systemic lupus erythematous, association with susceptibility to, 6},
KIF22, KNSL4, KID, OBP, SEMDJL2 | Spondyloepimetaphyseal dysplasia with joint laxity, type 2,
PRRT2, PKC, DYT10, EKD1 | Episodic kinesigenic dyskinesia 1, 128200 (3)
SRCAP, SWR1, KIAA0309, FLHS | Floating-Harbor syndrome, 136140 (3)
SLC5A2, SGLT2 | Renal glucosuria, 233100 (3)
TUFM, EFTU, COXPD4 | Combined oxidative phosphorylation deficiency 4, 610678 (3)
VKORC1, VKOR, VKCFD2, FLJ00289 | Vitamin K-dependent clotting factors, combined deficiency of, 2,
IL21R | Lymphoma, diffuse large B-cell (2); [IgE, elevated level of],
COG7, CDG2E | Congenital disorder of glycosylation, type IIe, 608779 (3)
GNPTAG | Mucolipidosis III gamma, 252605 (3)
IBD8 | {Inflammatory bowel disease 8} (2)
PSORS8 | {Psoriasis susceptibility 8} (2)
SLI1 | Specific language impairment QTL, 1 (2)
WT3 | Wilms tumor, type 3 (2)
AA2 | Alopecia areata 2 (2)
DUPC1 | Dupuytren contracture 1 (2)
NOD2, CARD15, IBD1, CD, ACUG, PSORAS1 | {Inflammatory bowel disease 1}, 266600 (3); Blau syndrome, 186580
ORC6, ORC6L | Meier-Gorlin syndrome 3, 613803 (3)
VPS35, MEM3, PARK17 | Parkinson disease 17, 614203 (3)
CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS | Cylindromatosis, familial, 132700 (3); Brooke-Spiegler syndrome,
PHKB | Phosphorylase kinase deficiency of liver and muscle, autosomal
SBS | Spiegler-Brooke syndrome (2)
ABCC11, MRP8, EWWD, WW | [Earwax, wet/dry], 117800 (3); [Axillary odor, variation in],
SALL1, HSAL1, TBS | Townes-Brocks syndrome, 107480 (3); Townes-Brocks
STHAG2, HYD2 | Tooth agenesis, selective, 2 (2)
BMIQ14 | [Body mass index QTL14] (2)
FTO | Growth retardation, developmental delay, coarse facies, and early
RPGRIP1L, KIAA1005, JBTS7, MKS5 | Joubert syndrome 7, 611560 (3); Meckel syndrome, type 5, 611561 (3);
SLC6A2, NAT1, NET1 | Orthostatic intolerance, 604715 (3)
C16orf57, PN | Poikiloderma with neutropenia, 604173 (3)
CNGB1, CNCG3L, CNCG2, RP45 | Retinitis pigmentosa 45, 613767 (3)
COQ9, C16orf49 | Coenzyme Q10 deficiency, 607426 (3)
GPR56, TM7XN1, BFPP | Polymicrogyria, bilateral frontoparietal, 606854 (3)
MMP2, CLG4A, MONA | Torg-Winchester syndrome, 259600 (3)
SLC12A3, NCCT, TSC | Gitelman syndrome, 263800 (3)
ANMA | Anisomastia (2)
CES1, SES1 | Carboxylesterase 1 deficiency (3)
EKD2 | Episodic kinesigenic dyskinesia 2 (2)
BBS2 | Bardet-Biedl syndrome 2, 209900 (3)
BEAN, SCA31 | Spinocerebellar ataxia 31, 117210 (3)
CETP, HDLCQ10 | Hyperalphalipoproteinemia, 143470 (3); [High density lipoprotein
DFNB89 | Deafness, autosomal recessive 89 (2)
HSF4, CTM | Cataract, Marner type, 116800 (3); Cataract, lamellar, 116800 (3)
BCMO1, BCDO, BCO1 | Hypercarotenemia and vitamin A deficiency, autosomal dominant,
SCAR12 | Spinocerebellar ataxia, autosomal recessive 12 (2)
AARS, CMT2N | Charcot-Marie-Tooth disease, axonal, type 2N, 613287 (2)
AGRP, ART, AGRT | {Obesity, late-onset}, 601665 (3); {Leanness, inherited} (3)
AMLCR2 | Leukemia, acute myelogenous, 601626 (2)
ANBC | Aneurysmal bone cysts (2)
ATFB8 | Atrial fibrillation, familial, 8 (2)
CBFB, PEBP2B | Myeloid leukemia, acute, M4/M4Eo subtype, 601626 (3)
CHST6, MCDC1 | Macular corneal dystrophy, 217800 (3)
CIRH1A, NAIC, TEX292, KIAA1988 | Cirrhosis, North American Indian childhood type, 604901 (3)
DHODH, URA1, POADS | Miller syndrome, 264750 (3)
HSD11B2, HSD11K, AME | Apparent mineralocorticoid excess, 218030 (3)
TK2, MTDPS2 | Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3)
MAF | Cataract, pulverulent or cerulean, with or without microcornea (3)
CDH1, UVO, LCAM, ECAD | Endometrial carcinoma, somatic, 608089 (3); Ovarian carcinoma,
CDH3, CDHP, PCAD, HJMD | Hypotrichosis, congenital, with juvenile macular dystrophy, 601553
COG4, COD1, CDG2J | Congenital disorder of glycosylation, type IIj, 613489 (3)
COG8, DOR1, CDG2H | Congenital disorder of glycosylation, type IIh, 611182 (3)
CRCS9 | {Colorectal cancer, susceptibility to, 9} (2)
HP | [Anhaptoglobinemia], 614081 (3); [Hypohaptoglobinemia], 614081 (3)
LCAT | Norum disease, 245900 (3); Fish-eye disease, 136120 (3)
NQO1, DIA4, NMOR1 | {Benzene toxicity, susceptibility to} (3); {Leukemia,
SCA4 | Spinocerebellar ataxia 4 (2)
TAT | Tyrosinemia, type II, 276600 (3)
OTSC4 | {Otosclerosis 4} (2)
KARS, CMTRIB | Charcot-Marie-Tooth disease, recessive intermediate, B, 613641 (3)
KTCN2 | Keratoconus 2 (2)
ZFHX3, ATBF1 | {Prostate cancer, susceptibility to}, 176807 (3)
ADAMTS18, KNO2 | Knobloch syndrome 2, 608454 (3)
BMND13 | [Bone mineral density QTL 13] (2)
FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35 | Spastic paraplegia 35, autosomal recessive, 612319 (3)
HSCR8 | {Hirschsprung disease, susceptibility to, 8} (2)
DHS | Dehydrated hereditary stomatocytosis (2); Pseudohyperkalemia,
FHASD | Foveal hypoplasia and anterior segment dysgenesis (2)
ADIPQTL5 | {Adiponectin, serum level of, QTL5] (2)
WWOX, FOR | Esophageal squamous cell carcinoma, 133239 (3)
CYBA | Chronic granulomatous disease, autosomal, due to deficiency of CYBA,
FOXF1, FKHL5, ACDMPV | Alveolar capillary dysplasia with misalignment of pulmonary veins,
GCSH, NKH | Glycine encephalopathy, 605899 (3)
MLYCD, MCD | Malonyl-CoA decarboxylase deficiency, 248360 (3)
STQTL22 | {Stature QTL 22} (2)
ZNF469, KIAA1858, BCS | Brittle cornea syndrome, 229200 (3)
GAN, GAN1 | Giant axonal neuropathy-1, 256850 (3)
HDLC3 | {High density lipoprotein cholesterol, low serum, 3} (2)
LRRC50, ODA7, CILD13 | Ciliary dyskinesia, primary, 13, 613193 (3)
PLCG2, FCAS3 | Familial cold autoinflammatory syndrome 3, 614468 (3)
ACSF3 | Combined malonic and methylmalonic aciduria, 614265 (3)
ANKRD11, ANCO1, KBGS | KBG syndrome, 148050 (3)
APRT | Urolithiasis, 2,8-dihydroxyadenine (3)
CDH15, CDH14, CDH3, MRD3 | Mental retardation, autosomal dominant 3, 612580 (3)
CDT1 | Meier-Gorlin syndrome 4, 613804 (3)
FANCA, FACA, FA1, FA, FAA | Fanconi anemia, complementation group A, 227650 (3)
FOXC2, FKHL14, MFH1 | Lymphedema-distichiasis syndrome, 153400 (3); Lymphedema-distichiasis
GALNS, MPS4A | Mucopolysaccharidosis IVA, 253000 (3)
IHPS5 | Pyloric stenosis, infantile hypertrophic, 5 (2)
JPH3, JP3, HDL2 | Huntington disease-like 2, 606438 (3)
MC1R, SHEP2, CMM5 | [Skin/hair/eye pigmentation 2, red hair/fair skin], 266300 (3);
PGN, SPG7, CMAR, CAR | Spastic paraplegia-7, 607259 (3)
TUBB3, TUBB4, CFEOM3A, CDCBM | Fibrosis of extraocular muscles, congenital, 3A, 600638 (3);
ASPA | Canavan disease, 271900 (3)
ENO3, GSD13 | Glycogen storage disease XIII, 612932 (3)
GP1BA, BSS, BDPLT1, VWDP, BDPLT3 | Bernard-Soulier syndrome, type A1 (recessive), 231200 (3);
PLI, SERPINF2 | Alpha-2-plasmin inhibitor deficiency, 262850 (3)
BCPR | Breast cancer (1)
MDLS, MDS, MDCR, DEL17p13.3, C17DELp13.3 | Miller-Dieker lissencephaly syndrome (4)
DUP17p13.3, C17DUPp13.3 | Chromosome 17p13.3 duplication syndrome (4)
P2RX1, P2X1 | Bleeding disorder due to P2RX1 defect (3)
PAFAH1B1, LIS1 | Lissencephaly 1, 607432 (3); Subcortical laminar heterotopia, 607432
PRPF8, PRPC8, RP13 | Retinitis pigmentosa 13, 600059 (3)
SERPINF1, PEDF, OI6 | Osteogenesis imperfecta, type VI, 613982 (3)
SHFLD3 | Split-hand/foot malformation with long bone deficiency 3 (2)
HES7, SCDO4 | Spondylocostal dysostosis 4, autosomal recessive, 613686 (3)
LI5 | Ichthyosis, lamellar, 5 (2)
MRT33 | Mental retardation, autosomal recessive 33 (2)
AIPL1, LCA4 | Leber congenital amaurosis 4, 604393 (3); Retinitis pigmentosa,
ALOX12B | Ichthyosiform erythroderma, congenital, nonbullous, 1, 242100 (3)
ALOXE3 | Ichthyosiform erythroderma, congenital, nonbullous, 1, 242100 (3)
C17orf68, AAF132, CTC1, CRMCC | Cerebroretinal microangiopathy with calcifications and cysts,
DEL17p13.1, C17DELp13.1 | Chromosome 17p13.1 deletion syndrome (4)
GUCY2D, GUC2D, LCA1, CORD6, RCD2 | Leber congenital amaurosis 1, 204000 (3); Cone-rod dystrophy 6,
MYH2 | Inclusion body myopathy-3, 605637 (3)
MYH3 | Arthrogryposis, distal, type 2A, 193700 (3); Arthrogryposis, distal,
MYH8 | Carney complex variant, 608837 (3); Trismus-pseudocamptodactyly
PITPNM3, NIR1, CORD5 | Cone-rod dystrophy 5, 600977 (3)
TP53, P53, LFS1 | Colorectal cancer, 114500 (3); Li-Fraumeni syndrome, 151623 (3);
MPDU1, SL15, CDGIF | Congenital disorder of glycosylation, type If, 609180 (3)
ACADVL, VLCAD | VLCAD deficiency, 201475 (3)
ASPG2 | {Asperger syndrome susceptibility 2} (2)
CTAA2 | Cataract, anterior polar-2 (2)
CTNS | Cystinosis, nephropathic, 219800 (3); Cystinosis, ocular
CMS1A1, FIM1 | Myasthenia, familial infantile, 1 (2)
NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1 | {Vitiligo-associated multiple autoimmune disease susceptibility 1},
NDIC | Nail dysplasia, isolated congenital (2)
SPAX2 | Ataxia, spastic 2, autosomal recessive (2)
SLC2A4, GLUT4 | {Diabetes mellitus, noninsulin-dependent}, 125853 (3)
SXGQTL1 | [Sex hormone-binding blobulin circulating level QTL 1] (2)
WRAP53, TCAB1, WDR79, DKCB3 | Dyskeratosis congenita, autosomal recessive 3, 613988 (3)
CHRNE, SCCMS, CMS2A, FCCMS, CMS1E, CMS1D | Myasthenic syndrome, slow-channel congenital, 601462 (3);
SCOD1, SCO1 | Hepatic failure, early onset, and neurologic disorder (3)
AOMS2 | Abdominal obesity-metabolic syndrome (2)
BRKS1 | Bruck syndrome 1 (2)
TTC19 | Mitochondrial complex III deficiency, 124000 (3)
COX10 | Encephalopathy, progressive mitochondrial, with proximal renal
UBB | Cleft palate, isolated, 119540 (2)
CHRNB1, ACHRB, SCCMS, CMS2A, CMS1D | Myasthenic syndrome, slow-channel congenital, 601462 (3);
DFNB85 | Deafness, autosomal recessive 85 (2)
ALDH3A2, ALDH10, SLS, FALDH | Sjogren-Larsson syndrome, 270200 (3)
ATPAF2, ATP12, MC5DN1 | Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1,
B9D1, MKSR1, MKS9 | Meckel syndrome 9, 614209 (3)
FLCN, BHD | Birt-Hogg-Dube syndrome, 135150 (3); Pneumothorax, primary
IS2, AIS2 | Scoliosis, idiopathic 2 (2)
KCNJ18, KIR2.6, TTPP2 | {Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3)
MYO15A, DFNB3 | Deafness, autosomal recessive 3, 600316 (3)
PMP22, CMT1A, CMT1E, DSS | Charcot-Marie-Tooth disease, type 1A, 118220 (3); Dejerine-Sottas
PTLS | Potocki-Lupski syndrome (4)
RAI1, SMCR, SMS | Smith-Magenis syndrome, 182290 (3)
TNFRSF13B, TACI, CVID2 | Immunoglobulin A deficiency 2, 609529 (3); Immunodeficiency, common
AKAP10 | {Cardiac conduction defect, susceptibility to}, 115080 (3)
ADHD2 | {Attention deficit-hyperactivity disorder}, 143465 (2)
ELAC2, HPC2 | {Prostate cancer, susceptibility to}, 176807 (3)
CACD1 | Choroidal dystrophy, central areolar 1 (2)
CAMRQ2 | Cerebellar hypoplasia, mental retardation, and quadrupedal
NOS2A, NOS2 | {Hypertension, susceptibility to}, 145500 (2); {Malaria, resistance
HYT1 | {Hypertension, essential, susceptibility to, 1}, 145500 (2)
AUTS6 | {Autism susceptibility 6} (2)
RAD51L3, RAD51D, BROVCA4 | {Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3)
RNF135, MMFD | Macrocephaly, macrosomia, facial dysmorphism syndrome, 614192 (3)
FOXN1, WHN | T-cell immunodeficiency, congenital alopecia, and nail dystrophy,
ITGB4 | Epidermolysis bullosa, junctional, with pyloric atresia, 226730 (3);
NEK8, JCK, NPHP9 | Nephronophthisis 9, 613824 (3)
SLC46A1, HCP1, PCFT | Folate malabsorption, hereditary, 229050 (3)
TAF15, TAF2N, RBP56 | Chondrosarcoma, extraskeletal myxoid, 612237 (1)
CRYBA1, CRYB1 | Cataract, congenital zonular, with sutural opacities, 600881 (3)
SLC6A4, HTT, OCD1 | {Anxiety-related personality traits}, 607834 (3);
BLMH, BMH | {Alzheimer disease, susceptibility to}, 104300 (3)
CCL3L1, SCYA3L1, LD78 | {HIV/AIDS, susceptibility to}, 609423 (3)
DEL17q11.2; C17DELq11.2 | Chromosome 17q11.2 deletion syndrome, 1.4Mb (4)
JJAZ1, KIAA0160 | Endometrial stromal tumors (2)
MPVQTL3 | [Mean platelet volume QTL3] (2)
NF1, VRNF, WSS, NFNS | Neurofibromatosis, type 1, 162200 (3); Leukemia, juvenile
STAT5B | Leukemia, acute promyelocytic, STAT5B/RARA type (3); Growth hormone
THRA, ERBA1, THRA1, CHNG6 | Hypothyroidism, congenital, nongoitrous, 6, 614450 (3)
UNC119, HRG4 | Cone-rod dystrophy (3)
CCL2, SCYA2, MCP1, MCAF | {HIV-1, resistance to}, 609423 (3); {Spina bifida, susceptibility
CCL5, SCYA5, D17S136E, TCP228 | {HIV-1 disease, delayed progression of} (3); {HIV-1 disease, rapid
MHS2 | {Malignant hyperthermia susceptibility 2} (2)
CCL3, SCYA3, MIP1A | {HIV infection, resistance to}, 609423 (2)
HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11 | Renal cysts and diabetes syndrome, 137920 (3); Diabetes mellitus,
HPC11 | {Prostate cancer, hereditary, 11} (2)
KRT12 | Meesmann corneal dystrophy, 122100 (3)
PBC5 | Biliary cirrhosis, primary, 5 (2)
TCAP, LGMD2G, CMD1N | Muscular dystrophy, limb-girdle, type 2G, 601954 (3);
KRT9, EPPK | Epidermolytic palmoplantar keratoderma, 144200 (3)
KRT14 | Epidermolysis bullosa simplex, Dowling-Meara type, 131760 (3);
KRT16, FNEPPK | Pachyonychia congenita, Jadassohn-Lewandowsky type, 167200 (3);
KRT17, PC2, PCHC1 | Pachyonychia congenita, Jackson-Lawler type, 167210 (3);
SOST, VBCH | Sclerosteosis, 269500 (3); Van Buchem disease, 239100 (3)
WT4 | Wilms tumor, type 4 (2)
SGCA, ADL, DAG2, LGMD2D, DMDA2 | Muscular dystrophy, limb-girdle, type 2D, 608099 (3); Adhalinopathy,
ACACA, ACAC, ACC1, ACACAD | Acetyl-CoA carboxylase deficiency, 613933 (1)
ASRT6 | {Asthma-related traits, susceptibility to, 6} (2)
AUTS7 | {Autism susceptibility 7} (2)
BRCA1, PSCP, BROVCA1, PNCA4 | {Breast-ovarian cancer, familial, 1}, 604370 (3); {Pancreatic cancer,
G6PC, G6PT | Glycogen storage disease Ia, 232200 (3)
G6PC3, UGRP, SCN4 | Neutropenia, severe congenital 4, autosomal recessive, 612541 (3);
GFAP | Alexander disease, 203450 (3)
GOSR2, GS27, EPM6 | Epilepsy, progressive myoclonic 6, 614018 (3)
HCRT, OX, NRCLP1 | Narcolepsy 1, 161400 (3)
JUP, DP3, PDGB, ARVD12 | Naxos disease, 601214 (3); Arrhythmogenic right ventricular
NAGLU, MPS3B | Mucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3)
PHB | {Breast cancer, susceptibility to}, 114480 (3)
PTRF, CAVIN, CGL4 | Lipodystrophy, congenital generalized, type 4, 613327 (3)
PYY | {Obesity}, 601665 (3)
STAT3, APRF, HIES | Hyper-IgE recurrent infection syndrome, 147060 (3)
WNT3, INT4 | Tetra-amelia, autosomal recessive, 273395 (3)
GPSC | Gliosis, familial progressive subcortical (2)
HPC9 | {Prostate cancer, hereditary, 9} (2)
KRT10, EHK, BCIE, BIE | Epidermolytic hyperkeratosis, 113800 (3); Ichthyosis, cyclic, with
KRT13 | White sponge nevus, 193900 (3)
MYP5 | Myopia 5 (2)
PNMT, PENT | ?Hypertension, essential, 145500 (1)
PTLAH, FPAH | Patella aplasia or hypoplasia (2)
SLC4A1, AE1, EPB3 | Ovalocytosis (3); Spherocytosis, type 4, 612653 (3); [Malaria,
TBX4 | Small patella syndrome, 147891 (3)
TOP2A, TOP2 | DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)
WNK4, PRKWNK4, PHA2B | Pseudohypoaldosteronism, type IIB, 614491 (3)
ERBB2, NGL, NEU, HER2 | Adenocarcinoma of lung, somatic, 211980 (3); Glioblastoma, somatic,
MAPT, MTBT1, DDPAC, MSTD | Dementia, frontotemporal, with or without parkinsonism, 600274 (3);
RARA | Leukemia, acute promyelocytic, 612376 (1)
CCL11, SCYA11 | {HIV1, resistance to}, 609423 (3); {Asthma, susceptibility to},
CDC6, CDC18L | Meier-Gorlin syndrome 5, 613805 (3)
FKBP10, FKBP65, OI11 | Osteogenesis imperfecta, type XI, 610968 (3)
IBD22 | {Inflammatory bowel disease 22} (2)
PSMC3IP, TBPIP, GT198, HOP2, ODG3 | Ovarian dysgenesis 3, 614324 (3)
NME1, NM23 | Neuroblastoma, 256700 (3)
PLEKHM1, AP162, KIAA0356, OPTB6 | Osteopetrosis, autosomal recessive 6, 611497 (3)
TBX21, TBET | {Asthma, aspirin-induced, susceptibility to}, 208550 (3); Asthma and
DLX3, TDO, AI4 | Trichodontoosseous syndrome, 190320 (3); Amelogenesis imperfecta,
XYLT2, XT2 | {Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3)
DEL17q21.31, C17DELq21.31 | Chromosome 17q21.31 microdeletion syndrome (4)
DUP17q21.31, C17DUPq21.31 | Chromosome 17q21.31 duplication syndrome (4)
NAGS | N-acetylglutamate synthase deficiency, 237310 (3)
COL1A1 | Osteogenesis imperfecta, type I, 166200 (3); OI type II, 166210 (3);
GRN | Frontotemporal lobar degeneration with ubiquitin-positive inclusions,
ITGA2B, GP2B, CD41B, GT, BDPLT2 | Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia,
ITGB3, GP3A, GT, BDPLT2 | Glanzmann thrombasthenia, 273800 (3); Thrombocytopenia, neonatal
PNPO | Pyridoxamine 5'-phosphate oxidase deficiency, 610090 (3)
RCCP3 | Renal cell carcinoma, papillary, 3 (2)
BRIP1, BACH1, FANCJ | Breast cancer, early-onset, 114480 (3); Fanconi anemia,
NOG, SYM1, SYNS1 | Symphalangism, proximal, 185800 (3); Multiple synostosis syndrome 1,
PRCD, RP36 | Retinitis pigmentosa 36, 610599 (3)
RAD51C, FANCO, BROVCA3 | Fanconi anemia, complementation group 0, 613390 (3); {Breast-ovarian
PPM1D, WIP1 | Breast cancer, 114480 (3)
TRIM37, MUL, KIAA0898 | Mulibrey nanism, 253250 (3)
PRKCA, PKCA | Pituitary tumor, invasive (3)
CSH1, CSA, PL | [Placental lactogen deficiency] (1)
GH1, GHN, IGHD1B | Growth hormone deficiency, isolated, type IA, 262400 (3); Growth
ACE, DCP1, ACE1, MVCD3 | {Myocardial infarction, susceptibility to} (3); {Alzheimer disease,
BSZQTL | {Bone size QTL} (2)
CA4, RP17 | Retinitis pigmentosa 17, 600852 (3)
CD79B, IGB, B29, AGM6 | Agammaglobulinemia 6, 612692 (3)
MKS1, MKS, BBS13 | Meckel syndrome, type 1, 249000 (3); Bardet-Biedl syndrome 13,
POLG2, POLGB, PEOA4 | Progressive external ophthalmoplegia with mitochondrial DNA
PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ADOHR | Carney complex, type 1, 160980 (3); Myxoma, intracardiac, 255960 (3);
RGS9, PERRS | Bradyopsia, 608415 (3)
EPX | Eosinophil peroxidase deficiency, 261500 (3)
MPO | Myeloperoxidase deficiency, 254600 (3); {Alzheimer disease,
DEL17q23.1q23.2, C17DELq23.1q23.2 | Chromosome 17q23.1-q23.2 deletion syndrome (4)
DUP17q23.1q23.2, C17DUPq23.1q23.2 | Chromosome 17q23.1-q23.2 duplication syndrome (4)
KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9 | Long QT syndrome-7, 170390 (3); Short QT syndrome-3, 609622 (3);
SCN4A, HYPP, NAC1A, HOKPP2 | Hyperkalemic periodic paralysis, type 2, 613345 (3); Paramyotonia
BMIQ15 | [Body mass index QTL 15] (2)
STRADA, STRAD, LYK5 | Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3)
AXIN2 | Colorectal cancer, 114500 (3); Oligodontia-colorectal cancer
CCA1 | Cataract, cerulean, type 1 (2)
GALK1 | Galactokinase deficiency with cataracts, 230200 (3)
SANS, USH1G | Usher syndrome, type 1G, 606943 (3)
FAM20A, AIGFS | Amelogenesis imperfecta and gingival fibromatosis syndrome,
HTGH, DEL17q24 | Hypertrichosis terminalis, generalized, with or without gingival
SRXX2, DUP17q24.3, DEL17q24.3 | 46XX sex reversal 2, 278850 (4)
PRBNS | Pierre Robin syndrome (2)
SOX9, CMD1, SRA1 | Campomelic dysplasia with autosomal sex reversal, 114290 (3);
AANAT, SNAT, DSPS | {Delayed sleep phase syndrome, susceptibility to}, 614163 (3)
ASPSCR1, RCC17, ASPL, ASPS | Alveolar soft-part sarcoma, 606243 (3)
CBX2, M33, SRXY5 | 46XY sex reversal 5, 613080 (3)
DNAI2, CILD9 | Ciliary dyskinesia, primary, 9, with or without situs inversus,
TMC8, EVER2, EV2 | Epidermodysplasia verruciformis, 226400 (3)
FSCN2, RFSN, RP30 | Retinitis pigmentosa 30, 607921 (3)
PSORS2, PSS1 | {Psoriasis susceptibility 2} (2)
GCGR | {Diabetes mellitus, noninsulin-dependent}, 125853 (3)
PDE6G, PDEG, RP57 | Retinitis pigmentosa 57, 613582 (3)
RNF213, ALO17, KIAA1618, MYMY2 | {Moyamoya disease 2, susceptibility to}, 607151 (3)
SEPT9, MSF, MSF1, NAPB | Leukemia, acute myeloid, therapy-related (1); Ovarian carcinoma (1);
TMC6, EVER1, EV1 | Epidermodysplasia verruciformis, 226400 (3)
TOC, TEC | Tylosis with esophageal cancer (2)
ACOX1, ACOX, SCOX | Peroxisomal acyl-CoA oxidase deficiency, 264470 (3)
COG1, LDLB, KIAA1381, CDG2G | Congenital disorder of glycosylation, type IIg, 611209 (3)
NDNC9 | Nail disorder, nonsyndromic congenital, 9 (2)
SLC9A3R1, EBP50, NHERF1, NPHLOP2 | Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3)
TSEN54, SEN54, PCH2A, PCH4 | Pontocerebellar hypoplasia type 2A, 277470 (3); Pontocerebellar
UNC13D, MUNC13-4, HPLH3, HLH3, FHL3 | Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)
GAA | Glycogen storage disease II, 232300 (3)
ACTG1, DFNA20, DFNA26 | Deafness, autosomal dominant 20/26, 604717 (3)
ATOD4 | {Dermatitis, atopic, susceptibility to, 4} (2)
CANT1, SCAN1, DBQD | Desbuquois dysplasia, 251450 (3)
CCDC40, KIAA1640 | Ciliary dyskinesia, primary, 15, 613808 (3)
DCXR, P34H | Pentosuria, 260800 (1)
PYCR1, PRO3, ARCL2B, ARCL3B | Cutis laxa, autosomal recessive, type IIB, 612940 (3); Cutis
SGSH, MPS3A, SFMD | Mucopolysaccharidisis type IIIA (Sanfilippo A), 252900 (3)
SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4 | Microcephaly, Amish type, 607196 (3); Thiamine metabolism dysfunction
ZNF750, FLJ13841 | Seborrhea-like dermatitis with psoriasiform elements, 610227 (3)
ODS1 | {Opioid dependence, susceptibility to, 1} (2)
PEX12 | Peroxisome biogenesis factor 12 (3)
DFNB46 | Deafness, autosomal recessive 46 (2)
MYP2 | Myopia-2 (2)
NDUFV2 | Mitochondrial complex I deficiency, 252010 (3)
DSAP4 | Porokeratosis, disseminated superficial actinic, 4 (2)
MRT19 | Mental retardation, autosomal recessive 19 (2)
TGIF, HPE4 | Holoprosencephaly-4, 142946 (3)
AA1 | Alopecia areata 1 (2)
STUT1 | Stuttering, familial persistent 1 (2)
PSORS10 | {Psoriasis susceptibility 10} (3)
ANIC | Anosmia, isolated congenital (2)
DYX6, DYXQTL18 | {Dyslexia, susceptibility to, 6} (2)
FEB6 | Febrile seizures, familial, 6 (2)
MC2R | Glucocorticoid deficiency, due to ACTH unresponsiveness, 202200 (3)
AFG3L2, SCA28 | Spinocerebellar ataxia 28, 610246 (3)
APCDD1, HHS, HTS | Hypotrichosis simplex, 605389 (3)
DYT15 | Dystonia-15, myoclonic (2)
IBD21 | {Inflammatory bowel disease 21} (2)
DEL18p, C18DELp | Chromosome 18p deletion syndrome (4)
DYT7 | Dystonia-7, torsion (2)
LPIN2 | Majeed syndrome, 609628 (3)
MAFD1, BPAD, MD1 | {Major affective disorder 1} (2)
SCZD8 | {Schizophrenia}, 181500 (2)
TET18P | Tetrasomy 18p (4)
DEL18q | Chromosome 18q deletion syndrome (4)
OHDS | Orthostatic hypotensive disorder of Streeten (2)
NPC1, NPC | Niemann-Pick disease, type C1, 257220 (3); Niemann-Pick disease,
SLC14A1, JK, UTE, UT1 | [Blood group, Kidd], 111000 (3)
GATA6, AVSD5, ASD9, AVSD5, PACHD | Atrioventricular septal defect 5, 614474 (3); Atrial septal defect 9,
LAMA3, LOCS | Epidermolysis bullosa, junctional, Herlitz type, 226700 (3);
RBBP8, RIM, SCKL2, JWDS | Pancreatic carcinoma, somatic (3); Seckel syndrome 2, 606744 (3);
SS18, SSXT, SYT | Sarcoma, synovial (1)
TTR, PALB | Amyloidosis, hereditary, transthyretin-related, 105210 (3);
APMR3 | Alopecia-mental retardation syndrome 3 (2)
DSG4, LAH | Hypotrichosis, localized, autosomal recessive, 607903 (3)
IER3IP1, MEDS | Microcephaly, epilepsy, and diabetes syndrome, 614231 (3)
LOXHD1, DFNB77 | Deafness, autosomal recessive 77, 613079 (3)
DYM, FLJ90130, DMC, SMC | Dyggve-Melchior-Clausen disease, 223800 (3); Smith-McCort dysplasia,
DSC2, DSC3, ARVD11 | Arrhythmogenic right ventricular dysplasia 11, 610476 (3)
DSC3, DSC4 | Hypotrichosis and recurrent skin vesicles, 613102 (3)
DSG1, PPKS1, SPPK1 | Keratosis palmoplantaris striata I, 148700 (3)
DSG2, ARVD10, ARVC10, CMD1BB | Arrhythmogenic right ventricular dysplasia 10, 610193 (3);
DTNA, D18S892E, DRP3, LVNC1 | Left ventricular noncompaction 1, with or without congenital heart
OPA4 | Optic atrophy-4 (2)
VUR6 | Vesicoureteral reflux 6 (2)
ATP8B1, FIC1, BRIC, PFIC1 | Cholestasis, progressive familial intrahepatic 1, 211600 (3);
ALS3 | Amyotrophic lateral sclerosis 3 (2)
IDDM6 | {Diabetes mellitus, insulin-dependent, 6} (2)
MALT1, MLT | MALT lymphoma (3)
ME2, ODS1 | {Epilepsy, idiopathic generalized, susceptibility to}, 600669 (3);
MYO5B, KIAA1119 | Microvillus inclusion disease, 251850 (3)
MADH4, DPC4, SMAD4, JIP, MYHRS | Pancreatic cancer (3); Polyposis, juvenile intestinal, 174900 (3);
SETBP1, KIAA0437, SEB | Leukemia, acute T-cell lymphoblastic (3); Schinzel-Giedion midface
SMAD7, MADH7, CRCS3 | {Colorectal cancer, susceptibility to, 3}, 612229 (3)
CORD1, CRD1 | Cone-rod retinal dystrophy-1 (2)
HYT8 | {Hypertension, essential, susceptibility to, 8} (2)
TCF4, SEF2, ITF2, PTHS | Pitt-Hopkins syndrome, 610954 (3)
FECD3, FCD2 | Corneal dystrophy, Fuchs endothelial, 3 (2)
BCL2 | Leukemia/lymphoma, B-cell, 2 (3)
CNSN | Carnosinemia (2)
DCC | Colorectal cancer (3); Mirror movements, congenital, 157600 (3)
FECH, FCE | Protoporphyria, erythropoietic, autosomal recessive, 177000 (3)
FVT1 | Lymphoma/leukemia, B-cell, variant (1)
RAX, RX, MCOP3 | Microphthalmia, isolated 3, 611038 (3)
LMAN1, ERGIC53, F5F8D, MCFD1 | Combined factor V and VIII deficiency, 227300 (3)
CCBE1, KIAA1983 | Hennekam lymphangiectasia-lymphedema syndrome, 235510 (3)
PIGN, MCAHS | Multiple congenital anomalies-hypotonia-seizures syndrome, 614080 (3)
DUP18pDEL18q, DUP81qDEL18p | Chromosome 18 pericentric inversion (4)
MC4R | Obesity, autosomal dominant, 601665 (3)
TNFRSF11A, RANK, ODFR, OFE, OPTB7 | Osteolysis, familial expansile, 174810 (3); Paget disease of bone,
TSHZ1, TSH1, CAA | Aural atresia, congenital, 607842 (3)
CAA | Aural atresia, congenital (2)
CTDP1, FCP1, CCFDN | Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3)
CYB5A, MCB5 | Methemoglobinemia, type IV, 250790 (3)
FPH1, MUH, HPP | Hyperpigmentation, familial progressive, 1 (2)
ANGPTL4, PGAR, HFARP, FIAF | {Reduced triglycerides, susceptibility to} (3)
IS1, AIS | Scoliosis, idiopathic 1 (2)
ATCAY, CLAC, KIAA1872 | Ataxia, cerebellar, Cayman type, 601238 (3)
BSG | [Blood group, OK], 111380 (3)
CD209, CDSIGN | {Dengue fever, protection against}, 614371 (3); {HIV type 1,
CFD, ADN | Complement factor D deficiency, 613912 (3)
CLEC4M, CD209L, LSIGN, DCSIGNR | SARS infection, protection against (2)
ELANE, ELA2, SCN1 | Neutropenia, cyclic, 162800 (3); Neutropenia, severe congenital 1,
FEB2 | Febrile seizures, familial, 2 (2)
FUT3, LE | [Blood group, Lewis] (3)
FUT6 | Fucosyltransferase 6 deficiency, 613852 (3)
GAMT | GAMT deficiency, 612736 (3)
GIPC3, DFNB15, DFNB72, DFNB95 | Deafness, autosomal recessive 15, 601869 (3)
HHC2, FHH2 | Hypocalciuric hypercalcemia, type II (2)
KISS1R, GPR54 | Hypogonadotropic hypogonadism, 146110 (3); Precocious puberty,
LMNB2, LMN2 | {Lipodystrophy, partial, acquired, susceptibility to}, 608709 (3)
ICAM4, CD242, LW | [Blood group, Landsteiner-Wiener], 111250 (3)
MAP2K2, PRKMK2, MEK2, MKK2 | Cardiofaciocutaneous syndrome, 115150 (3)
MDRV | Muscular dystrophy with rimmed vacuoles (2)
NDUFA11 | Mitochondrial complex I deficiency, 252010 (3)
PIP5K1C, LCCS3 | Lethal congenital contractural syndrome 3, 611369 (3)
PNPLA6, NTE, SPG39, NTEMND | Spastic paraplegia 39, 612020 (3)
RAXL1, QRX, CORD11, ARMD6 | Macular degeneration, age-related, 6, 613757 (3); Cone-rod dystrophy
SCA26 | Spinocerebellar ataxia 26 (2)
SH3GL1, EEN | Leukemia, acute myeloid, 601626 (1)
STK11, PJS, LKB1 | Peutz-Jeghers syndrome, 175200 (3); Melanoma, malignant sporadic (3);
TBXA2R, BDPLT13 | {Bleeding disorder, platelet-type, 13, susceptibility to}, 614009
TCF3, E2A | Leukemia, acute lymphoblastic (1)
ADAMTS10, WMS1 | Weill-Marchesani syndrome 1, recessive, 277600 (3)
AMH, MIF | Persistent Mullerian duct syndrome, type I, 261550 (3)
ATHS, ALP | {Atherosclerosis, susceptibility to} (2)
C3, ARMD9, AHUS5 | C3 deficiency, 613779 (3);
DNMT1, MCMT, HSN1E | Neuropathy, hereditary sensory, type IE, 614116 (3)
EPOR | [Erythrocytosis, familial, 1], 133100 (3)
ICAM1 | {Malaria, cerebral, susceptibility to}, 611162 (3)
MCOLN1, ML4 | Mucolipidosis IV, 252650 (3)
STXBP2, UNC18B, FHL5 | Hemophagocytic lymphohistiocytosis, familial, 5 (3)
ACP5, SPENCDI | Spondyloenchondrodysplasia with immune dysregulation, 607944 (3)
AD9 | {Alzheimer disease 9, late onset, susceptibility to}, 104300 (2)
CD320, 8D6, 8D6A, TCBLR | Methylmalonic aciduria due to transcobalamin receptor defect,
DNM2, CMTDIB, CMTDI1, CMT2M | Charcot-Marie-Tooth disease, dominant intermediate B, 606482 (3);
DOCK6, KIAA1395, AOS2 | Adams-Oliver syndrome 2, 614219 (3)
GCDH | Glutaricaciduria, type I, 231670 (3)
INSL3 | Cryptorchidism, idiopathic, 219050 (3)
INSR, HHF5 | Leprechaunism, 246200 (3); Rabson-Mendenhall syndrome, 262190 (3);
LDLR, FHC, FH, LDLCQ2 | Hypercholesterolemia, familial, 143890 (3); LDL cholesterol
NRCLP6 | Narcolepsy 6 (2)
PCOS1, PCO1, PCO | Polycystic ovary syndrome 1 (2)
RETN, RSTN, FIZZ3 | {Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853
SMARCA4, BRG1, RTPS2 | Rhabdoid tumor predisposition syndrome 2, 613325 (3)
TCO | Thyroid carcinoma, nonmedullary, with cell oxyphilia (2)
TYK2 | Tyrosine kinase 2 deficiency, 611521 (3)
INLNE | Ichthyosis, nonlamellar and nonerythrodermic, congenital (2)
LYL1 | Leukemia, T-cell acute lymphoblastoid (2)
NDUFA13, GRIM19 | {Thyroid carcinoma, Hurthle cell}, 607464 (3)
NOTCH3, CADASIL, CASIL | Cerebral arteriopathy with subcortical infarcts and
PAPA3 | Polydactyly, postaxial, type A3 (2)
PRKCSH, G19P1, PCLD | Polycystic liver disease, 174050 (3)
SLC5A5, NIS, TDH1 | Thyroid dyshormonogenesis 1, 274400 (3)
LPSA, D19S381E | Liposarcoma (1)
DEL19p13.13, C19DELp13.13, DUP19p13.13, C19DUPp13.13 | Chromosome 19p13.13 deletion syndrome (4); Chromosome 19p13.13
RNASEH2A, RNHIA, AGS4 | Aicardi-Goutieres syndrome 4, 610333 (3)
KLF1, EKLF, INLU, HBFQTL6 | Blood group--Lutheran inhibitor, 111150 (3); [Hereditary
CALR3, CRT2, CMH19 | Cardiomyopathy, familial hypertrophic, 19, 613875 (3)
CC2D1A, MRT3 | Mental retardation, autosomal recessive 3, 608443 (3)
CYP4F22, LI3 | Ichthyosis, lamellar, 3, 604777 (3)
TECR, GPSN2, TER, SC2, MRT14 | Mental retardation, autosomal recessive 14, 614020 (3)
COMP, EDM1, MED, PSACH | Pseudoachondroplasia, 177170 (3); Epiphyseal dysplasia, multiple 1,
IL12RB1 | {Mycobacterial and salmonella infections, susceptibility to}, 209950
JAK3, JAKL | SCID, autosomal recessive, T-negative/B-positive type (3)
MYO9B, MYR5, CELIAC4 | {Celiac disease, susceptibility to, 4}, 609753 (3)
CACNA1A, CACNL1A4, SCA6 | Migraine, familial hemiplegic, 1, 141500 (3); Episodic ataxia, type
CRTC1, MECT1, KIAA0616, FLJ14027 | Mucoepidermoid salivary gland carcinoma (3)
DFNB81 | Deafness, autosomal recessive 81 (2)
IBD6 | {Inflammatory bowel disease 6} (2)
MGR5 | {Migraine with or without aura, susceptibility to, 5} (2)
NDUFS7, PSST | Leigh syndrome, 256000 (3)
PSORS6 | {Psoriasis susceptibility 6} (3)
CRLF1, CISS | Cold-induced sweating syndrome, 272430 (3); Crisponi syndrome,
GDF1, DTGA3, DORV | Double-outlet right ventricle, 217095 (3); Tetralogy of Fallot,
RFXANK | MHC class II deficiency, complementation group B, 209920 (3)
EXT3 | Exostoses, multiple, type 3 (2)
MAN2B1, MANB | Mannosidosis, alpha-, types I and II, 248500 (3)
PEPD | Prolidase deficiency, 170100 (3)
BFIS1, BFIC1 | Seizures, benign familial infantile, 1 (2)
HPCQTL19 | {Prostate cancer aggressiveness QTL}, 176807 (2)
SLI2 | Specific language impairment QTL, 2 (2)
C19orf12 | Neurodegeneration with brain iron accumulation 4, 614298 (3)
HSCR7 | {Hirschsprung disease, susceptibility to, 7} (2)
ATP1A3, DYT12, RDP | Dystonia-12, 128235 (3)
SDHAF1 | Mitochondrial complex II deficiency, 252011 (3)
AAA1, AAA | Aortic aneurysm, familial abdominal 1 (2)
ACTN4, FSGS1, FSGS | Glomerulosclerosis, focal segmental, 1, 603278 (3)
ANIB2 | Aneurysm, intracranial berry, 2 (2)
BCAT2, BCT2 | ?Hypervalinemia or hyperleucine-isoleucinemia (1)
BCL3 | Leukemia/lymphoma, B-cell, 3 (2)
BLOC1S3, BLOS3, HPS8 | Hermansky-Pudlak syndrome 8, 614077 (3)
CATCN1 | Cataract, congenital nuclear, 1 (2)
DLL3, SCDO1 | Spondylocostal dysostosis, autosomal recessive, 1, 277300 (3)
EA7 | Episodic ataxia, type 7 (2)
HAMP, LEAP1, HEPC, HFE2B | Hemochromatosis, type 2B, 613313 (3)
HHC3, FBH3 | Hypercalciuric hypercalcemia, type III (2)
OFC3 | Orofacial cleft-3 (2)
SPG12 | Spastic paraplegia-12 (2)
CEBPA, CEBP | Leukemia, acute myeloid, 601626 (3)
COX6B1 | Cytochrome c oxidase deficiency, 220110 (3)
CRCS10 | {Colorectal cancer, susceptibility to, 10} (2)
GPI | Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase
NPHS1, NPHN | Nephrotic syndrome, type 1, 256300 (3)
PSENEN, PEN2 | Acne inversa, familial, 2, 613736 (3)
RYR1, MHS, CCO | {Malignant hyperthermia susceptibility 1}, 145600 (3); Central core
SCN1B, GEFSP1 | Generalized epilepsy with febrile seizures plus, type 1, 604233 (3);
SLC7A9, CSNU3 | Cystinuria, 220100 (3)
SPINT2, HAI2, DIAR3 | Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3)
TGFB1, DPD1, CED | Camurati-Engelmann disease, 131300 (3); {Cystic fibrosis lung
TYROBP, PLOSL, DAP12 | Nasu-Hakola disease, 221770 (3)
AKT2, HIHGHH | Diabetes mellitus, type II, 125853 (3); Hypoinsulinemic hypoglycemia
BCKDHA, MSUD1 | Maple syrup urine disease, type Ia, 248600 (3)
LTBP4, LTBP4S, LTBP4L | Cutis laxa with severe pulmonary, gastrointestinal, and urinary
PRX, CMT4F | Dejerine-Sottas disease, autosomal recessive, 145900 (3);
DEL19q13.11, C19DELq13.11 | Chromosome 19q13.11 deletion syndrome (4)
RGS9BP, R9AP, RGS9, PERRS | Bradyopsia, 608415 (3)
WDR62, C19orf14, MCPH2 | Microcephaly 2, primary, autosomal recessive, with or without
IL28B | {Hepatitis C virus infection, response to therapy of}, 609532 (3)
APOE, AD2, LPG, LDLCQ5 | Hyperlipoproteinemia, type III (3); {Myocardial infarction
APOC2 | Hyperlipoproteinemia, type Ib, 207750 (3)
B9D2, MKS10 | Meckel syndrome 10, 614175 (3)
CD79A, IGA | Agammaglobulinemia 3, 613501 (3)
CYP2A6, CYP2A3, CYP2A, P450C2A | Coumarin resistance, 122700 (3); {Nicotine addiction, protection
ITPKC | {Kawasaki disease, susceptibility to}, 611775 (3)
LU, AU, BCAM | [Blood group, Lutheran system], 111200 (3); [Blood group, Auberger
RPS19, DBA, DBA1 | Diamond-Blackfan anemia 1, 105650 (3)
SARS2 | Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis,
TEC | Transient erythroblastopenia of childhood (2)
DMPK, DM, DMK | Myotonic dystrophy 1, 160900 (3)
ERCC1, UV20, COFS4 | Cerebrooculofacioskeletal syndrome 4, 610758 (3)
ERCC2, EM9, XPD, COFS2 | Xeroderma pigmentosum, group D, 278730 (3); Trichothiodystrophy,
LIG1 | DNA ligase I deficiency (3)
MRT11 | Mental retardation, autosomal recessive, 11 (2)
OPA3, MGA3 | 3-methylglutaconic aciduria, type III, 258501 (3); Optic atrophy
CCDC8, 3M3 | Three M syndrome 3, 614205 (3)
CFM1 | {Meconium ileus in cystic fibrosis, susceptibility to} (2)
CRX, CORD2, CRD, LCA7 | Cone-rod retinal dystrophy-2, 120970 (3); Leber congenital
ETFB, MADD | Glutaric acidemia IIB, 231680 (3)
FKRP, MDC1C, LGMD2I, MDDGA5, MDDGB5, MDDGC5 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye
FUT1, H, HH | [Bombay phenotype] (3)
FUT2, SE, B12QTL1 | {Norwalk virus infection, resistance to} (3); [Bombay phenotype]
GIPR, PGQTL2 | [Plasma glucose, 2-hour, QTL 2] (2)
GYS1, GYS | Glycogen storage disease 0, muscle, 611556 (3)
MED25, PTOV2, ARC92, CMT2B2 | Charcot-Marie-Tooth disease, type 2B2, 605589 (3)
NTF4 , NTF5, NT5, NT4, GLC1O | Glaucoma 1, open angle, 1O, 613100 (3)
SIX5, DMAHP, BOR2 | Branchiootorenal syndrome 2, 610896 (3)
BAX | Colorectal cancer (3); T-cell acute lymphoblastic leukemia (3)
FTL, NBIA3 | Hyperferritinemia-cataract syndrome, 600886 (3); Neurodegeneration
KCNC3, SCA13 | Spinocerebellar ataxia 13, 605259 (3)
CILD2, PCD | Ciliary dyskinesia, primary, 2 (2)
ETHE1, HSCO, D83198 | Ethylmalonic encephalopathy, 602473 (3)
LHB | Hypogonadism, hypergonadotropic (3); ?Male pseudohermaphroditism
TRPM4, PFHB1B | Progressive familial heart block, type IB, 604559 (3)
MYH14, KIAA2034, DFNA4, PNMHH | Deafness, autosomal dominant 4, 600652 (3); Peripheral neuropathy,
NUP62, SNDI, IBSN | Striatonigral degeneration, infantile, 271930 (3)
GP6, GPIV, BDPLT11 | Bleeding disorder, platelet-type, 11, 614201 (3)
HPC15 | {Prostate cancer, hereditary, 15} (2)
KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1 | {AIDS, delayed/rapid progression to}, 609423 (3)
KLK1, KLKR | [Kallikrein, decreased urinary activity of] (3)
KLK4, EMSP1, PRSS17, AI2A1 | Amelogenesis imperfecta, type IIA1, 204700 (3)
LIM2, MP19 | Cataract, cortical pulverulent, late-onset (3)
MENOQ2 | {Menopause, natural, age at, QTL2} (2)
NALP7, NOD12, PYPAF3, HYDM | Hydatidiform mole, 231090 (3)
NALP12, PYPAF7, RNO, FCAS2 | Familial cold autoinflammatory syndrome 2, 611762 (3)
PNKP, PNK, MCSZ, EIEE10 | Epileptic encephalopathy, early infantile, 10, 613402 (3)
PRKCG, PKCC, PKCG, SCA14 | Spinocerebellar ataxia 14, 605361 (3)
PRPF31, PRP31, RP11 | Retinitis pigmentosa 11, 600138 (3)
TSEN34, PCH2C, LENG5, SEN34 | Pontocerebellar hypoplasia type 2C, 612390 (3)
TNNI3, CMH7, CMD2A, RCM1, CMD1FF | Cardiomyopathy, familial hypertrophic, 7, 613690 (3); Cardiomyopathy,
TNNT1, ANM | Nemaline myopathy, Amish type, 605355 (3)
STK13, AIE2, SPGF5 | Spermatogenic failure 5, 243060 (3)
PRNP, PRIP | Creutzfeldt-Jakob disease, 123400 (3); Gerstmann-Straussler disease,
BMIQ6 | [Body mass index QTL6] (2)
ALS7 | Amyotrophic lateral sclerosis 7 (2)
AVP, AVRP, VP | Diabetes insipidus, neurohypophyseal, 125700 (3)
C20orf54, RFT2, BVVLS | Brown-Vialetto-Van Laere syndrome, 211530 (3); Fazio-Londe disease,
IDH3B, RP46 | Retinitis pigmentosa 46 (3)
KIND1, URP1, C20orf42 | Kindler syndrome, 173650 (3)
NOP56, SCA36 | Spinocerebellar ataxia 36, 614153 (3)
PDYN, SCA23 | Spinocerebellar ataxia 23, 610245 (3)
PROKR2, PKR2, GPR73L1, KAL3 | Kallmann syndrome 3, 244200 (3)
RLS5 | {Restless legs syndrome 5} (2)
RSPO4, CRISTIN4 | Anonychia congenita, 206800 (3)
PANK2, NBIA1, PKAN, HARP | Neurodegeneration with brain iron accumulation 1, 234200 (3);
TGM6, TG6, TGY, SCA35 | Spinocerebellar ataxia 35, 613908 (3)
SLC4A11, BTR1, NABC1, CHED2, CDPD, FECD4 | Corneal endothelial dystrophy 2, 217700 (3); Corneal endothelial
BMND7 | {Osteoporosis}, 166710 (2)
CRCS11 | {Colorectal cancer, susceptibility to, 11} (2)
MENOQ3 | {Menopause, natural, age at, QTL3} (2)
C20orf7 | Mitochondrial complex 1 deficiency, 252010 (3)
BFSP1, CP115 | Cataract, cortical, juvenile-onset, 611391 (3)
BMP2, BMP2A, BDA2 | {HFE hemochromatosis, modifier of}, 235200 (3); Brachydactyly,
GLC1K, JOAG3 | Glaucoma 1K, primary open angle, juvenile-onset (2)
JAG1, AGS, AHD | Alagille syndrome, 118450 (3); Tetralogy of Fallot, 187500 (3);
MKKS, HMCS, KMS, MKS, BBS6 | McKusick-Kaufman syndrome, 236700 (3); Bardet-Biedl syndrome 6,
PLCB1, KIAA0581, PLCB1A, PLCB1B, EIEE12 | Epileptic encephalopathy, early infantile, 12, 613722 (3)
SLEB7 | {Systemic lupus erythematosus, susceptibility to, 7} (2)
AGA3 | Alopecia, androgenetic, 3 (2)
RIN2, MACS | Macrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3)
CST3, ARMD11 | Cerebral amyloid angiopathy, 105150 (3); Macular degeneration,
ABHD12, PHARC | Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and
SEC23B, CDAN2, HEMPAS | Anemia, dyserythropoietic congenital, type II, 224100 (3)
THBD, THRM, AHUS6, THPH12 | Thrombophilia due to thrombomodulin defect, 614486 (3);
VSX1, RINX, PPCD, PPD, KTCN1, CAASDS | Keratoconus 1, 148300 (3); Corneal dystrophy, hereditary polymorphous
CHED1, CHED | Congenital hereditary endothelial dystrophy of cornea, autosomal
DYT17 | Dystonia-17, primary torsion (2)
ITPA | [Inosine triphosphatase deficiency], 613850 (3)
AHCY, SAHH | Hypermethioninemia with deficiency of S-adenosylhomocysteine
AD8 | Alzheimer disease 8, 104300 (2)
ATOD3 | {Dermatitis, atopic, susceptibility to, 3} (2)
HYT5 | {Hypertension, essential, susceptibility to, 5}, 145500 (2)
SCAR6, CLA3 | Spinocerebellar ataxia, autosomal recessive 6 (2)
ASIP, AGTIL, SHEP9 | [Skin/hair/eye pigmentation 9, dark/light hair], 611742 (3);
CMM7 | {Melanoma, cutaneous malignant, 7} (2)
DNMT3B, ICF1 | Immunodeficiency-centromeric instability-facial anomalies syndrome 1,
GDF5, CDMP1, SYNS2, OS5 | Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3);
GHRH, GHRF | ?Isolated growth hormone deficiency due to defect in GHRF (1);
GSS, GSHS | Hemolytic anemia due to glutathione synthetase deficiency, 231900
SAMHD1, AGS5, DCIP, CHBL2 | Aicardi-Goutieres syndrome 5, 612952 (3); Chilblain lupus 2, 614415
SNT1, LQT12 | Long QT syndrome 12, 612955 (3)
EPB41L1, MRD11 | Mental retardation, autosomal dominant 11, 614257 (3)
MMP9, CLG4B, MANDP2 | Metaphyseal anadysplasia 2, 613073 (3)
ASXL1, KIAA0978, BOPS, MDS | Bohring-Opitz syndrome, 605039 (3); Myelodysplastic syndrome,
COX4I2 | Exocrine pancreatic insufficiency, dyserythropoietic anemia, and
CHMP4B, SNF7, CTPP3 | Cataract, posterior polar, 3, 605387 (3)
STQTL14 | {Stature QTL 14} (2)
ITCH, AIP4, NAPP1 | Autoimmune disease, syndromic multisystem, 613385 (3)
JPH2, JP2, CMH17 | Cardiomyopathy, familial hypertrophic 17, 613873 (3)
SRC, ASV, SRC1 | Colon cancer, advanced (3)
HNF4A, TCF14, MODY1 | MODY, type I, 125850 (3); {Diabetes mellitus, noninsulin-dependent},
NIDDM3 | {Diabetes mellitus, noninsulin-dependent}, 125853 (2)
PLTP, HDLCQ9 | [High density lipoprotein cholesterol level QTL 9] (3)
TOP1 | DNA topoisomerase I, camptothecin-resistant (3)
PSMNSW | Parasomnia, sleepwalking type (2)
CD40, TNFRSF5 | Immunodeficiency with hyper-IgM, type 3, 606843 (3)
GEVQ2 | {Gene expression, variation in, QTL} (2)
HPC3 | {Prostate cancer, susceptibility to, 3}, 176807 (2)
IBD24 | {Inflammatory bowel disease 24} (2)
PSORS12 | {Psoriasis susceptibility 12} (2)
SLEB8 | {Systemic lupus erythematosus, susceptibility to, 8} (2)
CTSA, PPGB, GSL, NGBE, GLB2 | Galactosialidosis, 256540 (3)
SLC2A10, GLUT10, ATS | Arterial tortuosity syndrome, 208050 (3)
PTPN1, PTP1B | {Insulin resistance, susceptibility to}, 125853 (3)
ADA | Severe combined immunodeficiency due to ADA deficiency, 102700 (3);
GRD2 | {Graves disease, susceptibility to, 2} (2)
PTGIS, CYP8A1, PGIS, CYP8 | Hypertension, essential, 145500 (3)
ARFGEF2, BIG2, PVNH2 | Periventricular heterotopia with microcephaly, 608097 (3)
DPM1, MPDS, CDGIE | Congenital disorder of glycosylation, type Ie, 608799 (3)
SALL4, HSAL4 | Duane-radial ray syndrome, 607323 (3); IVIC syndrome, 147750 (3)
GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C | Pseudohypoparathyroidism Ia, 103580 (3); McCune-Albright syndrome,
GNASAS, NESPAS | Pseudohypoparathyroidism, type IB, 603233 (3)
MC3R, BMIQ9 | {Obesity, severe, susceptibility to, BMIQ9}, 602025 (3);
AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK | {Colon cancer, susceptibility to}, 114500 (3)
CHRNA4, ENFL1 | Epilepsy, nocturnal frontal lobe, 1, 600513 (3); {Nicotine
CYP24A1, CYP24, HCAI | Hypercalcemia, infantile, 143880 (3)
DFNB65 | Deafness, autosomal recessive 65 (2)
EDN3, WS4B, HSCR4 | Waardenburg syndrome, type 4B, 613265 (3); Central hypoventilation
ATP5E, MC5DN3 | Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3,
COL9A3, EDM3, IDD | Epiphyseal dysplasia, multiple, 3, 600969 (3); Epiphyseal dysplasia,
KCNQ2, EBN1, EIEE7, BFNS1 | Seizures, benign neonatal, 1, 121200 (3); Myokymia, 121200 (3);
MYLK2, MLCK | Cardiomyopathy, hypertrophic, midventricular, digenic, 192600 (3)
VAPB, VAPC, ALS8 | Amyotrophic lateral sclerosis 8, 608627 (3); Spinal muscular
PCK1 | ?Phosphoenolpyruvate carboxykinase-1, cytosolic, deficiency, 261680
TUBB1 | Macrothrombocytopenia, autosomal dominant, TUBB1-related, 613112 (3)
MTBS3 | {Mycobacterium tuberculosis, susceptibility to, 3} (2)
STX16, SYN16 | Pseudohypoparathyroidism, type IB, 603233 (3)
DNAJC5, DNAJC5A, CSP, CLN4B | Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3)
GLM6 | {Glioma susceptibility 6} (2)
PRPF6, PRP6, ANT1, TOM, C20orf14 | Retinitis pigmentosa 60, 613983 (3)
SOX18, HLTS | Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3)
AUTS12 | {Autism susceptibility 12} (2)
LIPI, LPDL, PRED5 | {Hypertriglyceridemia, susceptibility to}, 145750 (3)
NRCLP3 | Narcolepsy 3 (2)
TAM, MST | Leukemia, transient, of Down syndrome (2)
APP, AAA, CVAP, AD1 | Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic
PRSS7, ENTK | Enterokinase deficiency, 226200 (3)
USH1E | Usher syndrome, type 1E (2)
FEB7 | Febrile seizures, familial, 7 (2)
TUKLS | Tukel syndrome (2)
CRFB4, IBD25 | {Hepatitis B virus, susceptibility to}, 610424 (3); Inflammatory
DYRK1A, MNBH, MNB, MRD7 | Mental retardation, autosomal dominant 7, 614104 (3)
HLCS, HCS | Holocarboxylase synthetase deficiency, 253270 (3)
IFNAR2 | {Hepatitis B virus, susceptibility to}, 610424 (3)
KCNE2, MIRP1, LQT6, ATFB4 | Long QT syndrome-6, 613693 (3); Atrial fibrillation, familial, 4,
MRAP, FALP, C21orf61, GCCD2, FGD2 | Glucocorticoid deficiency 2, 607398 (3)
SOD1, ALS1 | Amyotrophic lateral sclerosis, due to SOD1 deficiency, 105400 (3)
IFNGR2, IFNGT1, IFGR2 | {Mycobacterial infection, atypical, familial disseminated},
KCNE1, JLNS, LQT5, JLNS2 | Jervell and Lange-Nielsen syndrome 2, 612347 (3); Long QT syndrome-5,
MAFD3, BPEO | {Major affective disorder 3, early onset} (2)
BMND6 | [Bone mineral density QTL 6] (2)
AIRE, APECED, APS1 | Autoimmune polyendocrinopathy syndrome , type I, with or without
CBS | Homocystinuria, B6-responsive and nonresponsive types, 236200 (3);
CLDN14, DFNB29 | Deafness, autosomal recessive 29, 614035 (3)
COL6A1, OPLL | Bethlem myopathy, 158810 (3); Ullrich congenital muscular dystrophy,
COL6A2 | Bethlem myopathy, 158810 (3); Ullrich congenital muscular dystrophy,
COL18A1, KNO1 | Knobloch syndrome, type 1, 267750 (3)
CRYAA, CRYA1 | Cataract, zonular central nuclear, autosomal dominant (3);
CSTB, STFB, EPM1, PME, EPM1A, ULD | Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg),
DCR, DSCR | Down syndrome (4)
FTCD | Glutamate formiminotransferase deficiency, 229100 (3)
HPE1 | Holoprosencephaly-1 (2)
ITGB2, CD18, LCAMB, LAD | Leukocyte adhesion deficiency, 116920 (3)
PCNT, PCNT2, KEN, SCKL4, MOPD2 | Microcephalic osteodysplastic primordial dwarfism, type II, 210720
PFKL | Hemolytic anemia due to phosphofructokinase deficiency (1)
RIPK4, NKRD3, DIK | Popliteal pterygium syndrome, lethal type, 263650 (3)
RUNX1, CBFA2, AML1 | Leukemia, acute myeloid, 601626 (3); Platelet disorder, familial,
TMPRSS3, ECHOS1, DFNB8, DFNB10 | Deafness, autosomal recessive 8, childhood onset, 601072 (3);
ACF | Cayler cardiofacial syndrome (2)
CECR, CES | Cat eye syndrome (4)
HCF2, HC2, SERPIND1, THPH10 | Thrombophilia due to heparin cofactor II deficiency, 612356 (3)
NAGA | Schindler disease, type I, 609241 (3); Kanzaki disease, 609242 (3);
RTN4R, NOGOR | {Schizophrenia, susceptibility to}, 181500 (3)
SCARF2, SREC2, VDEGS | Van den Ende-Gupta syndrome, 600920 (3)
SMARCB1, SNF5, INI1, RDT, RTPS1 | Rhabdoid tumors, somatic, 609322 (3); Rhabdoid predisposition
TUBA8, TUBAL2 | Polymicrogyria with optic nerve hypoplasia, 613180 (3)
FPEVF | Epilepsy, partial, with variable foci (2)
GGT1, GTG | Glutathioninuria (1)
GGT2 | [Gamma-glutamyltransferase, familial high serum] (2)
DEL22q11.2, C22DELq11.2 | Chromosome 22q11.2 deletion syndrome, distal (4)
DUP22q11.2 | Chromosome 22q11.2 microduplication syndrome (4)
DER22t8-22 | Supernumerary der(22)t(8-22) syndrome (4)
DER22t11-22 | Emanuel syndrome (4)
COMT | {Schizophrenia, susceptibility to}, 181500 (3); {Panic disorder,
GP1BB, BS, BDPLT1 | Bernard-Soulier syndrome, type B, 231200 (3);
MIF | {Rheumatoid arthritis, systemic juvenile, susceptibility to},
MYH9, MHA, FTNS, DFNA17, BDPLT6 | May-Hegglin anomaly, 155100 (3); Fechtner syndrome, 153640 (3);
OGS2, BBBG2, GBBB2 | Opitz G syndrome, type II (4)
PRODH, PRODH2, SCZD4 | Hyperprolinemia, type I, 239500 (3); {Schizophrenia, susceptibility
SNAP29, CEDNIK | Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar
TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR | Conotruncal anomaly face syndrome, 217095 (3); DiGeorge syndrome,
UPB1, BUP1 | Beta-ureidopropionase deficiency, 613161 (3)
CRYBB1, CATCN3 | Cataract, pulverulent (3); Cataract, congenital nuclear, autosomal
CRYBB2, CRYB2 | Cataract, cerulean, type 2, 601547 (3); Cataract, sutural, with
CRYBB3, CRYB3, CATCN2 | Cataract, congenital nuclear, 2, 609741 (3)
HPS4 | Hermansky-Pudlak syndrome 4, 614073 (3)
CRYBA4, MCOPCT4 | Cataract, lamellar 2, 610425 (3); Microphthalmia with cataract 4,
TCN2, TC2 | Transcobalamin II deficiency, 275350 (3)
BCR, CML, PHL, ALL | Leukemia, chronic myeloid, 608232 (3); Leukemia, acute lymphocytic,
IGLL1, IGO, IGL5, VPREB2, AGM2 | Agammaglobulinemia 2, 613500 (3)
PEX26 | Adrenoleukodystrophy, neonatal, 202370 (3); Refsum disease,
DFNB40 | Deafness, autosomal recessive 40 (2)
IL17RA, IL17R, CANDF5 | Candidiasis, familial, 5, autosomal recessive, 613953 (3)
SPECC1L, KIAA0376, OBLFC1 | Facial clefting, oblique, 1, 600251 (3)
BRV2 | Vertigo, benign recurrent, 2 (2)
EWSR1, EWS | Ewing sarcoma, 612219 (3); Neuroepithelioma, 612219 (3)
HMOX1 | Heme oxygenase-1 deficiency, 614034 (3); {Pulmonary disease,
KAZA | {Kala-azar, susceptibility to} (2)
MYP6 | Myopia-6 (2)
SQTL2 | {Smoking as a quantitative trait locus 2} (2)
XBP1, XBP2 | {Major affective disorder-7, susceptibility to}, 612371 (3)
CDAGS | CDAGS syndrome (2)
FBXO7, FBX7, FBX, PKPS, PARK15 | Parkinson disease 15, autosomal recessive, 260300 (3)
HCHGQ3 | [Hematocrit/hemoglobin quantitative trait locus 3] (2)
TMPRSS6, IRIDA | Iron-refractory iron deficiency anemia, 206200 (3)
PPARA, PPAR | {Hyperapobetalipoproteinemia, susceptibility to} (3)
CHEK2, RAD53, CHK2, CDS1, LFS2 | Li-Fraumeni syndrome, 609265 (3); Osteosarcoma, somatic, 259500 (3);
MIAT, C22orf35 | {Myocardial infarction, susceptibility to}, 608446 (3)
ITS | Insulinoma (1)
OPA5 | Optic atrophy 5 (2)
TIMP3, SFD | Sorsby fundus dystrophy, 136900 (3)
NEFH | {Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3)
NF2 | Neurofibromatosis, type 2, 101000 (3); Meningioma, NF2-related,
CSF2RB, SMDP5 | Surfactant metabolism dysfunction, pulmonary, 5, 614370 (3)
APOL1, FSGS4 | {Glomerulosclerosis, focal segmental, 4, susceptibility to},
APOL2 | {Schizophrenia}, 181500 (1)
APOL4 | {Schizophrenia}, 181500 (1)
HPC6 | {Prostate cancer, susceptibility to}, 176807 (2)
LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6 | Muscular dystrophy-dystroglycanopathy (congenital with brain and eye
MDNS | Mammary-digital-nail syndrome (2)
PDGFB, SIS | Meningioma, SIS-related (3); Dermatofibrosarcoma protuberans (3);
RAC2 | Neutrophil immunodeficiency syndrome, 608203 (3)
MN1, MGCR | Meningioma, 607174 (3)
ATXN10, SCA10 | Spinocerebellar ataxia 10, 603516 (3)
CHKB, CHKL, CKEKB, EKB, MDCMC | Muscular dystrophy, congenital, megaconial type, 602541 (3)
EP300, RSTS2 | Colorectal cancer, 114500 (3); Rubinstein-Taybi syndrome 2, 613684
MENAQ1 | {Menarche, age at, QTL} (2)
MKL1, AMKL, MAL | Megakaryoblastic leukemia, acute (3)
NAFLD1 | {Fatty liver disease, nonalcoholic, susceptibility to, 1} (2)
NRCLP4 | {Narcolepsy 4} (2)
SCO2 | Cardioencephalomyopathy, fatal infantile, due to cytochrome c
SOX10, WS4, WS4C, PCWH | Waardenburg syndrome, type 4C, 613266 (3); Waardenburg syndrome,
TRMU, MTO2, TRNT1 | {Deafness, mitochondrial, modifier of}, 580000 (3); Liver failure,
ADSL | Adenylosuccinase deficiency, 103050 (3)
CACNG2, MRD10 | Mental retardation, autosomal dominant 10, 614256 (3)
CYP2D6, CPD6, P450DB1 | {Debrisoquine sensitivity}, 608902 (3); {Codeine sensitivity}, 608902
LGALS2 | {Myocardial infarction, susceptibility to}, 608446 (3)
NCF4, P40PHOX | Granulomatous disease, chronic, autosomal recessive, cytochrome
PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14 | Infantile neuroaxonal dystrophy 1, 256600 (3); Neurodegeneration
SLC5A1, SGLT1 | Glucose/galactose malabsorption, 606824 (3)
TRIOBP, KIAA1662 | Deafness, autosomal recessive 28, 609823 (3)
TNFRSF13C, BAFFR, CVID4 | Immunodeficiency, common variable, 4, 613494 (3)
A4GALT, PK | [Blood group, P system], 111400 (3)
FBLN1 | Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal
SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15 | Chromosome 22q13.3 deletion syndrome, 606232 (3); {Schizophrenia 15},
UPK3A, UPK3, UPIII | Renal adysplasia, 191830 (3)
XPNPEP3, APP3, NPHPL1 | Nephronophthisis-like nephropathy 1, 613159 (3)
ARSA | Metachromatic leukodystrophy, 250100 (3)
CYB5R3, DIA1, B5R | Methemoglobinemia, type I, 250800 (3); Methemoglobinemia, type II,
TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1 | Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3)
ACR | ?Male infertility due to acrosin deficiency (2)
ALG12, CDG1G | Congenital disorder of glycosylation, type Ig, 607143 (3)
MLC1, LVM, VL | Megalencephalic leukoencephalopathy with subcortical cysts, 604004
SHOX, GCFX, SS, PHOG | Short stature, idiopathic familial, 300582 (3); Leri-Weill
HDPA | {Hodgkin disease susceptibility, pseudoautosomal} (2)
XG | [Blood group, XG system] (3)
NLGN4, KIAA1260, AUTSX2, ASPGX2 | {Autism susceptibility, X-linked 2}, 300495 (3); {Asperger
VSPA | Turner syndrome-associated neurocognitive phenotype (2);
CSF2RA, SMDP4 | Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3)
STS, ARSC1, ARSC, SSDD, XLI | Ichthyosis, X-linked, 308100 (3)
FAAP95, FAAP90, FLJ34064, FANCB | Fanconi anemia, complementation group B, 300514 (3)
ARSE, CDPX1, CDPXR | Chondrodysplasia punctata, X-linked recessive, 302950 (3)
EMWX | Episodic muscle weakness, X-linked (2)
GPR143, OA1, NYS6 | Ocular albinism, type I, Nettleship-Falls type, 300500 (3);
KAL1, KMS, ADMLX | Kallmann syndrome, 308700 (3)
LECD | Corneal dystrophy, Lisch epithelial (2)
MRX2 | Mental retardation, X-linked 2 (2)
MRX49 | Mental retardation, X-linked 49 (2)
OASD | Ocular albinism with sensorineural deafness (2)
OFD1, CXorf5, SGBS2, JBTS10 | Oral-facial-digital syndrome 1, 311200 (3); Simpson-Golabi-Behmel
AMELX, AMG, AIH1, AMGX, AI1E | Amelogenesis imperfecta, hypoplastic/hypomaturation type 1E, 301200
MRX29 | Mental retardation, X-linked 29 (2)
POLA | ?N syndrome, 310465 (1)
CMTX2 | Charcot-Marie-Tooth neuropathy, X-linked recessive, 2 (2)
HBFQTL3, FCP1, FCPX, FCP | Fetal hemoglobin quantitative trait locus 3 (2)
PDHA1, PHE1A | Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3); Leigh
PHEX, HYP, HPDR1, LXHR | Hypophosphatemic rickets, X-linked dominant, 307800 (3)
PHKA2, PHK, XLG, PHK, PYKL, GSD9A | Glycogen storage disease, type IXa1, 306000 (3); Glycogen storage
RPS6KA3, RSK2, MRX19 | Coffin-Lowry syndrome, 303600 (3); Mental retardation, X-linked
RS1, XLRS1 | Retinoschisis, 312700 (3)
TRAPPC2, SEDL, SEDT | Spondyloepiphyseal dysplasia tarda, 313400 (3)
ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32 | Epileptic encephalopathy, early infantile, 1, 308350 (3);
NHS, CXN | Nance-Horan syndrome, 302350 (3); Cataract, congenital, X-linked,
MEHMO | MEHMO syndrome (2)
MBTPS2, S2P, IFAP, KFSDX | IFAP syndrome with or without BRESHECK syndrome, 308205
DELXp22.11, CXDELp22.11, AUTSX4 | {Autism susceptibility, X-linked 4} (4)
GDXY, TDFX, SRVX | Gonadal dysgenesis, XY female type (2)
PIGA | Paroxysmal nocturnal hemoglobinuria, somatic, 300818 (3)
SAT1, SSAT, KFSD, KFSDX | Keratosis follicularis spinulosa decalvans, 308800 (3)
SMPX, DFNX4 | Deafness, X-linked 4, 300066 (3)
SMS, SRS, MRSR | Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)
IL1RAPL1, IL1R8, MRX21, MRX34 | Mental retardation, X-linked 21/34, 300143 (3)
ZNF81, MRX45 | Mental retardation, X-linked 45, 300498 (3)
ZNF41, MRX89 | Mental retardation, X-linked 89, 300848 (3)
AGMX2, XLA2, IMD6 | Agammaglobulinemia, X-linked 2 (2)
AIC | Aicardi syndrome (2)
AP1S2, MRX59, MRXSF, MRXS21 | Mental retardation, X-linked syndromic, Fried type, 300630 (3)
CDKL5, STK9, ISSX, EIEE2 | Epileptic encephalopathy, early infantile, 2, 300672 (3);
HCCS, MCOPS7 | Microphthalmia, syndromic 7, 309801 (3)
MID1, OGS1, BBBG1, FXY, OSX | Opitz G syndrome, type I, 300000 (3)
MNG2 | Goiter, multinodular, 2 (2)
RP23 | Retinitis pigmentosa 23 (2)
SGBS2 | Simpson-Golabi-Behmel syndrome, type 2 (2)
PDR | Pigment disorder, reticulate (2)
MENOQ1 | {Menopause, natural, age at, QTL1} (2)
DAX1, AHC, AHX, NROB1, SRXY2 | Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism,
GK | Glycerol kinase deficiency, 307030 (3)
RP6 | ?Retinitis pigmentosa, X-linked recessive, 6 (2)
DFNX3, DFN4 | Deafness, X-linked 3 (2)
DMD, BMD, CMD3B | Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,
XK, MCLDS | McLeod syndrome with or without chronic granulomatous disease,
CYBB, CGD, AMCBX2 | Chronic granulomatous disease, X-linked, 306400 (3); Atypical
OTC | Ornithine transcarbamylase deficiency, 311250 (3)
MRXS17 | Mental retardation, X-linked, syndromic 17 (2)
WTS, MRXS6 | Mental retardation syndrome, X-linked 6, with gynecomastia and
DELXp21, CXDELp21 | Chromosome Xp21 deletion syndrome (4)
ATP6AP2, ATP6M8-9, XMRE, MRXE | Mental retardation, X-linked, with epilepsy, 300423 (3)
BCOR, KIAA1575, MCOPS2, MAA2, ANOP2 | Microphthalmia, syndromic 2, 300166 (3)
CASK, MICPCH, FGS4, CMG | Mental retardation and microcephaly with pontine and cerebellar
NYX, CSNB1A, NBM1 | Night blindness, congenital stationary, type 1A, 310500 (3)
NDP, ND | Norrie disease, 310600 (3); Exudative vitreoretinopathy, X-linked,
NYS5 | Nystagmus 5, congenital, X-linked (2)
RPGR, RP3, CRD, RP15, COD1, CORDX1 | Retinitis pigmentosa 3, 300029 (3); Cone-rod dystrophy-1, 304020 (3);
MRX78 | Mental retardation, X-linked 78 (2)
PFC, PFD | Properdin deficiency, X-linked, 312060 (3)
OPA2 | Optic atrophy 2, X-linked (2)
SYN1 | Epilepsy, X-linked, with variable learning disabilities and
DELXp11.3, CXDELp11.3 | Chromosome Xp11.3 deletion syndrome (4)
MRX50 | Mental retardation, X-linked 50 (2)
AGSPX | Angio serpiginosum (2)
MRX14 | Mental retardation, X-linked 14 (2)
MRXS7 | Mental retardation, X-linked syndromic 7 (2)
MRX84 | Mental retardation, X-linked 84 (2)
CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2 | Night blindness, congenital stationary, X-linked, type 2A, 300071
FTSJ1, JM23, SPB1, MRX44, MRX9 | Mental retardation, X-linked 9, 309549 (3)
GATA1, GF1, ERYF1, NFE1, XLTT | Dyserythropoietic anemia with thrombocytopenia, 300367 (3);
MAOA | Brunner syndrome, 300615 (3)
PORCN, PORC, DHOF, FODH | Focal dermal hypoplasia, 305600 (3)
PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8 | Renpenning syndrome, 309500 (3)
RBM10, DXS8237E, KIAA0122, TARPS | TARP syndrome, 311900 (3)
RP2 | Retinitis pigmentosa 2, 312600 (3)
UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1 | Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)
DUPXp11.23p11.22, CXDUPp11.23p11.22 | Chromosome Xp11.23-p11.22 duplication syndrome (4)
EBP, CDPX2, CPXD, CPX | Chondrodysplasia punctata, X-linked dominant, 302960 (3)
SYP, MRXSYP | Mental retardation, X-linked 96, 300802 (3)
WAS, IMD2, THC1, SCNX | Wiskott-Aldrich syndrome, 301000 (3);
UBQLN2, PLIC2, CHAP1, ALS15 | Amyotrophic lateral sclerosis 15, with or without frontotemporal
FOXP3, IPEX, AIID, XPID, PIDX | Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked,
CLCN5, CLCK2, NPHL2, DENTS, NPHL1 | Dent disease, 300009 (3); Nephrolithiasis, type I, 310468 (3);
HPCX2 | {Prostate cancer, hereditary, X-linked 2} (2)
HYSP4 | {Hypospadias 4, X-linked, susceptibilty to} (2)
IQSEC2, KIAA0522, MRX1 | Mental retardation, X-linked 1, 309530 (3)
TFE3, RCCX1 | Renal cell carcinoma, papillary, 1, 300854 (3)
DXS423E, SMC1, CDLS2 | Cornelia de Lange syndrome 2, 300590 (3)
KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ | Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534
ALAS2, ANH1, ASB, XLEPP, XLSA, ANH1 | Anemia, sideroblastic, X-linked, 300751 (3); Protoporphyria,
FGD1, FGDY, AAS, MRXS16 | Aarskog-Scott syndrome, 305400 (3); Mental retardation, X-linked
SCAX1, CLA2, OPCA | Spinocerebellar ataxia, X-linked 1 (2)
MRX52 | Mental retardation, X-linked 52 (2)
BMP15, GDF9B, ODG2, POF4 | Ovarian dysgenesis 2, 300510 (3); Premature ovarian failure 4,
HSD17B10, HADH2, ERAB, MRXS10, MRX17, MRX31, DUPXp11.22 | 17-beta-hydroxysteroid dehydrogenase X deficiency, 300438 (3);
HUWE1, UREB1, KIAA0312, LASU1 | Mental retardation, X-linked syndromic, Turner type, 300706 (3)
KDM6A, UTX, KABUK2 | Kabuki syndrome 2, 300867 (3)
PHF8, ZNF422, KIAA1111, MRXSSD | Mental retardation syndrome, X-linked, Siderius type, 300263 (3)
SHROOM4, KIAA1202, SDSX | Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)
SSX2 | Sarcoma, synovial (3)
SSX4 | Sarcoma, synovial (1)
MRX81 | Mental retardation, X-linked 81 (2)
GRDX, GD3 | {Graves disease, susceptibility to, X-linked} (2)
IDDMX | {Diabetes mellitus, insulin-dependent, X-linked} (2)
LOAS | {Leber optic atrophy, susceptibility to} (2)
MRXS12 | ?Mental retardation, X-linked, syndromic 12 (2)
ZNF674, MRX92 | Mental retardation, X-linked 92, 300851 (3)
MRX20 | Mental retardation, X-linked 20 (2)
PRS, MRXS2 | Prieto syndrome (2)
CGF1 | [Social cognition] (2)
MGR2 | {Migraine, familial typical, susceptibility to, 2} (2)
TSPAN7, TM4SF2, MXS1, A15, MRX58 | Mental retardation, X-linked 58, 300210 (3)
AGA2 | Alopecia, androgenetic, 2 (2)
AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1 | Androgen insensitivity, 300068 (3); Spinal and bulbar muscular
MPDMRS | Martin-Probst deafness-mental retardation syndrome (2)
FAM123B, WTX, FLJ39827, OSCS | Osteopathia striata with cranial sclerosis, 300373 (3)
SPG16 | Spastic paraplegia-16, X-linked, complicated (2)
EFNB1, EPLG2, CFNS, CFND | Craniofrontonasal dysplasia, 304110 (3)
OPHN1, MRX60 | Mental retardation, X-linked, with cerebellar hypoplasia and
ATP7A, MNK, MK, OHS, SMAX3 | Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);
ED1, EDA, HED, STHAGX1 | Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3); Tooth
TBX22, CPX | Cleft palate with ankyloglossia, 303400 (3)
FGS3 | FG syndrome 3 (2)
MRX77 | Mental retardation, X-linked 77 (2)
MRXS9 | Mental retardation, X-linked, syndromic 9 (2)
ATRX, XH2, XNP, SHS, SFM1, MRXHF1 | Alpha-thalassemia/mental retardation syndrome, 301040 (3);
BRWD3, MRX93 | Mental retardation, X-linked 93, 300659 (3)
IL2RG, SCIDX1, SCIDX, IMD4 | Severe combined immunodeficiency, X-linked, 300400 (3); Combined
MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1 | Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)
NLGN3, ASPGX1, AUTSX1 | {Autism susceptibility, X-linked 1}, 300425 (3);
PGK1, PGKA | Phosphoglycerate kinase 1 deficiency, 300653 (3)
PHKA1 | Muscle glycogenosis, 300559 (3)
TAF1, TAF2A, CCG1, BA2R, DYT3 | Dystonia-Parkinsonism, X-linked, 314250 (3)
WWS | Wieacker-Wolff syndrome (2)
MCS, MRXS4 | Miles-Carpenter syndrome (2)
DLG3, NEDLG, SAP102, MRX90 | Mental retardation, X-linked 90, 300850 (3)
GJB1, CX32, CMTX1 | Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3)
MAGT1, IAP, XMEN | Mental retardation, X-linked 95, 300716 (3); Immunodeficiency,
ABCB7, ABC7, ASAT | Anemia, sideroblastic, with ataxia, 301310 (3)
IGBP1 | Corpus callosum, agenesis of, with mental retardation, ocular
CFTDX | Myopathy, congenital, with fiber-type disproportion, X-linked (2)
KIAA2022 | ?Mental retardation, nonsyndromic, X-linked (2)
MRXSAB | Mental retardation, X-linked syndromic, Abidi type (2)
SLC16A2, DXS128, XPCT | Allan-Herndon-Dudley syndrome, 300523 (3)
XIC, XCE, XIST, SXI1 | X-inactivation, familial skewed, 300087 (3)
ZDHHC15, MRX91 | Mental retardation, X-linked 91, 300577 (3)
FLJ22792, POF1B, POF2B | Premature ovarian failure 2B, 300604 (3)
PARK12 | Parkinson disease 12 (2)
POU3F4, DFN3, DFNX2 | Deafness, X-linked 2, 304400 (3)
ZNF711, ZNF6, CMPX1, MRX97 | Mental retardation, X-linked 97, 300803 (3)
CHM, TCD | Choroideremia, 303100 (3)
AD16 | {Alzheimer disease 16} (2)
BTK, AGMX1, IMD1, XLA, AT | Agammaglobulinemia, X-linked 1, 300755 (3); Agammaglobulinemia
MGC1, MGCN | Megalocornea, X-linked (2)
MRXSCS | Mental retardation, X-linked, syndromic, Chudley-Schwartz type, (2)
SRPX2, SRPUL, RESDX | Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643
DIAPH2, DIA, POF2 | Premature ovarian failure, 300511 (3)
GLA | Fabry disease, 301500 (3); Fabry disease, cardiac variant, 301500 (3)
PCDH19, KIAA1313, EFMR, EIEE9 | Epileptic encephalopathy, early infantile, 9, 300088 (3)
PLP1, PMD, HLD1 | Pelizaeus-Merzbacher disease, 312080 (3); Spastic paraplegia-2,
TIMM8A, DFN1, DDP, MTS, DDP1 | Deafness, X-linked 1, progressive (3); Mohr-Tranebjaerg syndrome,
AGTR2, MRX88 | Mental retardation, X-linked 88, 300852 (3)
PRPS1, CMTX5, DFNX1, DFN2 | Gout, PRPS-related, 300661 (3); Phosphoribosylpyrophosphate
AIH3 | ?Amelogenesis imperfecta-3, hypoplastic type (2)
ARHGEF9, PEM2, KIAA0424, EIEE8 | Epileptic encephalopathy, early infantile, 8, 300607 (3)
RAB40AL, RLGP | Mental retardation, profound (2)
TBG | Thyroxine-binding globulin deficiency (3)
MRX53 | Mental retardation, X-linked 53 (2)
ACSL4, FACL4, ACS4, MRX63 | Mental retardation, X-linked 63, 300387 (3)
AMMEC, DELXq22.3, CXDELq22.3 | Alport syndrome, mental retardation, midface hypoplasia, and
COL4A5, ATS, ASLN | Alport syndrome, 301050 (3)
COL4A6, DELXq22.3, CXDELq22.3 | Leiomyomatosis, diffuse, with Alport syndrome, 308940 (4)
FGS5 | FG syndrome 5 (2)
DCX, DBCN, LISX | Lissencephaly, X-linked, 300067 (3); Subcortical laminal
C1GALT1C1, COSMC, C1GALT2 | Tn syndrome, 300622 (3)
CUL4B, MRXSC, MRXHF2, SFM2, MRXS15 | Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3)
IHPS4 | Pyloric stenosis, infantile hypertrophic, 4 (2)
PAK3, MRX30, MRX47 | Mental retardation, X-linked 30/47, 300558 (3)
MRX23 | Mental retardation, X-linked 23 (2)
SLC6A14, OBX, BMIQ11 | {Obesity, susceptibility to, BMIQ11}, 300306 (3)
CHDS3 | {Coronary heart disease, susceptibility to, 3} (2)
MYP13 | Myopia 13 (2)
DFNX5, AUNX1 | Deafness, X-linked 5 (2)
LAMP2, LAMPB, LGP110 | Danon disease, 300257 (3)
MRSS | Mental retardation, X-linked, with short stature (2)
NDUFA1, MWFE | Mitochondrial complex I deficiency, 252010 (3)
MRX82 | Mental retardation, X-linked 82 (2)
RRDX | Radial ray deficiency (2)
SPG34 | Spastic paraplegia 34, X-linked (2)
STQTL6 | {Stature QTL 6} (2)
UBE2A, RAD6A, MRXSN, MRXS30 | Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3)
ADFN, ALDS | Albinism-deafness syndrome (2)
NAMSD, NADMR | Cowchock syndrome (2)
BZX | Bazex syndrome (2)
PTOS2, PTOSX | Ptosis, hereditary congenital 2 (2)
CND | Dermoids of cornea (2)
SH2D1A, LYP, IMD5, XLP, XLPD | Lymphoproliferative syndrome, X-linked, 308240 (3)
XECD | Corneal dystrophy, endothelial, X-linked (2)
XIAP, BIRC4, API3, XLP2 | Lymphoproliferative syndrome, X-linked, 2, 300635 (3)
XPNPEP2 | {Angioedema induced by ACE inhibitors, susceptibility to} (3)
AIFM1, PDCD8, AIF, COXPD6 | Combined oxidative phosphorylation deficiency 6, 300816 (3)
GRIA3, GLUR3, MRX94 | Mental retardation, X-linked 94, 300699 (3)
SXI2 | X inactivation, familial skewed, 2 (2)
UPF3B, RENT3B, MRXS14 | Mental retardation, X-linked, syndromic 14, 300676 (3)
THAS, TAS | Thoracoabdominal syndrome (2)
PGS, MRXS5 | Pettigrew syndrome (2)
LKMCD | Leukoencephalopathy with metaphyseal chondrodysplasia (2)
SCAX5 | Spinocerebellar ataxia, X-linked 5 (2)
ARHGEF6, MRX46, COOL2 | Mental retardation, X-linked 46, 300436 (3)
CMTX3 | Charcot-Marie-Tooth neuropathy, X-linked recessive, 3 (2)
GPC3, SDYS, SGBS1 | Simpson-Golabi-Behmel syndrome, type 1, 312870 (3); Wilms tumor,
GUST | Gustavson syndrome (2)
MRX42 | Mental retardation, X-linked 42 (2)
SHFM2, SHFD2 | Split hand/foot malformation 2 (2)
TNFSF5, CD40LG, HIGM1, IGM | Immunodeficiency, X-linked, with hyper-IgM, 308230 (3)
CFSS | ?Craniofacioskeletal syndrome (2)
HPT, HPTX, HYPX | Hypoparathyroidism, X-linked (2)
MRXS11, SMRXS | Mental retardation, X-linked syndromic, Shashi type (2)
RP24 | Retinitis pigmentosa 24 (2)
HPRT1, HPRT | Lesch-Nyhan syndrome, 300322 (3); HPRT-related gout, 300323 (3)
INDX | Wood neuroimmunologic syndrome (2)
OCRL, LOCR, OCRL1, NPHL2 | Lowe syndrome, 309000 (3); Dent disease 2, 300555 (3)
ZDHHC9, DHHC9, MRXSZ | Mental retardation, X-linked syndromic, Raymond type, 300799 (3)
FRMD7, NYS1, XIPAN | Nystagmus 1, congenital, X-linked, 310700 (3); Nystagmus, infantile
ZIC3, HTX1, HTX | Heterotaxy, visceral, 1, X-linked 306955 (3); Congenital heart
PHF6, BFLS | Borjeson-Forssman-Lehmann syndrome, 301900 (3)
SLC9A6, NHE6 | Mental retardation, X-linked syndromic, Christianson type, 300243 (3)
SOX3, MRGH | Mental retardation, X-linked, with isolated growth hormone
SRXX3 | 46XX sex reversal 3 (4)
BMND4 | [Bone mineral density QTL 4] (2)
COD2 | Cone dystrophy, progressive X-linked, 2 (2)
TGCT1 | Testicular germ cell tumor (2)
MCOPS4, ANOP1 | ?Microphthalmia, syndromic 4 (2)
HPCX1 | {Prostate cancer, hereditary, X-linked 1} (2)
MCOPS1, MAA, LZMS | Microphthalmia, syndromic 1 (2)
HTC2, HCG, CGH, CXINSq27.1, | Hypertrichosis, congenital generalized (4)
F9, HEMB, THPH8 | Hemophilia B, 306900 (3); {Warfarin sensitivity}, 122700 (3);
FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B | Scapuloperoneal myopathy, X-linked dominant, 300695 (3); Myopathy,
BPP, PMGX, CBPS | Polymicrogyria, bilateral perisylvian (2)
DYX9 | {Dyslexia, susceptibility to, 9} (2)
FMR1, FRAXA, POF1 | Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome,
ABCD1, ALD, AMN | Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)
AFF2, FMR2, FRAXE, MRX2 | Mental retardation, X-linked, FRAXE type, 309548 (3)
BED | Bornholm eye disease (2)
AVPR2, DIR, DI1, ADHR | Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndrome
DELXq28, MICRODELXq28 | Chromosome Xq28 microdeletion syndrome (4)
DUPXq28, CXq28 | Chromosome Xq28 duplication syndrome (4)
DKC1, DKCX | Dyskeratosis congenita, X-linked, 305000 (3);
EMD, EDMD, STA | Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3)
F8, F8C, HEMA | Hemophilia A, 306700 (3)
FAM58A, STAR | STAR syndrome, 300707 (3)
FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1 | Heterotopia, periventricular, 300049 (3); Otopalatodigital syndrome,
G6PD, G6PD1 | G6PD deficiency (3); Favism (3); Hemolytic anemia due
GDI1, RABGD1A, MRX41, MRX48 | Mental retardation, X-linked 41, 300849 (3)
HMS1, GAY1 | [?Homosexuality, male] (2)
IDS, MPS2, SIDS | Mucopolysaccharidosis II, 309900 (3)
IKBKG, NEMO, FIP3, IP2, IPD2, AMCBX1 | Incontinentia pigmenti, type II, 308300 (3); Ectodermal dysplasia,
IPOX, CIIPX | Intestinal pseudoobstruction, neuronal, X-linked (2)
L1CAM, CAML1, HSAS1 | Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,
MAFD2, MDX | {?Major affective disorder 2} (2)
MAMLD1, CXorf6, F18, HYSP2 | Hypospadias 2, X-linked, 300758 (3)
MEAX, XMEA | Myopathy, X-linked, with excessive autophagy (2)
MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13, MRX79, MRX16 | Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic
MRSD, CHRS | Mental retardation-skeletal dysplasia (2)
MRX3 | Mental retardation, X-linked 3 (2)
MRXSA | Mental retardation syndrome, X-linked, Armfield type (2)
MTM1, MTMX | Myotubular myopathy, X-linked, 310400 (3)
MYMY4, CXDELq38 | Moyamoya disease 4 (4)
MYP1 | Myopia-1 (2)
NAA10, ARD1A, ARD1, TE2, NATD | N-terminal acetyltransferase deficiency, 300855 (3)
NSDHL | CHILD syndrome, 308050 (3); CK syndrome, 300831 (3)
OPN1LW, RCP, CBP, CBBM | Colorblindness, protan, 303900 (3); Blue cone monochromacy, 303700
OPN1MW, GCP, CBD, CBBM | Colorblindness, deutan, 303800 (3); Blue cone monochromacy, 303700
RAB39B, MRX72 | Mental retardation, X-linked 72, 300271 (3)
RP34 | Retinitis pigmentosa 34 (2)
RPL10, DXS648, QM, AUTSX5 | {Autism, susceptibility to, X-linked 5}, 300847 (3)
SLC6A8, CRTR | Creatine deficiency syndrome, X-linked, 300352 (3)
SLEB15 | {Systemic lupus erthematosus, susceptibility to, 15} (2)
TAZ, EFE2, BTHS, CMD3A, LVNCX | Barth syndrome, 302060 (3);
TKCR, TKC | Goeminne TKCR syndrome (2)
WSN, BGMR | Waisman parkinsonism-mental retardation syndrome (2)
CATMANS | Catel-Manzke syndrome (2)
CPBHM | Chondrodysplasia with platyspondyly, distinctive brachydactyly,
CCCSX | Cerebral-cerebellar-coloboma syndrome, X-linked (2)
CVMRF | Cubitus valgus with mental retardation and unusual facies (2)
DFCTRPS | Deafness, cataract, retinitis pigmentosa, and sperm abnormalities (2)
FTX | Thrombocytosis, familial X-linked (2)
IMAGE | IMAGE syndrome (2)
MCOPCB1 | Microphthalmia with coloboma 1 (2)
RFMN | Roifman syndrome (2)
SPGFX2 | Spermatogenic failure, X-linked, 2 (2)
SHOXY | Short stature, idiopathic familial, 300582 (3); Leri-Weill
SRY, TDF, TDY, SRXX1, SRXY1 | 46XY sex reversal 1, 400044 (3); 46XX sex reversal 1, 400045 (3)
HEY | ?Hairy ears, Y-linked (2)
DAZ | ?Sertoli-cell-only syndrome (1)
DELYq11, CYDELq11, SPGFY1 | Spermatogenic failure, Y-linked, 1 (4)
USP9Y, DFFRY, SPGFY2 | Spermatogenic failure, Y-linked, 2, 415000 (3)
DFNY1 | Deafness, Y-linked 1 (1)
RPY | Retinitis pigmentosa, Y-linked (2)
